Insights into the structure and aggregation of lens crystallins and other aggregation-prone proteins by Grosas, Aidan
Insights into the structure and aggregation 
of lens crystallins and other aggregation‐
prone proteins 
 
 
 
 
Aidan Bradley Grosas 
December 2019 
 
A thesis submitted for the degree of Doctor of Philosophy of  
The Australian National University 
 
© Copyright by Aidan Bradley Grosas 
All Rights Reserved  
Memories made provide delight and growth, 
Memories lost cause despondence and decay, 
As twilight begets the shining dawn, 
We strive to pass on the lessons learnt, 
From those seen in pictures, present yet vacant, 
To those just beginning to recognise faces, 
One burgeoning, one slowly evanescing, 
Ships passing in the night, 
Both loved in their own right. 
 
For Oma and Avery
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ABSTRACT 
Cataract is the world’s leading cause of blindness. The destabilisation, partial unfolding, and 
aggregation of lens crystallin proteins cause the loss of lens transparency (opacification) and cataract 
formation. Numerous congenital mutations and age-related changes to the long-lived α-, β- and γ-
crystallins are associated with cataract and their study has provided insight into the molecular basis of 
this disease. In this thesis, α- and γ-crystallin isoforms have been characterised under crowded and 
oxidative conditions, respectively. In addition, the conformational heterogeneity of model proteins was 
studied by capillary electrophoresis as a prelude to such studies on the more complex crystallins.  
Chapter 2 details the structural characterisation of the disulfide-linked γS-crystallin dimer, an 
oxidative product in the aging lens. X-ray crystallography revealed an intermolecular disulfide bond 
from C24-C24’ and two intramolecular disulfides, one in each subunit, between C22 and C26. Small 
angle X-ray scattering confirmed the extended in-solution biological assembly in lieu of a compact 
state. It was demonstrated that the disulfide-linked dimer was stable at glutathione concentrations akin 
to those in aged and cataractous lenses. The dimer had a higher aggregation propensity compared to the 
monomeric form owing to uncooperative domain unfolding. These findings provide novel insight into 
the contributions of oxidative modification to the formation of age-related cataract. Finally, similarities 
noted upon comparison with cataract-associated mutants suggest both congenital and age-related forms 
may have similar developmental pathways. 
Chapter 3 describes the impacts that a highly crowded environment comparable to the eye lens 
has on the structure and function of the molecular chaperone αB-crystallin. Macromolecular crowding 
using Ficoll 400 induces significant destabilisation, unfolding, an increase in size/oligomeric state, and 
a loss of chaperone function leading to kinetically distinct amorphous and fibrillar aggregation. These 
results are recapitulated in-principle using the biologically relevant crowding agent bovine γ-crystallin. 
Aggregation of αB-crystallin is prevented by its lens partner protein αA-crystallin at physiologically 
relevant ratios through an increase in the αA/αB-crystallin complex stability. These results complement 
multiple dilute in vitro and in vivo studies, providing a mechanistic basis for their findings and also 
support therapeutic approaches that prevent and reverse cataract via α-crystallin stabilisation. 
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Chapter 4 investigates capillary electrophoresis as a method for studying the conformational 
heterogeneity of a protein. Bovine serum albumin (BSA), yeast alcohol dehydrogenase (YADH), and 
bovine α-lactalbumin (BLA) were used to assess the application of this method towards various 
conformational aspects in comparison to size-exclusion chromatography coupled to multiple angle light 
scattering. The method distinguished between BSA oligomers and two different monomer populations, 
multiple YADH monomer and tetramer conformations, and apo- and holo-BLA. The ‘dispersity of 
electrophoretic mobilities’ allowed a relative comparison of the levels of conformational heterogeneity 
between unrelated proteins. Novel structural findings were made despite the extensive previous 
characterisation of these model proteins. This study allows for better interpretation of the heterogeneity 
of more complex proteins such as post-translationally modified crystallins from in vivo sources and 
oligomeric α-crystallin. 
Overall, this thesis provides new insights into the impacts of post-translational and 
environmental changes to α- and γ-crystallin and provides a molecular basis for their aggregation and 
contribution to cataract. There is strong analogy to α- and γ-crystallin congenital mutants that exhibit 
similar physical and chemical changes noted in this thesis, an observation that is potentially of great 
benefit toward the elucidation of common structural deficiencies leading to crystallin aggregation. 
Lastly, capillary electrophoresis allows for a new view of protein conformational heterogeneity that 
may provide novel future insights into crystallin structure and function. 
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CHAPTER 1:  
INTRODUCTION 
 
 
 
 
 
 
 
“The secret of getting ahead is getting started.” 
– Mark Twain 
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Protein Folding, Misfolding, Aggregation and Molecular Chaperones 
Protein sequence and structure are inextricably linked to molecular function and a protein’s physical 
properties. Over 50 years of theoretical and experimental study has produced multiple theories to be 
ratified and problems to be overcome in the quest to understand how a protein folds (1, 2). Seminal 
work by Anfinsen and colleagues yielded a view that protein folding occurred because the native state 
is a protein’s most thermodynamically stable conformation and that all the information needed for a 
protein to fold was inherent to its primary sequence (3, 4). Soon thereafter, Levinthal and colleagues 
highlighted an issue regarding the kinetics of protein folding. They indicated that due to the high degree 
of freedom that an unfolded polypeptide chain can exhibit, the number of possible conformations to be 
sampled means it would be impossible for a protein to fold on a biologically relevant timescale via 
random sampling (5, 6). This led to the postulation that proteins must fold via a specific and sequential 
folding pathway or a few pathways in order to restrict the kinetic sampling issue, thereby satisfying 
Levinthal’s so called ‘paradox’ (7, 8). This process can be represented in a two-dimensional schematic 
whereby protein folding occurs on the on-folding pathway, usually via a high energy intermediate or 
intermediates, which ultimately leads to a low energy native protein (Figure 1. A, left).  
However, advances in theory, simulation and experimental methodology have invariably built 
upon these formative ideas to suggest that macroscopic states, such as the native or unfolded state, 
should be viewed as a distribution or ensemble of many conformations rather than a single state (1, 9, 
10). This ‘new view’ of protein folding has a strong basis in statistical mechanics and can be represented 
as a ‘folding funnel’ or ‘free-energy landscape’ (Figure 1. B, left) (11-13). This model does not ascribe 
to the idea of a finite folding pathway. Rather, it suggests that events leading to protein folding such as 
hydrophobic collapse, hydrogen bond and salt-bridge formation can occur in parallel for different 
protein molecules and in an order that is governed by the initial stochastic arrangement of the unfolded 
state (11, 14, 15). That is, some unfolded states might favour hydrophobic collapse first, then the 
formation of salt-bridges, or vice versa, depending on what is more favourable for the unfolded chain’s 
conformation at the time folding is initiated. Ultimately, these enthalpy-based interactions trend toward 
the most favourable energy state as they continue down the folding funnel, fulfilling Anfinsen’s  
3
 
 
 
Figure 1. Protein folding, unfolding and aggregation. A. schematic of the protein on-folding pathway (left) and 
the off-folding pathway (right) showing the formation native protein and amorphous aggregates or amyloid fibrils 
from one or more folding intermediates. The off-folding pathway can also be reached via a misfolded state. The 
junctures where chaperone interaction assists protein folding or disaggregation is indicated. B. a depiction of the 
free-energy landscape that proteins explore upon folding and unfolding, via intramolecular contacts (left), and 
aggregation, via intermolecular contacts (right). The high free-energy peaks at which chaperones assist in 
refolding or discourage aggregation are indicated. Modified from Hartl et al., 2011 (16). 
 
criterion. Because of these newly formed interactions, the conformational entropy is diminished thereby 
limiting the polypeptide chain’s available conformational search options and speeding up folding, 
thereby explaining Levinthal’s paradox (9, 15, 17). As the protein navigates this free energy landscape, 
there are peaks and troughs leading to kinetic traps which are ultimately overcome by a gain of 
conformational entropy, i.e. partial unfolding, before refolding continues toward the global energy 
minimum, i.e. the native state (15, 18, 19). 
 The ruggedness of this landscape, i.e. the number of troughs between an unfolded protein and 
its native state, can dictate how many intermediates are formed on the folding journey and their 
longevity due to kinetically trapping (19-21). Partially folded state(s), formed as a folding intermediate 
or via aberrations in a protein’s sequence, can provide access to additional conformational states which 
largely involves intermolecular contacts (16, 22, 23) (Figure 1. A and B, right). Amorphous aggregates 
and amyloid fibrils are protein conformations that are usually inherently more stable than the native 
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state, hence nature’s desire to form them. Their formation, properties and structures can produce 
deleterious consequences for the cell and they are often associated with disease (see below). The 
formation of amyloid fibrillar aggregates is often preceded by high-energy soluble oligomers that can 
be considered as kinetically trapped intermediates between misfolded protein and amyloid fibrils (16, 
22) and has been implicated as a species of high cytotoxicity (24, 25) (Figure 1. B, right).  
While the protein folding energy landscape aims to funnel a protein from its unfolded to its 
native state, some kinetic traps may be difficult to overcome and thus assistance is provided by 
molecular chaperones (15, 16). This class of proteins interacts with, stabilizes or helps another protein 
to reach its native conformation but is not incorporated into the final conformation (16). Molecular 
chaperones involved in protein folding are generally ATP-dependent, such as heat-shock protein 70 
(Hsp70) (26, 27) while those involved in preventing protein unfolding and aggregation are generally 
ATP-independent, such as the small heat-shock proteins (sHsps) like αB-crystallin (28, 29). Within the 
energy landscape, these molecular chaperones buffer the intramolecular contacts of kinetically trapped 
non-native conformations, be that folding intermediates or partially folded states, and assist with the 
necessary structural rearrangements needed to overcome the energy hurdle and continue folding to the 
native state (18, 30). Similarly, their role in preventing the formation of intermolecular contacts 
associated with the formation of aggregate states means moving a partially folded protein state from the 
off-pathway back to the on-pathway or, indeed, discouraging the transition to the off-folding pathway 
altogether (16, 22). The general mechanism of action for some ATP-dependent molecular chaperones, 
such as Hsp70, has been largely elucidated (31, 32). The ATP-independent sHsps are considered to 
interact with an abundance of surface-exposed hydrophobic residues that are yet to fully collapse in the 
partially folded or misfolded state however, the specifics of the interaction are yet to be fully elucidated 
(33, 34). In order to understand both the toxicity of protein aggregates and how molecular chaperones 
can interact with them, knowledge of protein aggregate formation, structures and cytotoxicity is 
prudent.  
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The Structure and Properties of Amyloid Fibrils and Amorphous Aggregates 
The structure and properties of amyloid fibrils have been studied for decades however, it is only very 
recently, with the advent and improvement of solid-state NMR (35) and cryo-electron microscopic (36) 
techniques, that their structures have been elucidated at atomic level resolution (37). For instance, the 
structure of amyloid fibrils formed from amyloid-β (Aβ) 1-42 peptide, which is intimately associated 
with the extracellular plaque deposits in Alzheimer’s disease, have been solved at atomic level 
resolution (38, 39) (Figure 2). An amyloid fibril’s defining structural feature, as present in all amyloid 
fibrils no matter the precursor’s primary sequence, is the cross-β-strand fold stacked perpendicular to 
the fibril axis with a distance of 4.7-4.8 Å between each strand (40, 41) (Figure 2. A). The Aβ(1-42) 
amyloid fibril consists of two twisted protofilaments (38, 39) (Figure 2. B). However, this is not the 
case for all amyloid fibrils such as those formed from α-synuclein (the putative causative agent in 
Parkinson’s disease) which presents as a single protofilament (42). Steric zippers, which are regions of 
hydrophobic side chains tightly packed and devoid of bonded or intercalated water molecules, are 
thought to be unique to amyloid fibrils (43, 44). Steric zippers stabilize both intra- and inter-
protofilament structure and the latter is also strengthened by salt bridges (Figure 2. A), although these 
features can differ between fibrils. Polymorphism in amyloid fibrils is becoming more evident with 
every structure solved and is even present when forming fibrils from the same protein (37, 45). The 
Aβ(1-42) amyloid fibril has been solved in two different conformations, the LS- (39) and S-shaped (38) 
(Figure 2. C, left and right, respectively), due to varied polypeptide chain packing likely induced by 
different solution conditions of formation. Potentially, the polymorphism among fibril structures for the 
same peptide or protein may manifest itself in different symptoms in the clinical context (37, 46). 
Due to their architecture, amyloid fibrils resemble rod shaped structures which have the 
capacity to scatter visible light, albeit to a lesser extent than spherical aggregates (47, 48). The repeating 
cross-β sheet motif accommodates amyloid sensitive dyes that become highly fluorescent or exhibit 
birefringence in their presence (49, 50). Amyloid fibrils exhibit strength comparable to that of steel, a 
mechanical stiffness comparable to silk and varying levels of flexibility (51, 52), making the non-
pathogenic forms attractive for the development of new lightweight materials. 
6
 
 
 
Figure 2. The structure of the amyloid-β (Aβ) amyloid fibril. A. The prominent structural features of an 
amyloid fibril including the β-sheet stacking/spacing, inter-protofilament salt bridges and intra- and inter-
protofilament steric zippers of the Aβ(1-42) fibril (PDB: 50QV) as determined by cryo-electron microscopy (39). 
B. A cross-sectional (left) and side-on (right) view of the 3D reconstruction of the Aβ(1-42) fibril with the two 
protofilaments coloured brown and blue. C. Space-filling representations of two different Aβ(1-42) fibril models 
showing the inter-protofilament packing arrangement described as a ‘LS-shaped’ (left) (39) and a ‘S-shaped’ 
(right) (38) fibril. Modified from Gremer et al., 2017 (39) and Iadanza et al., 2018 (37). 
 
By contrast, an amorphous protein aggregate consists of largely disordered clumps of unfolded 
or partially unfolded protein with no long-range order (53, 54). There are no atomic level resolution 
structures of amorphous protein aggregates due to their disordered nature and as such, compared to 
amyloid fibrils, as there is limited structural insight available (55, 56). However, these aggregates can 
be visualised as granular-like structures by techniques such as transmission electron microscopy (TEM) 
and atomic force microscopy (AFM) (56, 57) (Figure 3). Under the right conditions, most proteins can 
form amorphous aggregates including those that are prone to form amyloid fibrils, such as β2-
microglobulin which is responsible for dialysis-related amyloidosis (56, 58) (Figure 3). Despite the lack 
of atomic level resolution structures of amorphous aggregates, some insights at the atomic level have 
come from solid-state NMR. Eye lens γ-crystallin protein aggregates that appear amorphous-like via 
TEM have local order from solid-state NMR studies, suggesting that at least some amorphous 
aggregates may contain more order than originally thought (59-61). Generally, visible light is scattered 
far more effectively by amorphous aggregates relative to amyloid fibrils due to their spherical-like 
nature and larger cross-sectional area (47, 48). 
7
 
 
 
Figure 3. The formation, structure and visualisation of β2-microglobulin amorphous aggregates. The native 
structure of β2-microglobulin (PDB: 1LDS) from X-ray crystallography (62). Upon aggregation, this protein 
usually forms fibrils. However, under different conditions, e.g. high salt and low pH, it can undergo amorphous 
aggregation made up of multiple misfolded β2-microglobulin subunits and devoid of long-range order. The 
resultant aggregate can be visualised via TEM or AFM. It exhibits large clumps of protein without any definitive 
structure. Modified from Yoshimura et al., 2012 (56). 
 
Diseases Associated with Protein Aggregation 
Investigation into the pathological nature of protein aggregates has been of particular interest for many 
years, particularly since the observation of plaques in the brain of dementia patients was made by Alois 
Alzheimer (37, 63). Currently, there are approximately 50 proteins or peptides associated with human 
disease that undergo aggregation (37), with approximately 6.5 % of deaths in Australia in 2017 being 
attributed to protein aggregation diseases (Table 1). However, in the majority of cases, the exact role 
these aggregates play in the etiology of the associated disease is not clear (64, 65). Some modes of 
cytotoxicity ascribed to protein aggregation diseases are the disruption of cellular and/or organelle 
membranes (66, 67), circumvention and inhibition of cellular degradation mechanisms including 
ubiquitination and autophagy processes (68-71), impairment of mitochondrial function (72, 73), 
sequestration of molecules essential to cellular function (74, 75), the production of reactive oxygen 
species (76, 77), and the interference of cellular transport mechanisms (78, 79). While the identification 
of these cytotoxic mechanisms associated with protein aggregation have provided great insight into the 
diseases’ causes, it is still unclear what stage or stages of aggregate represents the most cytotoxic 
species. The challenge now lies in identifying the most cytotoxic aggregate species and elucidating the 
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Table 1: Selected protein aggregation diseases, their precursor and related percentage mortality in Australia 
(2017). Adapted from various sources (37, 80, 81). 
Disease Protein or peptide that exhibits 
aggregation 
% of related deaths 
in Australia (2017)a 
Alzheimer disease Amyloid-β peptide 2.66b 
Type II diabetes Islet amyloid polypeptide (amylin) 1.49c 
Parkinson disease α-Synuclein 1.14d 
Amyotrophic lateral sclerosis Superoxide dismutase 0.41e 
Spinal and bulbar muscular 
atrophy 
Androgen receptor with polyQ expansion  
0.37f 
Dementia with Lewy bodies α-Synuclein 
AL amyloidosis Immunoglobulin light chains or fragments  
 
 
 
 
 
 
 
0.11g 
AH amyloidosis Immunoglobulin heavy chains or 
fragments  
AA amyloidosis Fragments of serum amyloid A protein 
Senile systemic amyloidosis Wild-type transthyretin 
Familial amyloidotic 
polyneuropathy 
Mutants of transthyretin 
Haemodialysis-related 
amyloidosis 
β2-microglobulin 
ApoAI amyloidosis N-terminal fragments of ApoAI 
ApoAII amyloidosis N-terminal fragments of ApoAII 
ApoAIV amyloidosis N-terminal fragments of ApoAIV 
ApoCII amyloidosis ApoCII 
ApoCIII amyloidosis ApoCIII 
Lysozyme amyloidosis Mutants of lysozyme 
Fibrinogen amyloidosis Variants of fibrinogen α-chain 
Huntington Huntingtin with polyQ expansion 0.07h 
Spongiform encephalopathies Prion protein or fragments thereof 0.04i 
Frontotemporal dementia with 
Parkinsonism 
Tau 0.01j 
Spinocerebellar ataxias Ataxins with polyQ expansion 0.01k 
Cataract Crystallins 0l 
aAs per the Australian Bureau of Statistics (ABS) ‘Causes of Death, Australia, 2017’ (82). 
ABS cause of death and ICD-10 code for: 
bAlzheimer disease (G30). 
cnon-insulin-dependent diabetes mellitus (E11). 
dParkinson disease (G20). 
espinal muscular atrophy and related syndromes (G12). 
fother degenerative diseases of nervous system, not elsewhere classified (G31). 
gamyloidosis (E85). 
hHuntington disease (G10). 
islow virus infections of central nervous system (A81). 
jsecondary Parkinsonism (G21). 
khereditary ataxia (G11). 
lsenile cataract (H25). 
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mechanism by which they induce cytotoxicity and cell death. 
Alzheimer’s disease is associated with the aggregation of the Aβ peptide and has been 
thoroughly studied due to its prevalence among an aging population and its relatively high mortality 
rate (Table 1). The protein aggregates formed in Alzheimer’s disease can be characterised as fibrillar, 
adopting the canonical features of an amyloid fibril (83) as previously described. In comparison, 
cataract is attributed to the aggregation of the crystallin proteins in the eye lens (84, 85) but, unlike 
Alzheimer’s disease, cataract did not register a mortality rate in Australia in 2017 (Table 1). In cataract, 
crystallin aggregation is largely disordered and is characterised as amorphous in form (86), although a 
small amount of amyloid fibrillar aggregates has recently been identified in porcine and human cataract 
lenses (87, 88). While not directly contributing to mortality, cataract is highly correlated with aging (89, 
90) and disproportionately affects disadvantaged individuals in isolated communities (91) and 
developing countries (92). An estimated 30 million people are blind due to catatract making it the 
leading cause of blindness in the world (93). While the role of protein aggregation in driving the 
cytotoxic mechanisms underlying diseases such as Alzheimer’s is still unknown, the relationship is very 
clear for cataract as protein aggregation in the lens leads directly to light scattering which obscures 
vision (94). Therefore, an understanding of the aggregates formed in cataract is particularly important 
to elucidating their formation and subsequent prevention to decrease the incidence of blindness 
worldwide and reduce the economic burden of cataract. 
 
The Structure and Function of the Eye Lens 
The eye comprises several biological compartments used to facilitate its primary function as the organ 
of vision (95) (Figure 4. A). The cornea is situated on the front of the eye and both focusses visible light 
and filters potentially damaging ultra-violet (UV) light (96). The iris is made of coloured pigment and 
functions as a diaphragm to control the amount of light entering the eye (97). The lens refracts and 
focuses light via a mechanism termed accommodation to maintain a focal distance that allows images 
to be focused directly on to the retina, particularly from objects whose distance is varying (98). The 
photoreceptors in the retina capture the focused light which is translated into electro-chemical signals  
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Figure 4. Eye lens structure and the development of cataract. A. A cross-section of the eye depicting its 
general structural features. B. A cross-section of the lens showing radial cell growth whereby old lens fibre cells 
are in and around the centre of the lens (the nucleus) while younger fibre cells are near the outside of the lens (the 
cortex) close to the epithelial layer that differentiate into new fibre cells. C. A schematic of lens fibre cell 
morphology and packing. Ordered crystallin in the transparent lens is damaged by mechanisms either associated 
with age-related or early-onset cataract to produce misfolded and aggregated crystallin in the opaque lens. 
Modified from Toyama and Hetzer, 2013 (99). 
 
that are sent down the optic nerve and into the visual cortex of the brain where they are interpreted as 
an image (100). 
 Human lens organogenesis begins at approximately four weeks’ gestation (101) and during 
embryonic development, two cell types form from surface ectoderm: epithelial and fibre cells (102). 
Morphogenetic changes lead to the differentiation of the surface ectoderm into epithelial cells that form 
a spheroid structure within the optic cup termed the lens vesicle (103, 104). The cells at the posterior of 
the lens vesicle elongate and form primary lens fibre cells that become the lens embryonic nucleus, 
while the cells at the anterior form a monolayer of simple cuboidal epithelial cells (84, 105). This 
structure, a compact spheroidal accretion of fibre cells surrounded by a layer of epithelial cells, forms 
the basis for lens growth. The epithelial cells at the anterior undergo mitosis and differentiation over a 
lifetime to form secondary lens fibre cells that are shuttled toward the embryonic nucleus and compact 
in concentric layers forming the foetal, juvenile and adult nucleus, and finally the lens cortex (102, 106, 
107). Due to this process, the centre of the lens nucleus contains fibre cells that are as old as the 
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individual while the outer regions, including the adult nucleus and the cortex, contain progressively 
younger fibre cells out towards the epithelial layer (106, 108). As a result, a cellular age gradient forms 
in the lens from the centre to the periphery (Figure 4. B). The continued growth of the lens throughout 
life is noted at the macroscopic level as the human lens weighs approximately 65 mg at birth, grows 
rapidly in the first year of life and then slows significantly, before reaching about 250 mg at advanced 
age (109, 110).  
Lens epithelial cells undergo specific changes during differentiation into lens fibre cells that 
are pivotal to the maintenance of lens transparency. Epithelial cell differentiation is characterised by 
two main events; the degradation and subsequent loss of cellular organelles and the large-scale synthesis 
of crystallin proteins that adopt a short-range array (103, 111, 112) (Figure 4. C). By preventing the 
scatter of visible light, these factors facilitate the high level of transparency exhibited by lens fibre cells 
(113, 114). Fibre cells are largely metabolically inactive, elongated, and consist of high concentrations 
of crystallin proteins (108). High lens crystallin concentrations: (i) provide the necessary refractive 
index to allow correct focusing of light onto the retina (94, 115), (ii) help to maintain the fibre cells 
structural integrity which is essential for tight cellular packing, (iii) contribute to maximising surface 
area between cells thereby limiting interstitial space, and (iv) allow the formation of efficient gap-
junctions for cellular communication (106, 116, 117). Thus, any alteration in structure of the crystallins, 
e.g. unfolding or aggregation due to early-onset or age-related damage, has a significantly adverse effect 
on fibre cell transparency and morphology which can ultimately lead to the development of lens 
opacities and cataract (99, 104, 118) (Figure 4. C). 
 
The Crystallin Proteins of the Eye Lens 
The cytoplasm of lens fibre cells contains protein at concentrations of up to 300-400 mg/mL of which 
up to 90 % comprises crystallins (94, 119). There are three classes of human crystallins: α, β, and γ, 
each with numerous isotypes (115). The three classes have distinct differences in mass (oligomeric 
state), size, isoelectric point, and electrophoretic mobility (89, 120) and can be separated from lens cell 
cytoplasm via size-exclusion chromatography (SEC) (121). There is little protein turn-over in the lens 
12
 
 
fibre cells meaning crystallins are long-lived proteins that must maintain their structural integrity 
throughout life to preserve lens transparency (99). The highly soluble, stable and dynamic nature of the 
crystallins combine to facilitate their structural longevity (122). The structure and linearised domain 
organisation of representative crystallin isoforms of each class, i.e. αB-crystallin, truncated βB1-
crystallin, βB2-crystallin, γD-crystallin, and γS-crystallin (Figure 5. A, B, C, D, and E respectively), 
demonstrate the structural features of each crystallin class, which will be discussed. 
The α-crystallins constitute 30-40 % of the lens crystallins (123) and are members of the small 
heat-shock protein (sHsp) family. They are unrelated to the other (β and γ) crystallins (124). Two 
isoforms exist in the lens, αA- (more acidic - pI ~ 5.5 ) and αB-crystallin (more basic - pI ~6.8) that 
share ~ 60 % sequence similarity (115). In the young human lens, there is approximately a 2:1 ratio of 
αA- to αB-crystallin which changes to a 3:2 ratio by ~ 55 years of age (125). While αA-crystallin is 
exclusively lenticular, αB-crystallin is found extensively in many extra-lenticular tissues where its 
expression is upregulated in times of cellular stress (126, 127). The α-crystallins have a monomeric 
mass of ~ 20 kDa but form large, polydisperse, oligomeric structures with a molar mass range of 300 
kDa – 1 MDa (128, 129).  Both αA- and αB-crystallin have a similar domain organisation, consisting 
of a largely disordered N-terminal region, a central ACD in an immunoglobulin-like fold (130), and a 
short unstructured C-terminal region consisting of a highly flexible extension of 16 residues for αA-
crystallin and 12 residues for αB-crystallin (131, 132) (Figure 5. A). αA- and αB-crystallin associate 
together (forming α-crystallin in the lens) or, in the case of αB-crystallin, with other sHsps outside of 
the lens to form hetero-oligomers (133, 134). This association is facilitated by dynamic subunit 
exchange which occurs between both homo- and hetero-oligomers (135, 136). One of the major 
oligomeric species of αB-crystallin is the 24-mer, for which an atomic level model has been elucidated 
(137) (Figure 5. A). It shows αB-crystallin monomers form dimers via the central α-crystallin domain 
(ACD) which assemble into a trimer of dimers, i.e. a hexmeric ring, through interactions with the 
flanking C-terminal region and the ACD (136, 137). Finally, the N-terminal region is responsible for 
high-order assembly but the specifics of these interactions are not entirely clear.  
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Figure 5. The crystallins of the eye lens. A. An atomic model of the αB-crystallin monomer and 24-mer (137). 
B. The crystal structure of the ‘QR’ truncated βB1-crystallin dimer (138) and C. the ‘PQ’ domain-swapped βB2-
crystallin dimer (139). D. The crystal structure of monomeric γD-crystallin (140) and E. the NMR-derived 
solution structure of monomeric γS-crystallin (141). Linearised domain organisation coloured commensurate to 
the structure is included above each respective structure while the protein name and PDB accession code is 
included below. 
 
In addition to contributing to the refractive power of the lens, the α-crystallins also function as 
molecular chaperone proteins that can prevent protein aggregation (28, 33). This property is particularly 
important in the lens where the long-lived nature of the crystallins means they are particularly 
susceptible to damage, subsequent unfolding, and aggregation occasioning cataract (90). The 
mechanism for α-crystallin (and sHsp) chaperone function is elusive. Numerous studies implicate 
interactions from multiple regions of the protein as being involved in chaperone action, which is 
consistent with the dynamic nature of α-crystallin structure and hence chaperone function (142, 143). 
Both αA- and αB-crystallin are distributed evenly throughout the lens; they are expressed at low levels 
in lens epithelial cells and then at high levels upon differentiation to lens fibre cells (124, 144). Due to 
the high concentrations of crystallins in the lens, the effects of macromolecular crowding on crystallin 
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structure and function are anticipated to be significant. Thus, macromolecular crowding could affect 
the structure and function of eye lens crystallins including the α-crystallins with consequent 
implications for lens structure and cataract formation (145). The effects of macromolecular crowding 
on αB-crystallin structure and function was investigated in Chapter 3 of this thesis. 
The β- and γ-crystallins are structurally related proteins whose high concentrations, tight 
supramolecular packing and aromatic and sulphur-rich amino acid sequences provide a significant 
contribution to the refractive power of the lens (146, 147). They belong to a structurally homologous 
superfamily exhibiting a Greek-key motif (148). The β- and γ-crystallins consist of two structurally 
homologous domains which are connected by a flexible linker peptide (Figure 5. B-E). Within each 
domain, there are two Greek-key motifs of around 40 amino acids which are symmetrically intercalated 
forming a β-sheet sandwich about a set of hydrophobic residues (122, 149). Structural features such as 
interdomain interactions, hairpin loops, and tyrosine and tryptophan corners contribute to the high 
stability of these proteins (85, 150). 
The β-crystallins constitute 30-40 % of the lens crystallins with monomeric masses ranging 
from approximately 22 to 28 kDa (115, 123). There are seven β-crystallin isoforms expressed in the 
human lens that share 45-60 % sequence identity and are designated as either acidic, βA1, βA2, βA3, 
and βA4 (pI: 5.7-6.4), or basic βB1, βB2, βB3 (pI: 5.9-8.6) (115, 123).  The same gene encodes βA1- 
and βA3-crystallin but their respective gene synthesis is initiated at different start codons leading to an 
N-terminal extension that is 17 amino acids longer for βA3- than βA1-crystallin (151). The acidic and 
basic isotypes all have N-terminal extensions of varying lengths while only the basic β-crystallins, such 
as βB2-crystallin, also have a C-terminal extension (115, 152-154) (Figure 5. B and C). The extensions 
are unstructured and flexible. The β-crystallins share around 30 % sequence identity with the γ-
crystallins and the most pronounced sequence difference is the presence of the aforementioned long N-
terminal extensions in the β-crystallins (115, 122). Despite the structural relationship between the β- 
and γ-crystallins, the β-crystallins can form homo- or hetero-oligomeric complexes with oligomeric 
states ranging from dimers to octamers while γ-crystallins are largely monomeric (89, 122).  
Structures exist for truncated βB1- and full-length βB3- and βA4-crystallin (the latter two are 
deposited in the PDB but are otherwise unpublished) which all form dimeric structures with an interface 
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classically described by crystallographic dyads ‘QR’ due to a bent linking peptide (138, 149) (Figure 5. 
B). The structure of βB3-crystallin also exhibits a putative trimer presenting a previously undescribed 
oligomeric interface (149). The structure of βB2-crystallin is domain swapped which is facilitated by 
an extended linking peptide (Figure 5. C). A dimer is formed around a PQ interface and two dimers 
come together to form a lattice tetramer in the QR orientation (139, 155). However, it has also been 
shown that the structure of βB2-crystallin in solution, using SAXS and NMR, is a compact ‘face-en-
face’ (QR) conformation as opposed an extended domain-swapped one observed in the crystal lattice 
(156) (Figure 5. B and C). 
Temporal and spatial differences in the expression patterns of β-crystallins throughout lens 
development lead to differences in the abundance of β-crystallin isotypes throughout the lens (157). 
βB1- and βB3-crystallin are expressed early in lens development and as such are located primarily in 
the lens nucleus (158, 159). In contrast, βB2-crystallin is expressed sightly later but to a greater extent 
relative to βB1- and βB3-crystallin, thereby increasing its spatial abundance throughout the lens (159, 
160). Consequently, βB2-crystallin is the most abundant β-crystallin in the developed lens (123). 
Generally, the genes associated with the acidic β-crystallins are more widely expressed leading to a 
spatial distribution that spans both the nucleus and cortex of the lens (159, 160). The exception is βA2-
crystallin of which only trace amounts are found in humans in comparison to other mammals despite 
high levels of the relevant mRNA having been detected (161). These differences in expression patterns 
lead to variation in the distribution of the different oligomeric forms of the β-crystallins throughout the 
lens with larger oligomers (octamer/hexamer) in the nucleus and smaller oligomers (dimers) in the 
cortex (108, 162, 163). It is postulated that this could be a mechanism to control water content in 
different regions of the lens due to osmotic pressure effects (115, 164). In addition, larger oligomers 
may also impart greater stability to older regions of the lens. The former postulate is consistent with a 
shift in the β-crystallin oligomeric population from dimers to tetramers in the aging and cataract-prone 
lens (125, 165). 
The γ-crystallins constitute 20-30 % of the lens crystallins with monomeric masses ranging 
from approximately 20 to 21 kDa (115, 123). Six γ-crystallins, γA-F-crystallin, are closely linked on a 
gene cluster and exhibit 70-98 % sequence identity (149). In humans, γA-crystallin is expressed at low 
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levels while the genes encoding γE- and γF-crystallin are inactive due to premature stop codons that are 
not present in most other mammals (115, 149). The gene encoding the seventh γ-crystallin, γS-
crystallin, is on a different chromosome and has greater sequence divergence exhibiting approximately 
50 % identity compared to the other γ-crystallins (166). The γ-crystallins maintain the same general 
domain arrangement with the exception of differences in N- and C-terminal extensions and linking 
peptide length (Figure 5. D and E). The γA-F-crystallins contain a C-terminal extension consisting of 
two residues (Figure 5. D) in contrast to γS-crystallin which lacks this extension but instead has a 
flexible four-residue N-terminal extension (115, 167) (Figure 5. E). The linking peptides of γB- and γS-
crystallin are one and two residues longer than the other γ-crystallins, respectively (115). For γS-
crystallin, these differences originally it led to be characterised as a lens β-crystallin named βS-crystallin 
as it elutes between β- and γ-crystallin fractions during SEC separation but genetic sequence analysis 
suggested a closer relationship to the γ-crystallins (168, 169). Despite generally being considered 
monomeric proteins (170), γC-, γD-, and γS-crystallin form disulfide-linked dimers with the structure 
and stability for the latter being described and characterised in Chapter 2 of this thesis (171-173). 
The γ-crystallins are the last of the lens crystallins to be expressed during fibre cell 
differentiation and as such are not observed in immature fibre cells of the lens cortex (144, 174). Due 
to relatively early induction of their expression in lens development, there is a significant abundance of 
γB- and γD-crystallin in the nuclear region of the lens (115, 144, 174). Further, the expression of γB- 
and γC-crystallin lingers for longer than the other γ-crystallins thereby adding these isoforms to the 
inner lens cortex in addition to the nucleus (115, 122). Conversely, γS-crystallin is induced later in lens 
development with levels increasing drastically in the postnatal lens placing a significant portion of γS-
crystallin in the lens cortex (125, 175). As different species require different levels of accommodation 
from their eye lens, the abundance and variation in quantity of specific γ-crystallin isoforms contributes 
to the physical properties required to achieve this. Thus, soft human lenses contain an abundance of  
γC-, γD-, and γS-crystallin, the very soft avian lens contains γS-crystallin almost exclusively, and hard 
rodent lenses contain an abundance of γA-F-crystallin (123, 176-179). 
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Cataract and the Crystallins: the Development of Congenital, Early On-Set, and Age-
Related Cataract 
Cataract is defined as the loss of transparency and the opacification of the eye lens and can be classified 
as either congenital (present at birth), early on-set (present from birth to approximately 45 years of age) 
or age-related (onset from approximately 50 years of age) (180). Patients with congenital or early-onset 
cataract are generally genetically predisposed, largely due to deleterious mutations in lens crystallin 
proteins (181, 182) (Tables 2-4). Age-related cataract manifests due to accumulative damage caused to 
the long-lived lens crystallins by factors such as heat and time, leading crystallin destabilisation and 
spontaneous post-translational modifications (PTMs) resulting in crystallin aggregation (90, 183) 
(Table 5).  
Cataract can be heterogeneous in morphology and spatial location which has led to the 
classification of several different types. While distinct types have been observed for different congenital 
or age-related cataracts, it is still not clear what link these morphologies have with the associated disease 
etiology (94). However, determination of a definitive link between cataract morphology and the 
underlying biochemical process could be important for future treatment options for cataract. The various 
cataract morphologies and their locations in the eye lens are schematically depicted in Figure 5. Nuclear, 
cortical and subcapsular cataracts (Figure 5. A-D) are largely age-related (180, 183). However, 
numerous other types such as polar, cerulean, lamellar, pulverulent, aculeiform, polymorphic and total 
cataract have been associated with different crystallin mutations in patients with congenital or early on-
set cataract (Figure 5. E-L) (Tables 2-4) (182, 184). They can also be localised to a specific area of the 
lens, leading to a description that encompasses spatial and morphological features, e.g. nuclear 
pulverulent or cortical cerulean cataract. Other ocular abnormalities may also accompany cataract, some 
of which include microcornea (cornea < 10 mm in diameter), microphthalmia (abnormally small and 
anatomically malformed eye), nystagmus (uncontrolled and repetitive eye movements), and coloboma 
(missing pieces of eye tissue) (Tables 2-4) (185). Due to its extralenticular role as a molecular 
chaperone, some congenital αB-crystallin mutants can lead to muscular disorders such as myofibrillar 
myopathy in addition to cataract (186, 187) (Table 2). 
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Figure 6. Various morphologies of cataract and their locations within the eye lens. A. A schematic of the lens 
showing its anatomical features (normal typeface) and the location of the main cataract morphologies associated 
with age-related cataract (bold typeface, blue-grey dots). Slit lamp microscopy photos showing B. nuclear cataract, 
C. wedge-shaped cortical cataract, and D. posterior subcapsular cataract (180). Other types of cataract, which can 
appear with congenital and early-onset cataract, and their general morphology and spatial position in the lens are 
schematically represented (blue-grey dots) (182, 184), including E. anterior polar cataract, F. posterior polar 
cataract, G. cerulean/blue dot cortical cataract, H. lamellar/zonular cataract, I. pulverulent/Coppock-like nuclear 
cataract, J. aculeiform/coralliform cataract, K. polymorphic cataract, and L. total cataract. Modified from Liu et 
al., 2017 (180). 
 
 Congenital and early-on set cataracts are detected via genetic sequencing of a proband and their 
descendants to determine the mutation(s) that cosegregate with a cataract phenotype. A multitude of 
congenital mutations in humans have been identified across all α, β, and γ-crystallin isoforms (Tables 
2-4). Biophysical characterisation of some of these mutants has provided insight into the potential 
molecular mechanisms of cataract. For example, the R120G mutant of αB-crystallin disrupts a vital 
salt-bridge across the ACD dimer interface (188), which leads to unfolding of the protein, an increase 
in oligomeric size and significantly reduced chaperone activity (189, 190). The Q155X mutant of βB2-
crystallin results in a sequence truncation that leaves protein 51 amino acids short at its C-terminal end, 
causing the loss of the last Greek key motif (191) (Figure 5. C). Structural studies have demonstrated 
that this mutation results in a significant loss of ordered structure, reduced chemical stability, 
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Table 2: Documented mutations in human α-crystallins and their associated cataract types.  
Crystallin 
Protein 
Congenital 
Mutation 
Type of Cataract 
αA-crystallin W9Xa Recessive cataract (no morphology documented) (192) 
 R12C Posterior polar and nuclear cataract with associated microcornea 
(193, 194) 
 R21W Lamellar cataract with associated microcornea (193, 194) 
 R21L Nuclear cataract (195) 
 R49C Nuclear cataract (196) 
 R54C Total cataract with associated microcornea (194, 197) 
 G98R Total cataract (198) 
 R116C Various cataract phenotypes (193, 199-202) 
 R116H Various cataract phenotypes (193, 203, 204) 
αB-crystallin R11H Nuclear cataract (205) 
 P20S Posterior polar cataract (206) 
 R56W Nuclear and total cataract (207, 208) 
 D109A Posterior polar cataract with associated myofibrillar myopathy (209) 
 D109H Posterior polar cataract with associated myofibrillar myopathy and 
cardiomyopathy (210) 
 R120G Dominant cataract (no morphology documented) with associated 
myofibrillar myopathy (186) 
 D140N Lamellar cataract (206) 
 K150fsb Posterior polar cataract (211) 
 A171T Lamellar cataract (194) 
aX indicates a change to a stop codon. 
bfs indicates a ‘frameshift’ mutation in the reading frame beginning at the particular amino acid and position 
indicated. 
 
diminished protein-protein interactions, and high surface hydrophobicity (212). The G18V mutation of 
γS-crystallin replaces a highly conserved glycine in the protein’s first Greek-key motif with a valine 
residue (115). In comparison to the wild-type protein, G18V has an increased exposed hydrophobic 
surface area, a lower chemical and thermal stability, undergoes three-state unfolding, and has a 
perturbed protein hydration shell in crowded conditions (213-215).  
In general, crystallin mutations can alter folding (212, 216), surface hydrophobicity (214, 217), 
oligomerisation (189, 218), conformational dynamics (219, 220), stability (213, 221), protein-protein 
interactions (222, 223), solubility (224, 225), and chaperone activity (221, 226) relative to the wild-type 
protein. However, examples have also been documented of seemingly innocuous alterations to the 
structural features of mutant crystallins compared to their wild-type counterparts (140, 227). Thus, 
20
 
 
Table 3: Documented mutations in human β-crystallins and their associated cataract types. 
Crystallin 
Protein 
Congenital 
Mutation 
Type of Cataract 
βA1/A3-
crystallin 
G91dela Nuclear and lamellar pulverulent cataract (228-231) 
 Splice-
donorb 
Pulverulent nuclear and lamellar cataract (232, 233) 
βA2-crystallin V50M Dominant cataract (no morphology documented) (234) 
βA4-crystallin G64W Nuclear cataract with associated microcornea (235) 
 F94S Lamellar cataract with associated microphthalmia (236) 
βB1-crystallin M1K Pulverulent nuclear cataract (237) 
 N58fs Nuclear cataract (238) 
 S93R Nuclear cataract with associated microcornea and microphthalmia (239) 
 V96F Dominant cataract (no morphology documented) with associated 
microcornea (234) 
 L116P Nuclear cataract (240) 
 R123H Sporadic cataract (no morphology documented) (241) 
 S129R Nuclear cataract with associated microcornea (242) 
 Y206fs Nuclear cataract (243) 
 G220X Pulverulent cataract (237) 
 Q223X Nuclear cataract (244) 
 Q227X Nuclear cataract with associated nystagmus (245) 
 S228P Nuclear cataract (246) 
 R230C Cataract (no morphology documented) with associated coloboma (247) 
 R233H Nuclear cataract with associated nystagmus (248) 
 X253R Nuclear, anterior, and posterior polar cataract with associated 
microcornea (249) 
βB2-crystallin A2V Posterior subcapsular cataract (250) 
 I21N Nuclear cataract (248) 
 P115T Sporadic cataract (no morphology documented) (241) 
 G119R Nuclear cataract (240) 
 V146N Nuclear cataract with associated microcornea (248) 
 G149V Cataract (no morphology documented) with associated microcornea (247) 
 Q155X Polymorphic, pulverulent and cerulean cataract (191, 251, 252) 
 S186P Sporadic cataract (no morphology documented) (241) 
βB3-crystallin G165R Nuclear cataract (253) 
 V194E Nuclear, cortical, anterior, and posterior polar cataract (234) 
adel indicates at deletion mutation. In this instance, three base pairs are deleted resulting in the removal of a glycine 
residue at position 91. 
bsplice-donor indicates a mutation in the splice site at the beginning (5’ end) of an intron that results in aberrant 
exon assembly and the translation of a non-functional protein.   
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Table 4: Documented mutations in human γ-crystallins and their associated cataract types. 
Crystallin 
Protein 
Congenital 
Mutation 
Type of Cataract 
γC-crystallin T5P Coppock-like cataract (254) 
 M44fs Cataract (no morphology documented) with associated microcornea 
(247) 
 R48H Nuclear and lamellar cataract (255) 
 G62fs Lamellar pulverulent cataract (256) 
 C109X Nuclear cataract (257) 
 S119S Nuclear cataract with associated microcornea (258) 
 G129C Nuclear cataract (259) 
 Y144X Cataract (no morphology documented) with associated microcornea 
(247) 
 W157X Nuclear cataract with associated microcornea (260) 
 R168W Nuclear and lamellar cataract (261, 262) 
γD-crystallin R14C Nuclear and coralliform cataract (263, 264) 
 R14S Coralliform cataract (265) 
 P24T Cerulean, coralliform and lamellar cataract (261, 266-271) 
 P24S Polymorphic cortical cataract (272) 
 A36P Nuclear cataract (273) 
 R37P Nuclear cataract (274) 
 R37S Birefringent, pleiochroic crystals (275) 
 W43R Nuclear cataract (276) 
 M44V Blue dot cataract (277) 
 Y56X Nuclear cataract (258) 
 R58H Aculeiform cataract (254) 
 G61C Coralliform cataract (278) 
 R77S Anterior polar cataract (279) 
 E107A Nuclear cataract (280) 
 Y134X Dominant cataract (no morphology documented) with associated 
microcornea (193) 
 R140X Nuclear cataract (194) 
 W157X Nuclear cataract (261) 
 G165fs Nuclear cataract (281) 
γS-crystallin G18D Cortical and sutural cataract (282) 
 G18V Polymorphic cortical cataract (283) 
 D26G Coppock cataract (273) 
 S39C Lamellar and sutural cataract (194) 
 V42M Nuclear cataract (284) 
 G57W Pulverulent cataract (285) 
 Y67N Nuclear cataract (286) 
 G75V Lamellar cataract (282) 
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Table 5: Major PTMs of human lens crystallins. 
Post-
translational 
modification 
Chemical Process  
Result of Modification 
Residues Commonly Affected 
Examples Identified in Human Lens 
Crystallins 
Deamidation Elimination of a side-chain amide and 
formation and hydrolysis of a succinimide 
intermediate, typically converting the affected 
residue to its corresponding carboxylic acid 
derivative 
Q147 αA-crystallin (287) 
N82 βA4-crystallin (288) 
N76 γS-crystallin (288) 
Conversion of neutrally charged to negatively 
charged residue at physiological pH 
Asparagine and glutamine 
Racemisation 
 
Interconversion of an amino acid between its 
L- and D-forms, via deprotonation and 
protonation of the amino acid α-carbon or 
through a succinimide intermediate 
D109 αB-crystallin (289) 
D4 βB2-crystallin (290)  
D153 γS-crystallin (291) 
Conversion of amino acid from L- to D- 
enantiomer 
Asparagine, aspartic acid, and serine 
Phosphorylation Covalent addition of a phosphoryl group, 
likely via a protein kinase 
S45 αB-crystallin (292) 
T117 βB2-crystallin (293) 
Y62 γC-crystallin (293) Addition of negative charge and bulkier amino 
acid R-group 
Serine, threonine and tyrosine 
Truncation Protease-mediated and spontaneous cleavage 
of peptide bonds and loss of amino acids from 
the N- or C-termini 
S172a αA-crystallin (287) 
N22a βA3-crystallin (294) 
S87b γD-crystallin (295) 
Loss of one, several or many amino acids 
Asparagine and serine 
Oxidation Interaction with oxygen, a loss of hydrogen or 
electron(s). 
W9 αB-crystallin (296) 
M226 βB1-crystallin (293) 
C24 γS-crystallin (297) Intramolecular, intermolecular and mixed 
disulfides, sulfoxide formation, scission of 
indole ring 
Cysteine, methionine, and tryptophan 
atruncation occurs after the residue indicated. 
btruncation occurs before the residue indicated. 
 
while biophysical studies of specific congenital crystallin mutations might be able to rationalise their 
role in certain types of cataract, the overall role of these mutations in the structural and biochemical 
changes that lead to the development of cataract are less clear. However, it is important to note that 
despite the identification and study of congenital crystallin mutations associated with cataract being 
important to our fundamental understanding of crystallin structure and function and cataract 
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development, the majority of human cataracts occur as a result of aging and do not arise via mutations 
(94, 183). 
 Extensive proteomic analyses of lenses at different ages, both normal and cataractous, have 
identified numerous PTMs associated with the long-lived lens crystallins (287, 288, 298, 299). Some 
of the major PTMs are deamidation, racemisation, phosphorylation, truncation, and oxidation which 
have all, to some extent, been associated with age-related cataract formation (287, 288, 298) (Table 5). 
Some of these post-translationally modified crystallins have been biophysically characterised either via 
mutagenesis studies, e.g. deamidation and truncation studies, or via modification mimics, e.g. of 
racemisation and phosphorylation. As a result, these studies have enhanced our understanding of how 
these modifications might affect crystallin structure and function and contribute to the development of 
age-related cataract. 
Specifically, deamidation is arguably the most abundant PTM in the aged human lens (288). It 
can be studied in vitro via mutagenesis of relevant neutrally changed asparagine or glutamine residues 
into negatively charged aspartic acid or glutamic acid, respectively. Across all types of crystallins, 
deamidation has a mostly deleterious effect causing conformational change and destabilisation (300), 
altered protein dynamics (301), partial loss of chaperone activity (302), and an increase in protein-
protein interactions (303). However, the magnitude and nature of the changes relative to the wild-type 
crystallin are dependent on the amino acid sequence position of deamidation (302). For instance, the 
N76D γS-crystallin and Q143E αA-crystallin deamidation mutants had small and localised structural 
differences in comparison to their wild-type counterparts, however both mutants exhibited an increased 
tendency to oligomerise (304, 305).  
Racemisation is a prolific PTM in the aging and cataractous eye lens (306, 307). The impacts 
of this PTM has been difficult to study in full-length crystallins because the incorporation of an 
unnatural D-form amino acid has not yet been achieved. While biophysical studies on crystallins that 
exhibit racemisation are sparse, some insight has been provided from mutational studies on racemisation 
prone crystallin residues to understand how changes in that amino acid affect crystallin structure and 
function. Changes to crystallin residues that exhibit an increased abundance of racemisation between 
the water-soluble and water-insoluble fractions of the lens have been investigated e.g. D151                   
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αA-crystallin and D109 αB-crystallin (308, 309). Multiple mutations at D151 in αA-crystallin lead to a 
loss of stability and chaperone activity (310) while experimental studies on D109A αB-crystallin led to 
a loss of stability and solubility of the protein, recapitulating the results of molecular dynamics 
calculations which predicted the breakage of an important inter-subunit salt bridge due to D109 
racemisation (289). These results have provided a general understanding of the potential biophysical 
consequences of racemisation and its relation to aging and cataract formation.  
The incorporation of a phosphorylated amino acid is possible with unnatural amino acid 
incorporation methodology (311). However, this approach has not been applied to crystallin proteins. 
Previous studies have used phosphomimics and mutated residues at sites that have been identified to be 
phosphorylated in vivo with either a negatively charged aspartic or glutamic acid. The studies of 
crystallin phosphomimics have been confined to the α-crystallins as it is a major PTM for this crystallin 
type (34), including occurring to a significant degree early in life (312). Using either an aspartic or 
glutamic acid to substitute specific serine residues, the triple phosphomimic in the N-terminal region of 
αB-crystallin (S19/S45/S59) has an altered oligomeric state (313-315), increased subunit exchange rate 
(314), a more solvent exposed and flexible N-terminal region (315), and an increase in its in vitro 
chaperone activity for target proteins under stress conditions (313, 315). The consensus from these 
phosphomimic studies is that phosphorylation appears to be a ‘gain of function’ modification that 
regulates sHsp chaperone function (34). Currently, there has been no biophysical characterization of 
the effects of phosphorylation on β- or γ-crystallins despite this PTM being detected in the eye lens 
(Table 5).  
Truncation of the polypeptide from both termini has been identified across all crystallin types 
and particularly within unstructured and flexible terminal extensions which are a characteristic of all 
three crystallin types (316) (Figure 5). Truncation mutants can be generated via addition of either a late 
start or early stop codon in the gene sequence of the crystallin of interest. Significant (more than one 
amino acid) C-terminal truncation of αA-crystallin leads to lower oligomeric average mass (317, 318), 
a decreased rate of heterooligomeric subunit exchange (317), impaired structure and solubility (319), 
and reduced chaperone activity (318). The N-terminal truncation of βB1-crystallin resulted in phase 
25
 
 
separation (320), impaired higher order heterooligomer formation (165, 321), and a reduced 
heterooligomeric subunit exchange rate and solubility changes (321). 
Despite the diversity of PTMs identified in the human lens, oxidation can be considered the 
hallmark modification of age-related cataract as its abundance is highly correlated with age and the 
onset of age-related cataract, particularly nuclear cataract (90, 297, 322-325). Advanced age-related 
nuclear cataract leads to oxidation of more than 90% of cysteine thiol groups and approximately 50% 
methionine sulfhydryl groups (297, 322, 326). The major reason lens protein oxidation becomes more 
pronounced with age is due to a loss of the lens’s principal reducing agent glutathione, which is 
approximately 6 mM in concentration in young normal lenses but decreases to close to 1 mM or less in 
old and cataractous lenses (327-329). The in vitro oxidation of cysteine residues is possible through 
passive means, e.g. oxygenated solution, high crystallin protein concentration, and time (173), or active 
means, e.g. addition of a strong chemical oxidant (e.g. diamide or a redox active metal like copper) 
(330). Photo-oxidation of tryptophan can form the derivative kynurenine due to scission of tryptophan’s 
pyrrole ring, producing a far more polar side chain by introducing amino and carbonyl groups into the 
side chain (331). This oxidation can be mimicked via mutagenesis of tryptophan to glutamine (332). It 
has been demonstrated that copper(II) treated γD-crystallin, which produces a disulfide-linked γD-
crystallin dimer, and tryptophan oxidation mimic W42Q γD-crystallin both exhibit conformational 
change, instability, and increased aggregation propensity (330, 332). Interestingly, it has also been 
found that the presence of an intramolecular disulfide in the W42Q γD-crystallin tryptophan oxidation 
mimic, which further distorts the Greek-key fold, causes the oxidation mimic to be aggregation-prone 
while the same intramolecular disulfide is not deleterious to wild-type γD-crystallin (333). Disulfide-
linked γS-crystallin (via C24) is destabilised and has an increased aggregation propensity, aspects which 
are explored in-depth in Chapter 2 of this thesis (173). These examples provide a fascinating, albeit 
small, view into how oxidative changes can affect lens crystallin proteins structure and biophysical 
properties and lead to aggregation associated with cataract formation.  
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Biophysical Methods for the Characterisation of Crystallin Proteins  
Due to the long-lived nature of the crystallins, there has been intense interest in elucidating their 
structure and physical properties to understand the mechanisms behind their function, dysfunction and 
aggregation. However, the investigation of these properties has been hindered in some instances due to 
the highly soluble and dynamic nature of the lens crystallins. To counter this, the development of 
traditional and novel techniques has enabled a closer look at these proteins. Below, some of the 
prominent biophysical methodologies and associated findings that have contributed to our increased 
understanding of crystallin structure and function are described. 
X-ray crystallography was used to derive the first structure of a crystallin bovine γB-crystallin 
(isolated from the bovine lens and previously referred to as γII-crystallin) nearly 40 years ago (334). 
Nearly a decade later, the first structure of a β-crystallin, bovine βB2-crystallin, was elucidated as a 
domain-swapped dimer (155). Since then, structures of the human versions of γB-crystallin (335), γD-
crystallin (140) (Figure 5. D), truncated βB1-crystallin (138) (Figure 5. B), βB2-crystallin (139) (Figure 
5. C), βB3-crystallin, and βA4-crystallin have also been solved. There are still a number of β- and γ-
crystallins that have not been crystallised, however progress is being made. One such example is γS-
crystallin whose bovine (336) and human (150) forms of the isolated C-terminal domain have been 
crystallised but attempts to crystallise the full-length protein only came almost two decades later. The 
crystal structure of chicken γS-crystallin has now been solved (337) while the first full-length crystal 
structure of human γS-crystallin was determined of an oxidised form as a disulfide-linked dimer (173). 
The latter is described in detail in Chapter 2 of this thesis. These recent crystallographic achievements 
suggest that the remaining β- and γ-crystallins will likely be amenable to crystallisation, if only upon 
mild modification. Crystallography of the two full-length α-crystallins is unlikely due to their 
polydisperse, dynamic and flexible nature (338). To overcome this, the largely disordered N-terminal 
region and part of the C-terminal region were removed leaving the structured ACD which has been 
crystallised for multiple species and mutants of both αA- and αB-crystallin (130, 188, 339-342).  
X-ray crystallography has provided an unparalleled understanding of the structural homology 
of related β- and γ-crystallins previously inferred via sequence homology and gene duplication (343). 
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Examination of other structural features such as tyrosine corners, relative solvent exposure of residues 
and the positions and interactions of residues that are mutated or modified in association with cataract 
formation have been made possible by X-ray crystal structures (150). Crystallography has also provided 
significant insight into the interfacial interactions of the oligomeric α- and β-crystallins (139, 188). 
However, a shortfall of X-ray crystallography is that it deals with a static, solid-state structure. 
Therefore, experimental validation with the oligomeric structure formed in-solution is judicious. A 
prudent example is the domain-swapped conformation of the βB2-crystallin dimer which was shown to 
be a crystallographic artefact as small angle X-ray scattering and NMR methods determined the dimer 
formed around the more compact QR interface like the crystal structure of truncated βB1-crystallin 
(156) (Figure 5. B and C). While the structures that have been solved have provided relevant precursors 
for molecular dynamics simulations (289, 344), experimental validation of flexibility and dynamism is 
usually the domain of NMR spectroscopy. 
NMR spectroscopy has provided much information on crystallin structure and dynamics. The 
α-crystallins were thought to not be amendable to conventional solution-phase NMR due to their large 
oligomeric size. However, it was observed that 12-16 residues at the C-terminal end of αA- and αB-
crystallin are readily observable via NMR spectroscopy (131) (Figure 5. A), arising from a solvent-
exposed, highly flexible and dynamic C-terminal extension that protrudes from the high-mass oligomer 
(345). The C-terminal extension of α-crystallins and other mammalian sHsps has been a focus of further 
studies since its discovery approximately 25 years ago providing insight into its role in oligomerisation 
(346), chaperone action (132), proline isomerisation (347), and the identification of different 
conformers in solution (142). In addition to the α-crystallins, solution-state NMR has also been used to 
discern flexible N- and C-terminal extensions in β-crystallins (152, 153) (Figure 5. B and C) and the 
short flexible N-terminal extension in γS-crystallin (167) (Figure 5. E). 
Advances in solution- and solid-state NMR hardware and pulse sequences as well as isotopic 
protein labelling have been applied to both full-length αB-crystallin and the isolated ACD to elucidate 
residues involved in oligomerisation (137, 348-350), chaperone action (141, 142, 349), structural 
dynamics (351, 352), metal binding (353) and derive structures of the wild-type ACD (137, 349, 352). 
While NMR studies of β-crystallin calcium binding (354) and structure (156) have provided insight into 
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their structural and physical properties, the ~40 kDa mass of the β-crystallin dimer limits the resolution 
available from solution-state NMR. However, NMR studies on the ~ 20 kDa monomeric γ-crystallins 
have been numerous providing complementary and orthogonal information to that derived from X-ray 
crystallography. The structures of γS- and γC-crystallin and some of their cataract-associated mutants, 
which have proven recalcitrant to crystallisation, have been solved using NMR spectroscopy (141, 355-
357) (Figure 5. E). NMR spectroscopy has also been used to investigate sparsely populated conformers 
and the unfolding mechanism of a cataract-associated variant of γS-crystallin providing insight into 
structural changes that precede aggregation (358, 359). Furthermore, solid-state NMR has shown that 
aggregates of a cataract-associated mutant of γD-crystallin that appear largely amorphous in form via 
TEM still retained a significant portion of its native structure, with potential implications for the 
targeting and prevention of such aggregates in cataract (60).  
While size limitations currently preclude the structural determination of the dimeric β-
crystallins and all monomeric γ-crystallins via negative stain TEM or cryo-electron microscopy (cryo-
EM), major insight into the quaternary structure of the large α-crystallins has been obtained for over 
two decades. The first structural model via cryo-EM data of αB-crystallin’s quaternary structure was 
from an asymmetric 32-subunit oligomer with a large central cavity (360), confirming a previous 
hypothesis that the α-crystallin oligomer contained a central cavity (361). Later, negative stain 
transmission electron microscopy data were used to build a three-dimensional model of an αB-crystallin 
24-mer showing a similar central cavity but an overall symmetrical oligomer (362). In an effort to 
incorporate more detail into these models, hybrid approaches have been adopted to derive pseudo-
atomic models (363) utilising NMR and structural modelling in combination with either small angle X-
ray scattering (349), negative stain TEM (137), or cryo-EM (364). Cryo-EM also allowed for other 
oligomeric quaternary structures of αB-crystallin to be determined from a 12-mer to a 48-mer with some 
oligomers also exhibiting different conformers (364). Despite the usefulness of these quaternary 
structures and pseudo-atomic models, it is difficult to depict αB-crystallin as a single structure given 
the wide distribution and conformational heterogeneity of the oligomers (365). Indeed, the 
conformational heterogeneity of αB-crystallin and probably most, if not all, sHsps is an integral feature 
of their structure and chaperone action. 
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 Mass spectrometry has provided detailed information on the continuum of oligomeric states in 
the α-crystallins with technological advances allowing structural models of the α-crystallin oligomeric 
arrangements to be proposed. Mass spectrometry has also been important in obtaining structural data 
for the smaller β- and γ-crystallins. Mass spectrometry has been used extensively for investigating 
crystallin PTMs including phosphorylation (293), truncation (160), isomerisation (291), oxidation 
(287), acetylation (366), methylation (367), and deamidation (288). Structural studies have also used 
hydrogen-deuterium exchange, cross-linking, and ion mobility mass spectrometry techniques. They 
have been applied to β-crystallins to discern crystallin-crystallin interactions and solvent accessibility 
(368, 369), size and stability (370), and dynamic conformational changes (371). Native mass 
spectrometry of αA- and αB-crystallin has been particularly useful in elucidating the mass and number 
of oligomeric states (128, 372), subunit stoichiometry (128, 373), chaperone action (373, 374), oligomer 
and ACD dimer conformation (188, 375), and subunit exchange (317, 376) of these proteins. Mass 
spectrometry data have also been used to build a model of αB-crystallin, in conjunction with NMR data, 
which rationalises the underlying thermodynamics and kinetics of oligomerisation and subunit 
exchange (350, 351, 372, 376). While native mass spectrometry has provided an unprecedented insight 
into the polydisperse nature of the α-crystallins, the analysis occurs in the gas phase (377). No technique 
currently exists to resolve oligomeric species of α-crystallins in-solution under native-like conditions 
(378). 
Solution separation techniques enable characterisation of crystallins in a native-like 
environment (aqueous solution at physiological temperature and pH) which is important given the 
aforementioned techniques either do not involve separation and therefore rely on averaging or do 
separate but under non-native-like conditions. Techniques such as SEC and analytical ultracentriguation 
(AUC) have been used to study β- (154, 379) and γ-crystallins (173, 304) and provided great insight. 
However, for the α-crystallins, SEC and AUC have only been able to provide information on shifts in 
oligomeric population due to changes in solution conditions (e.g. pH changes) or mutations (e.g. 
phosphomimics), otherwise giving poor resolution for individual oligomeric species (338, 362).  
These methods also rely on separation via hydrodynamic size and thereby miss information related to 
charge and conformational differences of these proteins, which is particularly important for some post-
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translationally modified crystallins (293) and the structurally heterogeneous α-crystallins (142). Any 
alternative method would need a separation mechanism that is particularly sensitive to conformation 
and, in the case of resolving α-crystallin’s oligomeric states, a separation timescale that is less than that 
of α-crystallin subunit exchange, i.e. seconds to minutes depending on temperature and solution 
conditions. Very recently, it has been observed that oligomeric states of αB-crystallin could be discerned 
using a microfluidic device and second-derivative signal analysis (378). The separation was effected by 
electrophoretic mobility on a time-scale shorter than subunit exchange, providing the first evidence that 
individual oligomeric states of native αB-crystallin can be resolved in solution (378).  
Free-solution capillary electrophoresis (CE) also separates on the basis of electrophoretic 
mobility, and is far more common and less specialised than in-house fabricated microfluidic devices. 
The CE instrumentation consists of a capillary which is usually made of fused silica but can be coated 
with an inert surface to minimise analyte adsorption (380) (Figure 7, left). Commonly, capillaries will 
range in diameter from 25 to 500 µm and be anywhere between 7 to 100 cm long (381). The sample is 
introduced into the capillary before the start of each run via hydrodynamic pressure at the end opposite 
to the detector. Once the sample is in the capillary, small reservoirs of buffer are used to submerge both 
ends of the capillary along with two electrodes that then produce a potential difference across the 
capillary from 5 to 30 kV using direct current (Figure 7, left). Detection is usually spectrophotometric 
(UV-visible or fluorescence) with coupling to mass spectrometry also becoming a common feature 
(381). CE can create an electroosmotic flow (EOF) which is due, for a fused silica capillary in a solution 
above pH 3, to negatively charged deprotonated silanol groups on the capillary surface (380) (Figure 7, 
top right). A mass transfer of buffer cations towards the negatively charged capillary surface occurs, 
forming a fixed layer. A second layer, called the diffuse layer, is free to move laterally along the 
capillary while remaining close to the capillary wall. Given there are predominately cations in the 
diffuse layer, their migration toward the negatively charged cathode drags the bulk solution toward this 
electrode, thereby rationalising where the detector is placed (381, 382) (Figure 7, top right).  
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Figure 7. A schematic of a CE apparatus, the origin of the electroosmotic flow (EOF), separation of positive, 
neutral and negative molecules, and the corresponding flow profile compared with SEC. The features of a 
CE apparatus include the anodic and cathodic electrodes, buffer reservoirs, sample vial, capillary and 
spectrophotometer (left). Positive buffer ions form an electric double layer (the fixed and diffuse layers together) 
and pull the solution towards the negative cathode generating an EOF (top right). As there is a high concentration 
of positive ions in the diffuse layer near the capillary wall, application of a potential difference across the capillary 
causes the solution to flow towards the cathode from the edge of the capillary wall resulting in a flat-flow profile. 
Positive ions are detected first as they migrate faster than the EOF due to attraction to the cathode, neutral ions 
are detected second as they migrate at the same rate as the EOF, and negative ions are detected last as they migrate 
slower than the EOF due to attraction toward the anode (top right). Due to the EOF induced flat-flow profile in 
CE, this leads to sharp peaks and higher resolution separation in comparison to parabolic flow profiles from 
hydrodynamic methods, such as SEC, that lead to peak broadening and lower resolution separation (bottom right).  
 
Due to the solution uniformly moving toward the cathode, positively charged species migrate 
faster due to electrostatic attraction toward the cathode and are thus detected first. Neutrally changed 
species are detected second as they are unaffected by the electric field and travel at the same rate as the 
EOF. As such, neutral molecules are usually used as markers to determine the EOF rate. Finally, 
negatively charged molecules travel the slowest as they are retarded due to their electrophoretic mobility 
counteracting the direction of the EOF as they are attracted toward the anode (Figure 7, top right). As 
a consequence of the solution being ‘dragged’ from the edges of the capillary, the EOF creates a ‘flat’ 
flow profile leading to very sharp CE peaks greatly increasing peak resolution in separation (382). This 
is in contrast to hydrodynamic parabolic flow profiles, such as in SEC, which consequently leads to 
broad peaks/signals (383) (Figure 7, top left). 
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Above a protein mass of ~10 kDa, CE separation becomes independent of mass (384, 385), a 
situation that is referred to as CE in the ‘critical conditions’ (386). The same behaviour has also been 
noted for different polyelectrolytes such as DNA (387) and charged polymers (388). CE instead 
separates based on conformational or compositional features of a polyelectrolyte. For a protein, this is 
largely reflected in conformational differences inherent to species of the same oligomer. This includes 
different oligomeric states e.g. dimer and hexamer (389), open and closed forms (390), and proteins 
that have been modified at the amino acid level e.g. via PTM (391). Conformational separation can 
result in three possible outcomes, i.e. the complete separation of distinct conformations resulting in 
resolved peaks, peak broadening due to high conformational heterogeneity and a narrow peak due to 
low conformational heterogeneity (Figure 8). When this CE separation is plotted as a distribution of 
electrophoretic mobilities (392), the dispersity value for a protein peak can be calculated (386) akin to 
the ‘polydispersity index’ or PDI from SEC coupled to multi-angle light scattering.  As such, separation 
can yield complementary and analogous information to that of the common size-based separation 
technique SEC. This aspect is experimentally examined in Chapter 4 of this thesis.  
CE could provide significant advantages for the conformational characterisation of crystallin 
proteins as its mechanism of separation is underscored by the ability to separate via conformation and 
charge (393, 394). CE separation could be particularly useful for separating and characterising post-
translationally modified crystallins and conformationally heterogeneous proteins such as the α-
crystallins. As a prelude to such crystallin studies, model proteins with varying degrees of 
conformational heterogeneity have been examined in Chapter 4. 
 
Aims of this Thesis 
Protein misfolding and aggregation disorders, such as eye lens cataract, cause numerous health, social, 
and economic issues. However, despite the already substantial body of knowledge on crystallin proteins 
and their potential contributions to the development of cataract, there is no clear understanding of the 
biochemical or molecular reason(s) as to why cataract develops. This thesis uses in vitro biophysical 
characterisation to provide a molecular understanding of how oxidation and the crowded lens  
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Figure 8. A schematic of a CE separation and resultant distribution of electrophoretic mobilities. Provided 
a protein has distinct conformational species that exist on a timescale amenable to CE separation, these species 
will be resolved as two separate peaks (red). A protein that exhibits high conformational heterogeneity but does 
not have conformations distinct enough to be resolved as two separate peaks will present as a broadened CE peak 
(yellow). A protein that exhibits low conformational heterogeneity will present with a sharp CE peak (blue). The 
corresponding separations from each of these samples are compared as a distribution of electrophoretic mobilities 
which allows calculation of their dispersity value (right). 
 
environment impacts crystallin structure, function, and aggregation. It also demonstrates the use of a 
technique that has not yet been used to characterise crystallin proteins which may provide new 
information on crystallin heterogeneity in the future. The specific aims are to: 
1. Investigate the structural features, biophysical properties and physiological relevance of an 
oxidised form of γS-crystallin.  
2. Use multiple means of mimicking the highly crowded environment of the eye lens and thereby 
elucidate its effect on the structural and functional features of αB-crystallin. 
3. Demonstrate the ability of capillary electrophoresis to characterise the conformational 
heterogeneity of model proteins as a proof-of-concept for its application towards the 
conformationally and post-translationally heterogeneous crystallins. 
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CHAPTER 2:  
DISULFIDE-LINKED γS-CRYSTALLIN DIMER 
 
 
 
 
 
 
 
“No problem is too small or too trivial if we can really do something about it.” 
– Richard Feynman
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Edited by Sheena RadfordAbstract
The reducing environment in the eye lens diminishes with age, leading to significant oxidative stress.
Oxidation of lens crystallin proteins is the major contributor to their destabilization and deleterious aggregation
that scatters visible light, obscures vision, and ultimately leads to cataract. However, the molecular basis for
oxidation-induced aggregation is unknown. Using X-ray crystallography and small-angle X-ray scattering,
we describe the structure of a disulfide-linked dimer of human γS-crystallin that was obtained via oxidation of
C24. The γS-crystallin dimer is stable at glutathione concentrations comparable to those in aged and
cataractous lenses. Moreover, dimerization of γS-crystallin significantly increases the protein’s propensity to
form large insoluble aggregates owing to non-cooperative domain unfolding, as is observed in crystallin
variants associated with early-onset cataract. These findings provide insight into how oxidative modification
of crystallins contributes to cataract and imply that early-onset and age-related forms of the disease share
comparable development pathways.
© 2018 Elsevier Ltd. All rights reserved.Introduction
The eye lens contains a high concentration of
crystallin proteins arranged in a well-ordered, short-
range array that allows for lens transparency and
the refraction of light onto the retina, thus ensuring
proper vision [1–3]. In mammals, the crystallins
comprise three types (α, β, and γ), of which there are
several isoforms. The α-crystallins are members
of the small heat-shock protein family, whereas the
β- and γ-crystallins are a structurally homologous
superfamily of proteins that are not related to small
heat-shock proteins [4–6]. β- and γ-crystallins have
a monomeric mass of approximately 20 kDa and
consist of two domains, each containing twoGreek-key
β-sheet motifs, which are adjoined by a short linking
peptide [6–9].
There is little protein turnover in the eye lens, and
thus, the crystallins are long-lived proteins that must
maintain their structural integrity throughout life to
preserve lens transparency [10–12]. Cataract occurs
due to a loss of crystallin protein stability and
the subsequent propensity of crystallins to partiallyr Ltd. All rights reserved.unfold, leading to aggregation and precipitation
[6,13]. While cataract acquired during early life
commonly stems from destabilizing, inheritable mu-
tations in crystallin proteins, age-related cataract is
thought to originate from cumulative post-translational
modifications (PTMs) [14,15]. Oxidation is a prevalent
crystallin PTM in both aged and cataractous lenses
[16,17] that increases the aggregation propensity of
some crystallins in vitro [18–20]. Cysteine residues
are the principal site of protein oxidation [16,21], and
disulfide-linked crystallins are a major component of
the insoluble fraction of cataractous lenses [22,23].
The key factor in preventing crystallin oxidation is the
cellular reductant glutathione, the levels of which
diminish with age, to the extent that it is severely
depleted in cataractous lenses [24–26].
γS-crystallin (γS) is one of the major crystallins in
the human lens [27], and its abundance increases
with age due to postnatal expression [28]. Human
γS in cataractous lenses is oxidized at specific
cysteine residues [17], including S-methylation [29],
S-glutathionylation [30], and intermolecular disulfide
bond formation [23]. Indeed, γS forms disulfide-Journal of Molecular Biology (2019) 431, 483–497
Table 1. Data processing and refinement statistics for γS
disulfide-linked dimer
Data collection
Wavelength (Å) 0.9763
Space group P1
Cell dimensions
a, b, c (Å) 49.63, 52.37, 53.97
α, β, γ (°) 108.72, 111.46, 105.50
Total reflections 61,796 (5062)
Unique reflections 23,548 (2372)
Multiplicity 2.6 (2.6)
Completeness (%) 93.6 (94.4)
Mean I/sigma(I) 7.8 (1.3)
Wilson B-factor (Å2) 33.3
R-merge 0.032 (0.559)
R-pim 0.022 (0.390)
CC1/2 0.997 (0.757)
Refinement
R-work/R-free 0.2248/0.2716 (0.3067/0.3783)
484 Disulfide-Linked γS-Crystallin Dimerlinked dimers in vitro [31]. Disulfide-linked dimeriza-
tion similarly occurs for the R14C mutant of γD-
crystallin, leading to increased aggregation propensity
and hereditary juvenile-onset cataract [32]. In light of
this and the enhanced oxidative conditions in the
aging lens, a detailed understanding of the structural
and physiological implications of disulfide-linked
dimerization of wild-type γS is needed. Herein, we
isolated disulfide-linked, dimeric human γS and de-
termined its structure by X-ray crystallography and
small-angle X-ray scattering (SAXS). The significance
of the disulfide bonding arrangement of the three
clustered cysteine residues at positions 22, 24, and 26
is discussed. Furthermore, we provide biophysical
and biochemical evidence for the role of the γS dimer
in age-related cataract and the potential molecular
mechanisms underlying this role.Number of non-hydrogen atoms 3029
Macromolecules 2892
Water 137
Protein residues 348
RMS (bonds, Å) 0.008
RMS (angles, °) 0.95
Ramachandran preferred (%) 94.45
Ramachandran allowed (%) 4.36
Ramachandran outliers (%) 1.16
Clashscore 6
Average B-factor (Å2) 32.55
Macromolecules 32.53
Solvent 32.88
PDB ID 6FD8
Highest-resolution shell is shown in parentheses.Results
Structure of human γS disulfide-linked dimer
Human γSmonomer was expressed heterologously
in Escherichia coli and purified using anion-exchange
and size-exclusion chromatography (SEC). Previous-
ly, γS was reported to undergo time-dependent dimer
formation under ambient, oxidative conditions at
slightly elevated pH, for example, pH 8 [31]. In the
present study, γS monomer was readily converted to
dimer at physiological pH (i.e., pH 7) by concentrating
themonomer to aminimumof 20mgmL−1 and leaving
the protein at 4 °C for 1 week. Monomeric and dimeric
forms of γS were isolated and checked for homoge-
neity and correct mass using SEC coupled to multi-
angle light scattering (Fig. S1a).
The γS dimer was crystallized and its structure
determined by X-ray crystallography to a resolution
of 2.1 Å (Table 1). The crystal structure shows
the canonical two-domain Greek-key motif β-strand
arrangement for each monomeric subunit (Fig. 1a,
top). The asymmetric unit consists of a dimer of γS
arranged in the same orientation as is observed for
the crystal structure of truncated βB1-crystallin [34]
and the solution structure of full-length βB2-crystallin
[35], which has been previously described as a QR
configuration [36]. There are three cysteine residues
in a loop close to the N-terminus of γS: C22, C24,
C26. In each monomer in the asymmetric unit, the
loop is cyclized by one intramolecular disulfide bond
between C22 and C26 in each subunit (Fig. 1a,
bottom, c and d). No other disulfide bonds were
present in the crystallographic dimer observed in the
asymmetric unit. However, electrospray ionization
mass spectrometry (MS) of the γS dimer indicated
the presence of three disulfide bonds, that is, a loss
of 6 Da from the expected mass of two monomers
(Fig. S1b). Inspection of symmetry mates within the72crystal lattice revealed an alternative dimer interface
having a C24:C24’ disulfide bond as its principal
intermolecular contact. Analysis of the dimer inter-
face using PISA [37] indicated that this alternative
interface buries 648 Å2 of protein surface area. In
addition to the intermolecular disulfide bond, there
are several non-covalent intermolecular interactions
at the dimer interface, most notably two hydrogen
bonds between the δ-oxygen of D23 and the amide
hydrogen of A27 on either subunit, as well as an
aromatic ring interaction between Y32 of each
subunit.
Proteins can adopt quaternary arrangements in
solution that are distinct from their crystal structure,
for example, the structurally and functionally related
βB2-crystallin dimer [35]. Thus, we used SAXS to
characterize the structure of the monomer and
disulfide-linked γS dimer in solution. The pairwise
distance distribution function (P(r)) was examined
to ensure shape and size differences between γS
monomer and dimer were evident in the SAXS data.
The P(r) of the monomer shows a unimodal dis-
tribution consistent with both domains being closely
associated with a maximum diameter (Dmax) of 59 Å
and a radius of gyration (Rg) of 18.5 Å. The P(r) of the
dimer shows a bimodal distribution consistent with
Fig. 1. Structure of the γS dimer. (a) Crystal structure of γS dimer with the inter- (C24) and intramolecular (C22 and C26)
disulfide bond arrangement shown as a whole view of the dimer (top) and as a magnified view within the 2mFo − dFc map
(blue lines, contoured at 1.5σ) centered on the intermolecular disulfide bond (bottom). (b) Crystal structure of γS dimer
fitted into the ab initio SAXS shape envelope (grey line, contoured at 2σ) as shown from a side view (top) and from above
(bottom). (c) Linearized schematic of the γS dimer structure with prominent structural features and residues indicated and
colored concordantly with the crystal structure above. (d) Comparison of the percentage SAS of all cysteine residues in
monomers of γB (PDB: 2JDF), γC (PDB: 2NBR), γD (PDB: 1HK0), and γS (PDB: 2M3T). The structure for γA is not
available. SAS is relative to a Gly-Cys-Gly tripeptide in an extended conformation [33]. The positions of cysteine residues
in the amino acid sequences of γS and other human γ-crystallins are in bold and normal typeface, respectively. C108 and
C109 denote cysteine residues in γC/γD and γB, respectively. (e) Sequence alignment of human γS (residues 1–40) with
four other human γ-crystallins highlighting: (i) invariant and chemically conserved amino acid residues as shown in the key;
(ii) cysteine residues, C, in bold typeface and red; and (iii) C24 with a blue arrow.
485Disulfide-Linked γS-Crystallin Dimerthe “V” shape of the disulfide-linked dimer, which
exhibits greater distance between the C-terminal
domains of each subunit than the alternative non-
disulfide linked dimer, giving a Dmax of 74 Å and a Rg73of 24.3 Å (Fig. S1d). A direct comparison of the
predicted one-dimensional scattering profiles from
the structures of the monomer (PDB: 2M3T) and
disulifde-linked dimer with that of the experimentally
486 Disulfide-Linked γS-Crystallin Dimerobtained scattering data shows that the monomer
structure fits well with a χ value of 1.19 (Fig. S1e,
light blue). However, the dimer's fit is not as good
with a χ value of 2.19 due to a discrepancy in the
mid-q range (Fig. S1e, orange). To explore the
basis of this structural discrepancy in the dimer, an
ab initio shape envelope was built using the γS
dimer SAXS data within which the crystal structure
was fitted (Fig. 1b, top and bottom). The general
domain arrangement along the longitudinal axis is
consistent with that of the disulfide-linked dimer
(Fig. 1b, top), thus verifying the conformation of the
biological assembly. There are, however, two
protuberances in the transverse plane of the
SAXS envelope that correlate with the three-
dimensional space that would be sampled by an
unstructured and flexible N-terminal extension
(Fig. 1b, bottom), encompassing the first four
N-terminal residues (Fig. 1c, black, and e, black
boldface text) [38]. A similar protuberance is noted
in the ab initio SAXS envelope of βB2-crystallin
dimer due to flexible terminal extensions [35,39].
Given the absence of the first three residues of the
N-terminal extension in the crystal structure (due
to insufficient electron density) and the high B-
factor for the fourth residue (G4) (Fig. S1f), it is
clear the N-terminal extension maintains flexibility
in the dimer. Taken together, these results highlight
the source of the discrepancy between the crystal
structure and the solution SAXS data as being the
N-terminal extension which protrudes from the
domain core structure in the dimer (Fig. S1g), as
it does in the monomer [40].
C24 is unique to γS and is the most solvent-
exposed cysteine in human γ-crystallins
To explore whether this disulfide bonding ar-
rangement observed in human γS is likely to be
conserved in γ-crystallins, we compared the
sequence of γS to that of human isoforms γA-
crystallin (γA), γB-crystallin (γB), γC-crystallin
(γC), and γD-crystallin (γD) (Fig. 1e). C22 and
C26 (C18 and C22 in other γ-crystallins) are both
conserved in γA and γB (Fig. 1e), implying that an
intramolecular disulfide bond could form between
C18 and C22 in these two γ-crystallins. However,
C24 (Fig. 1e, blue arrow) is unique to γS with either
serine or threonine substituting for cysteine at the
analogous site (position 20) in other isoforms. To
assess the relative probability of other human
isoforms forming disulfide-linked dimers, we also
examined the solvent accessible surface area
(SAS) of all cysteines in the monomeric structures
of γS, γB, γC, and γD relative to the side-chain SAS
of Cys in a Gly-Cys-Gly tripeptide in an extended
conformation [33] (Fig. 1d). C24 is significantly
more solvent-exposed than any other cysteine in
human γ-crystallins, followed by C26, although the74latter is unlikely to be involved in the formation of an
intermolecular disulfide bond owing to its partici-
pation in an intramolecular disulfide bond to C22
(Fig. 1a, bottom, c and d). With the exception of
C110 in γD, all other cysteine residues in human γ-
crystallins have a SAS of 20% or less (Fig. 1c and
d), implying that significant formation of a native
disulfide-linked dimer is confined to γS. An inter-
species comparison of γS revealed that C24 (Fig.
S1c, blue arrow) is highly conserved in eutherians
(placental mammals), whereas it is not present
in marsupials, birds, reptiles and fish, implying that
disulfide-linked dimerization of a variety of eutherian
orthologs is possible, ashas beenobserved for bovine
γS [31]. Moreover, the absence of C24 in other
vertebrates suggests that it is a recent mutation on the
evolutionary timescale, arising in a late common
ancestor to eutherians (Fig. S1c).
The γS dimer persists in a reducing environment
relevant to aging and cataractous lenses
The young human lens is a reducing environment
due to the abundance of reduced glutathione (GSH)
at a concentration of approximately 6 mM, which
diminishes to approximately 2 mM upon aging and
to less than 1 mM upon cataract formation [24–26].
We investigated the susceptibility of the γS dimer to
dissociation over a range of physiologically relevant
reducing environments using analytical SEC. Ratios
of GSH and oxidized glutathione (GSSG) to a total
concentration of 6 mM were used to modulate the
reduction potential of the solution. Analytical SEC
profiles showed significant changes over a 72-h
period for those samples containing GSH (Fig. S2a).
Interestingly, there was a minor linear shift, most
prominent at 72 h, in the retention volume of the
monomer peak maximum over the GSH:GSSG
series (Fig. S2b), which most likely reflects an
increase in hydrodynamic size of the monomer due
to glutathionylation of the protein (see the following
paragraph). From the peak integration values, the
percentage of dimer was calculated for each time
point and reduction potential, and then plotted
against time (Fig. 2a). The results show that over
72 h, the dimer dissociates at an exponential rate
that slows with decreasing reducing potential. For
example, the dimer was reduced twice as fast by 3
mMGSH, and five times as fast by 6 mMGSH, when
compared with 1 mM GSH (Fig. 2b). By 72 h, the
percentage of the dimer remained relatively constant
over time for all conditions; at 1, 3, and 6 mM GSH,
there was 22%, 9%, and 3% dimer remaining,
respectively (Fig. 2a). The fully oxidized environment
(6 mM GSSG) showed no significant changes in the
quantity of disulfide-linked dimer over the experimen-
tal time course. Thus, γS ismonomeric at GSH:GSSG
ratios associated with healthy young lenses, but the
dimer becomes increasingly stable as GSH:GSSG
Fig. 2. The effect of glutathione on the abundance, reduction rate and reduction products of the γS dimer. (a) Percentage
abundance of the γS dimer with different GSH:GSSG ratios over time asmonitored by SEC. The data were fitted to a single
exponential decay curve (R2 N 0.99) except for 0:6GSH:GSSG,whichwas fitted to a straight line function. (b) Time constant
from the single exponential decay curve fitted against the relevant GSH:GSSG ratio. The errors are the standard deviation
of two independent repeats. The asterisk denotes data for 0:6 GSH:GSSG that were not fitted to a single exponential decay
curve. (c) Relative percentage abundance of the γS dimer, monomer, and glutathionylated monomer (monomer-SG)
determined by electrospray ionization MS. The errors are the standard deviation of three independent repeats.
487Disulfide-Linked γS-Crystallin Dimerratios approach those found in aged and cataractous
lenses.
MS was used to confirm the analytical SEC results
and to detect any chemical modifications to γS upon
reduction of the dimer. Masses for the disulfide-linked
dimer and the monomer were detected as well as a
third species corresponding to S-glutathionylated γS
monomer (Fig. S2c). Semi-quantitative analysis of all
detectable MS species was achieved with a standard
curve using purified monomer and dimer (Fig. S2d).
It is evident that the dimer ionizes poorly compared
to the monomer, thus affecting quantification of the
dimer by MS, particularly at lower concentrations, and
thereby accounting for discrepancies in its abundance
when compared to the concentration sensitive UV-
detection in SEC. Nonetheless, the data acquired
following 72 h of reduction showed that the abun-
dance of the dimer decreases with increasing
reduction potential, alongside a concomitant increase
in the abundance of monomeric species (Fig. 2c),
concordantwith the trend observed by analytical SEC.
The abundance of unmodified and S-glutathionylated
monomer changes across the GSH:GSSG series.
At 1:5 GSH:GSSG, for example, 85% of monomer is
S-glutathionylated; however, this decreases linearly
across the series, falling to 22% at 6:0 GSH:GSSG
(Fig. 2c). The unmodified monomer consequently
shows the inverse trend, consistent with the linear
decrease in themonomer’s retention volume at higher
GSSG concentrations, as noted in SEC (Fig. S2b),
implying that glutathionylation occurs via a disulfide
exchangemechanismwhereby the protein thiol reacts
with GSSG. Furthermore, given that no glutathionyla-
tion was detected for the dimer (Fig. S2c), glutathio-
nylation occurs at either C22, C24, or C26, which are
otherwise disulfide bonded in the dimer. Examination75of the unmodifiedmonomermass peak after reduction
of the dimer reveals the highest intensity mass peak
shiftswith increased reduction potential from20872Da
to 20874 Da at 1:5 and 6:0 GSH:GSSG, respectively
(Fig. S2e). A similar trend can be observed for the
S-glutathionylated monomer mass peak, largely shift-
ing from 21177 to 21179 Da at 1:5 and 6:0 GSH:
GSSG, respectively (Fig. S2f). This 2-Da difference
implies that the C22–C26 intramolecular disulfide
remains intact after initial reduction of the dimer, but
the bond is ultimately reduced at higher reduction
potentials. It also implies that γS glutathionylation
occurs initially at C24, consistent with it being themost
solvent-exposed cysteine (Fig. 1d).
Aggregation propensity is significantly increased
when γS forms a disulfide-linked dimer
In view of the link between the oxidation of crystal-
lins and cataract [41] and the increased aggregation
propensity of the R14C γD disulfide-linked dimer [32],
we investigated the aggregation propensity of the
disulfide-linked γS dimer compared to its monomeric
counterpart. A light scattering assay at 60 °C
showed that the disulfide-linked γS dimer was far
more aggregation prone than the monomer from 0.5
to 3.0 mg mL−1 (Fig. 3a). On average, the dimer’s
light scatteringmaximumwasapproximately 3.6 times
greater than that of the monomer (Fig. 3b). Similarly,
the rate of aggregation of the dimerwas approximately
2.8 times faster (Fig. 3c). However, the lag time,
reflecting the time required for the protein to form a
critical nucleus (from which to seed aggregation),
was approximately 1.2 times longer for the dimer than
for the monomer (Fig. 3d). Thus, while the dimer
aggregates faster and to a greater extent,
Fig. 3. Aggregation propensity of the γS monomer and
dimer. (a) Light scattering (360 nm) assay of γS monomer
(hollow squares) and dimer (filled circles) from 0.5 to 3.0 mg
mL−1 with 0.5 mg mL−1 increments. Light scattering kinetic
parameters including (b) maximum light scattering, (c)
aggregation rate, and (d) lag time of aggregation for γS
monomer (light blue) and dimer (orange). Errors are givenas
the standard deviation of three independent repeats. (e)
Negative stain TEM of 1 mgmL−1 monomer (top) and dimer
(bottom) aggregates formed after 2 h at 60 °C. The scale bar
(black, bottom left) represents 500 nm. (f) Dynamic light
scattering of 2 mg mL−1 native monomer (light blue, solid
line) and dimer (orange, solid line) at 25 °C, and aggregated
monomer (light blue, dashed line) and dimer (orange,
dashed line) after 35 min at 60 °C.
488 Disulfide-Linked γS-Crystallin Dimerintermolecular interactions in the early stages of
aggregation are hindered in comparison to the
monomer. The reduced accessibility of specific
interfacial residues in the dimer, along with steric
considerations, may be factors underlying the extend-
ed lag time for the dimer. Transmission electron
microscopy (TEM) showed that the aggregates
formed by the monomer (Fig. 3e, top) and dimer
(Fig. 3e, bottom) appeared essentially amorphous in
form with little ordered structure. Dynamic light
scattering showed that the aggregates formed by the
dimer were, on average, larger than those of the
monomer. Initially, the native monomer and dimer76measured at 25 °C had an average hydrodynamic
diameter (Dh) of 4.0 ± 0.9 and 5.8 ± 0.8 nm,
respectively (Fig. 3f, solid line). Upon incubation at
60 °C, there was a rapid, time-dependent increase in
Dh for both the monomer and dimer, as anticipated.
After 35 min of incubation, the approximate time at
which a steady state was observed in the light
scattering assay (Fig. 3a), the monomer and dimer
exhibited a Dh of 2,541 ± 173 and 3,787 ± 301 nm,
respectively (Fig. 3f, dashed line). Thus, the increased
light scattering in solution is due, in part, to the
increased hydrodynamic size of the dimer aggre-
gates, as well as a potentially higher yield of
aggregated protein.
γS dimer undergoes non-cooperative thermal
unfolding despite having a similar structure
to the monomer
Far-UV circular dichroism (CD) spectra and
8-anilinonaphthalene-1-sulfonic acid (ANS) binding
experiments, respectively, showed that the overall
secondary structure (Fig. 4a) and surface hydropho-
bicity (Fig. 4b) of γS are not significantly altered upon
dimerization. Indeed, structural alignment of the γS
dimer with three other γS structures, that is, the human
γS C-terminal domain crystal structure [42] (PDB:
1HA4), thehuman γSNMRstructure [40] (PDB: 2M3T),
and the chicken γS crystal structure [43] (PDB: 5VH1)
(Fig. 4c–e, respectively), gave Cα RMSD values no
greater than 1.9 Å, indicating that the overall fold of the
dimer is similar to those previously determined for γS.
However, the dimer shows increased intrinsic trypto-
phan fluorescence relative to that of the monomer
(Fig. 4c), suggesting that the fluorescence of one or
more of the protein’s four tryptophan residues is less
efficiently quenched in the dimeric form. Close exam-
ination of the environment of the tryptophan residues
within the dimer structure revealed that the otherwise
highly quenched W162 is not coordinated to a water
molecule, in contrast to the truncated γS C-terminal
domain structure (PBD: 1HA4), thereby having an
impact on the efficient quenching of W162 and
potentially accounting for the higher quantum yield [44].
In the absence of evidence of any significant
perturbations in the native structure of the disulfide-
linked dimer, we examined its thermal stability in
an effort to account for its increased aggregation
propensity. Four spectroscopic methods, intrinsic
tryptophan fluorescence, light scattering, ANS fluores-
cence, and CD (Fig. 5a–d, respectively), were used to
compare the thermal stability of the monomer and
dimer. It is apparent in all the unfolding curves that
the dimer exhibits biphasic behavior while the mono-
mer is monophasic in its unfolding. It is concluded that
the dimer unfolds non-cooperatively, that is, one
domain before the other, whereas unfolding of the
monomer is concerted (Fig. 5e). Similar thermally
induced biphasic unfolding has been noted in the
489Disulfide-Linked γS-Crystallin Dimercataract-associated G18V variant in monomeric γS
[45]. From the data in Fig. 5, a mid-point of thermal
unfolding (Tm) or aggregation (Tagg) was calculated for
each transition (TableS1),which showed themid-point
of the dimer's first transition to be lower than that for the
single value of the monomer but the second transition
to be at a higher temperature. Examination of the
difference in Tm values (ΔTm) between the monomer
and those of the dimer and comparison to ΔTm values
reported in the literature for γS and its independent
domains (Fig. S3a) implied that the first and second
transitions of the dimer represent the unfolding of the
N- andC-terminal domains, respectively. For example,
while Mills et al. [46] reported a ΔTm for the isolated N-
and C-terminal domains of γS of 6.0 °C, the ΔTm
between the first and second transition of the dimer is
6.7 °C (Fig. S3b). Similarly, the ΔTm between the full-
length monomer and each domain [46] is comparable
to the ΔTm between the monomer and each transition
of the dimer, implying that domain stability differences
are largely conserved and, moreover, that unfolding of
the N-terminal domain precedes that of the C-terminalFig. 4. Comparison of the secondary structure, surface hydr
dimer and related structures. (a) Far-UV CD, (b) ANS fluor
monomer (light blue) and dimer (orange). Structural overlay bet
domain crystal structure (blue; PDB: 1HA4), (e) human γS NM
structure (red; PDB: 5VH1). The RMSD is given as a quantita
77domain in the γS dimer (Fig. 5f). Interestingly, the
G18V variant, which also exhibits biphasic thermal
unfolding, gave a ΔTm between its first and second
transition of 8.0 °C [45], comparable with the ΔTm of
7.9 °C between the first and second transition of the
dimer (Fig. S3c). Potentially, therefore, the biphasic
unfolding induced in γS by the cataract-associated
G18V mutation parallels the behavior induced by
disulfide-linked dimerization.Discussion
The evidence for cysteine oxidation, including
disulfide crosslinks, between crystallin proteins in
aging and cataractous lenses is extensive [16,17,
21–23,47]. Previous studies have shown that disul-
fide bonds can form in vitro in γ-crystallins [18,31,
32,48], but most studies do not demonstrate the
ability for these disulfides to be viable in a reducing
environment commensurate with that of the lens.
Human lens GSH concentrations decrease with ageophobicity and overall conformation of the γS monomer, γS
escence, and (c) tryptophan fluorescence spectra of γS
ween human γS dimer (beige) and (d) human γSC-terminal
R structure (green; PDB: 2M3T) and (f) chicken γS crystal
tive measure of structural similarity.
490 Disulfide-Linked γS-Crystallin Dimerfrom approximately 6 to 2 mM and can fall below
1 mM in cataract [24–26]. We have shown that the
γS disulfide-linked dimer becomes increasingly
stable at GSH concentrations found in aging and
cataractous lenses. While these studies were
completed at physiological GSH concentrations, it
is worth noting that the concentration of γS in the
lens is likely to be in the order of 100 times more than
that studied here [6,49]. Furthermore, the aging,
GSH-depleted lens would need to contend with the
stress associated with the oxidation of other lentic-
ular components [50]. Thus, we consider the
experimental values of dimer abundance determined
herein to be conservative estimates in relation to the
prevalence of the disulfide-linked γS dimer in vivo.
Glutathionylation of crystallin proteins in normal and
cataractous human lenses has been noted numerous
times with the prevalence of this modification being
positively correlated with aging [24,51–53]. γS ex-
tracted from the human lens is S-glutathionylated at
two sites, with one modification at either C22, C24, or
C26 and another at C82 [30]. We observed a single
glutathionylation of γS by MS and inferred that theFig. 5. Thermal stability of the γSmonomer and dimer. The
γS monomer (light blue) and dimer (orange) were monitored
using (a) tryptophan fluorescence (Trp) (ratio 345/329 nm), (b)
light scattering at 360 nm, (c) ANS fluorescence at 480 nm,
and (d) CD at 218 nm. Curves are the average of three
independent repeats, and the errors are given as standard
deviation. (e) Schematic diagram depicting how the γS
monomer unfolds cooperatively, while the γS dimer (f) unfolds
non-cooperatively, initially via its N-terminal domain. Structural
features of the monomer and dimer are denoted in the key
adjacent to panel e.
78modification occurred at C24, consistent with its high
solvent exposure (Fig. 1d). In natively folded γS, C82
is unlikely to be glutathionylated due to its very low
solvent exposure, and as such, glutathionylation at
C82 in vivo is likely an indicator of partial unfolding of
the N-terminal domain. The abundance of glutathio-
nylated γS monomer is directly proportional to the
concentration of GSSG (Fig. 2c and S2b), indicative
of mixed disulfide formation via an exchange
mechanism which has been previously noted as
the preferred mechanism for the addition of
glutathione to crystallins [52,54]. Furthermore, the
amount of glutathionylation at 6:0 GSH:GSSG is
likely due to the reduction of dimer consequently
forming GSSG. This mechanism is consistent with
C24 being present largely in the reduced thiol
(protonated) form at physiological pH, due to an
elevated pKa value as a result of flanking nega-
tively charged aspartyl residues in the “DCDCDC”
motif from residues 21–26 [31]. A disulfide ex-
change mechanism also has implications for the
formation of the γS dimer, which could foreseeably
arise via a reaction between S-glutathionylated
and unmodified γS monomers, resulting in the
formation of a protein-protein disulfide link and
GSH (Fig. 6). Indeed, γS has been proposed to
function as a “redox sink” in the aging lens, that is,
acting as a reducing agent to consume GSSG and
replenish GSH levels in the process of forming
disulfide-linked dimers [6,31]. However, given the
enhanced aggregation propensity of the γS dimer,
such replacement would be a trade-off in order to
maintain a reducing environment in the lens.
The link between PTMs, particularly oxidation,
disulfide bond formation, and cataract is prevalent,
with a prevailing sentiment being that the formation
of age-related cataract is a function of PTMs, heat,
and time [14–16]. Single-residue mutations such as
G18V in γS [45] and R14C (which can form disulfide-
linked dimers) in γD [32] have a heightened
aggregation propensity and are associated with
cataract. However, both variants are structurally
comparable to their wild-type counterparts. Similarly,
the γS disulfide-linked dimer is also far more
aggregation prone, but its structure is not altered
when compared to the monomer. The thermal
denaturation of the γS dimer also resembles that of
the cataract-associated G18V variant [45]. Overall,
thermal denaturation indicates that disulfide-linked
dimerization of γS decouples the unfolding coopera-
tivity of the N- and C-terminal domains. However,
while a loss of cooperativity is evident, the relative
stability difference between the N- and C-terminal
domains does not appear to be affected upon
comparison with the isolated N- and C-terminal
domains (Fig. S3a). Possible causes of this are likely
to be related to subtle changes in domain flexibility
and altered interactions with water upon dimeriza-
tion. Indeed, molecular dynamics studies on
491Disulfide-Linked γS-Crystallin Dimerhomology structures of wild-type and G18V γS
reveal that changes in inter-strand salt-bridge
interactions accompany changes in dynamics that
allow water permeable openings in the N-terminal
domain of G18V [55]. This could further disrupt
bonding networks that lead to a loss of the
cooperative unfolding mechanism between the two
domains as has been noted for this cataract-
associated variant [45]. Furthermore, NMR studies
on murine cataract-associated F9S, which also
exhibits non-cooperative domain unfolding, show
changes to the tryptophan (a “Trp corner”) involved
in hydrogen bonding and stabilization of a β-turn in
the N-terminal domain. As Trp or Tyr corners have
been intimately linked to the folding/unfolding mech-
anism of Greek-key folds [56,57], this could highlight
an additional role in the maintenance of folding/
unfolding cooperativity.
The biphasic unfolding of the dimer indicates a
thermodynamically stabilized intermediate, which
is likely characterized by an unfolded N-terminal
domain and a folded C-terminal domain, as has been
observed in other destabilized γ-crystallins [18,45,
58–60]. Consistent with this, molecular dynamics
simulations have implied that γD can aggregate
through domain swapping via a partially folded inter-
mediate characterized by an unfolded N-terminal
domain but an otherwise folded C-terminal domain
[61]. Indeed, the γS disulfide-linked dimer is far
more aggregation prone compared to the monomer,
displaying ostensibly amorphous looking aggregates
via TEM (Fig. 3e, bottom). However, it has been
demonstrated that partially ordered P23T γD aggre-
gates are indistinguishable from amorphous aggre-
gates when viewed by TEM [62], indicating that
further investigation into the substructure of the
aggregates observed here is needed to obtain a
more complete understanding of their molecular
underpinnings. The present study suggests that the
disulfide-linked γS dimer is highly analogous to the
G18V and dimer-forming R14C variants, which are
both associated with progressive juvenile-onset
cataract [32,45]. Such cataract-associated variants
therefore appear to exhibit structural markers similar
to those that may emerge in wild-type γ-crystallins
later in life due to aging, for example, the formation of
non-native disulfides [18]. We propose that oxidation
and subsequent dimerization of γS preferentially
destabilizes its N-terminal domain, as is evident
in G18V, resulting in a thermodynamically stable
intermediate that exhibits increased aggregation and
thereby exacerbates light scattering associated with
age-related cataract (Fig. 6).
In summary, we have characterized an oxidative
PTM of human γS and provided a molecular basis
for its role in age-related cataract. Determination of
the crystal structure of the oxidation product showed
γS in the form of a dimer linked via an intermolecular
disulfide bond at C24 [31] and also revealed an79intramolecular disulfide between C22 and C26. No
gross conformational changes were observed upon
oxidation. We have demonstrated that this PTM
is stable at GSH concentrations akin to those in
aged and cataractous lenses and the PTM increases
the propensity of γS to aggregate. Along with other
conformational features shared by the γS dimer and
cataract-associated variants, these findings strongly
suggest that the occurrence of this PTM in the aging
lens leads to or worsens the severity of cataract. The
mechanism outlined here may apply more broadly to
other crystallin proteins that undergo oxidative PTMs
as part of the oxidation-driven aggregation cascade
that underlies age-related cataract.Materials and Methods
Production of γS monomer and dimer
A pET43.1 plasmid encoding recombinant human
γS (178 amino acids; UniProt P22914) was pur-
chased from Genscript and expressed in BL21(DE3)
E. coli cells. Cells were cultured initially at 37 °C for
4–5 h. Expression was then induced with 500 μM
IPTG, and the cell culture was incubated overnight at
30 °C. Cells were pelleted, resuspended in DEAE
column buffer (20 mM Tris–HCl, pH 8.0), and lysed
using sonication. The cell lysate was loaded onto an
anion-exchange column (HiPrep DEAE FF 16/10;
GE Healthcare) and a peak containing γS eluted
in the flow-through. Fractions containing predomi-
nantly γS were concentrated to ~1 mL, loaded onto
a preparative SEC column (HiLoad 16/600 Superdex
75 pg; GE Healthcare) and separated in PBS (50
mM sodium phosphate, 100 mM NaCl, pH 7.0. The
peak corresponding to monomeric γS was collected.
This initial fraction of monomeric γS was concen-
trated to a minimum of 20 mg mL−1 using an Amicon
Ultra-15 Centrifugal Filter Unit (Merck Millipore) and
left at 4 °C for 1 week to allow for large-scale
dimerization of γS (up to 60% of the total protein).
Monomeric and dimeric forms of γS were then
purified by two sequential separations via prepara-
tive SEC, eluting with 20 mM sodium phosphate
buffer (pH 7.0). Within 30 min of elution, respective
fractions of monomer and dimer were frozen with dry
ice in 0.2–0.5 mL aliquots at protein concentrations
of 4-8 mg mL−1. Aliquots were thawed immediately
prior to use.
Crystallization, data collection, and refinement
Purified γS dimer was buffer exchanged to 10 mM
HEPES (pH 7.2) and concentrated to 10 mg mL−1.
Crystals were obtained by vapor diffusion in sitting
drops containing 0.2 M sodium tartrate dibasic
dihydrate (pH 7.3) and 20% w/v polyethylene glycol
Fig. 6. Putative schematic representation of the process of oxidation/dimerization, destabilization, and aggregation of
human γS.
492 Disulfide-Linked γS-Crystallin Dimer3350 (Hampton Research). For cryoprotection,
drops were supplemented with 30% w/v polyethyl-
ene glycol 3350 and crystals were subsequently
vitrified by submersion in liquid nitrogen. Diffraction
data were collected at a wavelength of 0.9763 Å on
the MX2 beam line of the Australian Synchrotron.
Diffraction data were indexed, scaled, and integrated
using XDS [63]. Phases were obtained, via molec-
ular replacement, using PhaserMR [64] with the
crystal structure of chicken γS [43] (PDB 5VH1) as
the search model. Cycles of refinement and manual
rebuilding were completed using PHENIX and Coot,
respectively [65,66].
SAXS measurements and ab initio envelope
reconstruction
Experiments were conducted on a NanoSTAR II
SAXS (Bruker) with a rotating anode Cu Kα radiation
source at a wavelength of 1.541 Å and using a q
range of 0.013–0.39 Å−1. Samples of γS monomer
(3 mg mL−1) and dimer (6 mg mL−1) were prepared
in 20 mM sodium phosphate (pH 7.0). Samples were
loaded into a sealed 2 mm quartz capillary cell
and placed under vacuum. Scattering was collected
in 1-h increments for a total of 4 h in a temperature
controlled sample environment at 25 °C. No change
in the scattering of the monomer or dimer was
observed over the 4-h acquisition period. The data
were averaged and subtracted from the scattering of
the buffer using PRIMUS [67]. Low q points near the
beam stop were excluded. The P(r) and the Rg were
calculated using GNOM [68]. Using CRYSOL, the
scattering profiles of the γS monomer (PBD: 2M3T)
and dimer structures (PDB: 6FD8) were modeled
and fitted to their respective experimental scattering
profiles [69]. Using GASBOR [70], 15 ab initio shape
envelopes were initially generated which were then
aligned, filtered, and averaged using the DAMAVER
suite [71]. This averaged structure underwent refine-
ment using DAMMIN [72] to produce the final80ab initio envelope. Using UCSF Chimera [73], the
final envelope was converted to a volumetric map,
contoured to 2σ and aligned with the γS dimer crystal
structure, giving a correlation coefficient for the fit
of 0.89.
Structural and sequence analysis
The SAS of all cysteine residues in the monomeric
structures of γB (PDB: 2JDF), γC (PDB: 2NBR),
γD (PDB: 1HK0), and γS (PDB: 2M3T) was inves-
tigated using UCSF Chimera [73]. In the case of
NMR-derived structures (γC and γS), the SAS was
averaged across all conformers. The SAS was
converted to a percentage relative to the side-chain
SAS of a Cys in a Gly-Cys-Gly tripeptide in an
extended conformation [33]. Sequence alignments
were generated using the Clustal Omega server [74]
and colored according to the consensus symbols
generated on the basis of their Gonnet PAM 250
matrix score [≤0.5 (.) weakly conserved (green);
N0.5 (:) strongly conserved (blue); = 1.0 (*) invariant
(orange)]. The phylogenetic tree was constructed
using the National Center for Biotechnology Infor-
mation taxonomy database. Structural overlay of the
γS dimer was completed using UCSF Chimera and
the RMSD of the Cα atoms was reported as the
measure of structural similarity between other γS
structures with the PDB accession codes 1HA4,
2M3T, and 5VH1.
Reduced and oxidized glutathione treatments of
γS dimer
The γS dimer at a concentration of 0.3 mg mL−1
was incubated in filtered (0.44 μm) 20 mM sodium
phosphate (pH 7.0) at room temperature with dif-
ferent ratios of GSH (G4251, Sigma) and GSSG
(G4376, Sigma). GSH:GSSG molar ratios were 0:6,
0.5:5.5, 1:5, 2:4, 3:3, 4:2, 5:1, and 6:0, maintaining a
6 mM final concentration of glutathione.
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γS dimer was prepared with GSH:GSSG ratios as
previously detailed. Following treatment for 0, 4, 8,
12, 24, 48, and 72 h, γS dimer was separated into its
monomeric anddimeric components usingaSuperdex
75 10/300 GL SEC (GE Healthcare) column attached
to an ÄKTA Pure FPLC (GE Healthcare) with UV
absorbance (280 nm) detection. Monomer and dimer
peaks were baseline corrected and integrated using
Unicorn 6.3 software (GE Healthcare). All experiments
were performed at room temperature using filtered
(0.44 μm) 20 mM sodium phosphate (pH 7.0) at a flow
rate of 0.8 mL min−1.
Mass spectrometry
Experiments were performed using an Orbitrap
Elite mass spectrometer equipped with a HESI-II
electrospray ionization source coupled to an Ulti-
Mate 3000 UHPLC (Thermo Scientific). γS dimer
was prepared with GSH:GSSG ratios as previously
detailed. Samples (7 μL) were injected into the mass
analyzer following treatment for 24 and 72 h. A mass
range of 200 to 4000 at a resolution of 240,000 was
acquired. The data were extracted and analyzed
using Thermo Xcalibur Qual software. Peaks corre-
sponding to the monomer, monomer–glutathione
adduct, and dimer were plotted as intensity versus
mass (Fig. S2c) and quantified (Fig. 2c) using
standard curves. Standard curves were generated
using purified γS monomer and dimer at approxi-
mately 0.02, 0.05, 0.1, 0.2, 0.3, 0.35, and 0.4 mg
mL−1 and mixed to achieve a total concentration of
approximately 0.4 mg mL−1 (Fig. S2d). The standard
curve samples were mixed to diminish any effects on
the final intensity count due to ionization transfer
between monomer and dimer species during exper-
iments where the monomer was being generated
from the dimer. The ionization intensity of the
monomer–glutathione adduct was assumed to be
the same as that of the monomer.
Transmission electron microscopy
Samples for TEM were prepared by adding 2 μL
of 1 mg mL−1 γSmonomer or dimer incubated for 2 h
at 60 °C to Formvar and carbon-coated copper grids
(ProSciTech, Australia). The grids were then
washed three times with 10 μL of Milli-Q water and
negatively stained with 10 μL of uranyl acetate (2%
w/v). Samples were viewed using a Hitachi
H7100FA transmission electron microscope
(Tokyo, Japan).
Thermal stability
Experiments were performed using an Applied
Photophysics Chirascan spectrophotometer attached81to a Quantum Northwest TC 125 PELTIER tempera-
ture controller. CD measurements were acquired in a
0.1 cmpathlength quartz cuvette, while light scattering
and Trp/ANS fluorescence experiments were ac-
quired in a 1 cmpathlength quartz cuvette. All cuvettes
were fitted with stoppers to prevent evaporation.
Proteins were prepared in 20 mM sodium phosphate
(pH 7.0) at a protein concentration of 0.3 mg mL−1.
Thermal stability was assessed by ramping the
temperature in 0.5 °C increments from 25 to
90 °C. At each increment, measurements at a single
wavelength were acquired for 1.5 s for 5 repeats with
a 30 s equilibration between each temperature
increment. Trp andANS fluorescenceweremeasured
at excitation wavelengths of 295 and 350 nm,
respectively. The concentration of ANS used was
300 μM. The acquisition wavelengths were 218 nm
(CD), 345/329 nm (Trp fluorescence), 360 nm (light
scattering), and 480 nm (ANS fluorescence). Exper-
iments were performed in triplicate. A single or double
Boltzmann sigmoidal function was fitted to the thermal
unfolding curves to obtain the Tm or Tagg values.
Aggregation assay
Kinetic aggregation assays were performed using
a Biotek Synergy 2 microplate reader. Protein
aggregation was induced at 60 °C and monitored
using light scattering at 360 nm. A “slow shaking”
setting was engaged for the duration of the assay.
The aggregation of γS monomer and dimer was
studied at 0.5, 1.0, 1.5, 2.0, 2.5, and 3.0 mg mL−1.
Aggregation kinetics were fitted to a single Boltzmann
function using Origin (OriginLab Corporation) and the
fitting parameters were used to calculate the lag time
and rate of aggregation as previously described [75].
Dynamic light scattering
Experiments were performed using a Zetasizer
Nano ZS (Malvern Instruments) with a built-in
PELTIER temperature control system. A standard
He–Ne laser operating at a wavelength of 633 nm
and a scattering detection angle of 173° (back-
scattering) was used for data collection. γS mono-
mer and dimer solutions were filtered through Millex
Durapore (0.22 μm) filters and subsequently loaded
into a semi-micro quartz cuvette fitted with a stopper.
The final concentration of protein was 2 mg mL−1 in
20 mM sodium phosphate (pH 7.0). Size measure-
ments of the native monomer and dimer were
performed at 25 °C. The sample was then placed at
60 °C, and aggregation was monitored continuously
until the protein was fully aggregated. Size measure-
ments collected within each 2-min increment were
averaged. Figure 3e shows data for the fully
aggregated sample acquired after 35 min, consistent
with the time at which a steady state is reached in
aggregation assays monitored by light scattering.
494 Disulfide-Linked γS-Crystallin DimerSEC with multi-angle light scattering detection
γS monomer and dimer were loaded onto a Super-
dex 75 10/300 GL SEC (GE Healthcare) column in
filtered (0.22 μm) 20 mM sodium phosphate (pH 7.0)
with multi-angle light scattering (DAWN HELEOS 8;
Wyatt Technologies) and refractive index detection
(Optilab rEX; Wyatt Technologies). The multi-angle
detectors were normalized using monomeric bovine
serum albumin (Sigma, A1900). A dn/dc value of
0.1983 mL g−1 for human γS [3] was used. The data
were processed using ASTRA (Wyatt Technologies).
Spectroscopy
CD and ANS fluorescence spectra were acquired
in 2 mM sodium phosphate (pH 7.0), while Trp
fluorescence was acquired in 20 mM sodium
phosphate (pH 7.0). All experiments were per-
formed at a concentration of 0.3 mg mL−1 at 25 °C.
CD spectra were acquired from 180 to 260 nm, ANS
fluorescence from 400 to 600 nm, and Trp fluores-
cence from 300 to 400 nm. Fluorescence parame-
ters were the same as those used for the thermal
stability experiments, except that the excitation
bandwidth was set to 5 nm for ANS fluorescence
experiments. Three repeats were acquired with a
step width of 1 nm for 4 s. These parameters were
used for three independent experiments, which
were averaged to produce the final spectrum.
Data deposition and accession numbers
The coordinates and structure factors have been
deposited in the Protein Data Bank with accession
number PDB ID 6FD8. SAXS data were deposited
in the Small Angle Scattering Biological Data
Bank (SASBDB) under the accession codes SAS-
DEZ6 (gamma-crystallin S disulfide-linked dimer) and
SASDE27 (gamma-crystallin S monomer).
Supplementary data to this article can be found
online at https://doi.org/10.1016/j.jmb.2018.12.005.CRediT authorship contribution state-
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Fig. S1. Further structural characterization of the γS dimer. (a) SEC-MALS of purified monomeric (Mw: 19.5 
kDa) and dimeric (Mw: 38.5 kDa) fractions of γS. (b) Intact mass spectrometry of the γS dimer with the inset 
showing the relevant mass peak and the weight average mass (Mw) for the isotopic distribution of the dimer. 
(c) Interspecies γS sequence alignment of the region centered around C24 (indicated with a blue triangle) and 
phylogenetic analysis using whole genome sequences. Species are indicated with both common and 
taxonomic, binomial names. Cysteines are colored red and in bold typeface. Sequence conservation is 
highlighted according to the key at the bottom of the figure. The horizontal dotted line indicates a 
differentiation between eutherians and other vertebrates. (d) P(r) function from SAXS data for γS monomer 
and dimer with the Dmax and real-space Rg values generated by GNOM. (e) CRYSOL fits of the crystal 
structure (solid line) to the experimental SAXS data (scatter) for the γS monomer (light blue) (PDB: 2M3T) 
and dimer (orange) (6FD8). The χ value indicates the goodness of the fit. (f) B-factor plot for subunits A 
(left) and B (right) of γS dimer colored by secondary structure as noted in the key below. The N- and C-
terminal domains, as well as the N-terminal extension, are indicated. C24 residue is highlighted. (g) γS dimer 
structure colored by B-factors. For residues with higher B-factors, the polypeptide backbone is represented 
as broader and colored nearer to red. 
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Fig. S2. Monitoring the resistance of the γS dimer to reduction using SEC and MS. (a) Chromatograms 
showing the separation of γS monomer and dimer as well as oxidized glutathione (GSSG) and reduced 
glutathione (GSH) in samples of γS dimer treated with increasing ratios of GSH to GSSG for various lengths 
of time. GSH:GSSG treatments of the dimer are colored as per the figure legend. (b) The retention volumes 
at peak maxima for the γS monomer from SEC experiments after 72 hours. A shift in retention volume 
indicates an increase in the hydrodynamic size of the monomer with increasing GSSG, indicative of protein 
glutathionylation. Error bars represent the standard deviation from two independent experiments. (c) Mass 
spectra of γS dimer as a function of increasing GSH:GSSG. Spectra are stacked along the y-axis for ease of 
comparison. (d) Standard curves for the intensity of intact mass spectra against either γS monomer or dimer 
concentration. To account for possible ionization exchange between the monomer and dimer, the standard 
curve samples were formulated using mixtures of different concentrations of both monomer and dimer. No 
exchange between these species was evident on the experimental timescale. Error bars represent the standard 
deviation from two independent experiments. (e) Isotopic peak distributions of the γS monomer produced 
when dimer is treated with the low (1:5) or high (6:0) GSH:GSSG. Maximum intensity of the distribution 
shows a shift from 20,872 Da to 20,874 Da with increased GSH concentration, implying the loss of the 
intramolecular disulfide bond in the monomer at higher reduction potential. The respective sample intensities 
were normalized and the masses offset by 0.1 Da for comparison. (f) As in E, except here the S-
glutathionylated monomer species. The mass of 21,179 Da for 6:0 GSH:GSSG is indicative of S-
glutathionylation only while a mass of 21,177 Da for 1:5 GSH:GSSG is indicative of S-glutathionylation 
with an additional disulfide bond.  
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Fig. S3. Correlation of the thermal unfolding transitions of the γS monomer and dimer with those of the N- 
and C-terminal domains. (a) A correlation plot between ∆Tm determined in this study on wildtype γS (Thorn 
et al. 2018, black, x-axis) and those reported in previous studies on the isolated N- and C-terminal domains 
(Mills et al. 2007, purple, y-axis) (17) as well as the biphasic G18V variant (Ma et al. 2009, orange, y-axis) 
(18). Abbreviations: wildtype γS (γSWT), γS N-terminal domain only (γSN), γS C-terminal domain only (γS), 
monomeric γS (γSM), dimeric γS first transition (γSD,1), dimeric γS second transition (γSD,2), G18V γS first 
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transition (γSG18V,1), and G18V γS second transition (γSG18V,2). Asterisk indicates a ∆Tm derived from Trp 
fluorescence. (b) Schematic representation of γS unfolding and their respective ∆Tm values derived from 
thermal unfolding monitored via CD. The red line indicates the subtraction of one Tm from another to 
calculate ∆Tm. (c) As in (b) except here comparing ∆Tm values from Trp fluorescence. The valine side-chain 
in G18V γS is represented as a blue Y-shaped protrusion from the polypeptide backbone.  
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Table S1. Thermal unfolding mid-point (Tm) and difference (ΔTm) for γS monomer and dimer. 
  Tm (°C) 
Oligomeric 
State 
Transition Trp FL 
(345/329 nm) 
LS 
(360 nm) 
ANS FL 
(480 nm) 
CD 
(218 nm) 
Monomer Single (M) 67.9 ± 0.1 68.5 ± 0.2 71.0 ± 0.2 72.9 ± 0.1 
Dimer First (D,1) 63.9 ± 0.0 65.4 ± 0.1 66.5 ± 0.1 67.9 ± 0.2 
 Second (D,2) 71.8 ± 0.2 72.4 ± 0.1 72.7 ± 0.4 74.6 ± 0.1 
  ΔTm 
 D,2 – D,1 7.9 7.0 6.2 6.7 
 M – D,1 3.9 3.1 4.5 5.0 
 M – D,2 -4.0 -3.8 -1.7 -1.7 
Errors for Tm values are given as the standard deviation of three independent repeats. 
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“Above all, don’t fear difficult moments. The best comes from them.” 
– Rita Levi-Montalcini
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Abstract 
One of the most crowded biological environments is the eye lens which contains a high concentration 
of crystallin proteins. The molecular chaperones αB-crystallin (αBc) with its lens partner αA-crystallin 
(αAc) prevent deleterious protein aggregation and cataract formation. However, some forms of cataract 
are associated with structural alteration and dysfunction of αBc. While many studies have investigated 
the structure and function of αBc under dilute in vitro conditions, the effect of crowding on these aspects 
is not well understood despite its in vivo relevance. The structure and chaperone ability of αBc under 
conditions that mimic the crowded lens environment were investigated using Ficoll 400 and bovine γ-
crystallin as crowding agents and a variety of biophysical methods, principally contrast variation small-
angle neutron scattering. Under crowding conditions, αBc unfolds, increases in size/oligomeric state, 
decreases in thermal stability and chaperone ability, and forms kinetically distinct amorphous and 
fibrillar aggregates. However, the presence of αAc stabilizes αBc against aggregation. These results 
provide a molecular rationale for the aggregation of αBc in the crowded lens, which exhibits marked 
structural and functional similarities to cataract-associated mutants R120G and D109A αBc under dilute 
conditions. Strategies that maintain or restore αBc stability, as αAc natively does, might therefore 
provide an avenue for the therapeutic treatment of cataract. 
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Introduction 
There are three types of mammalian lens crystallins: α-crystallins, which are members of the 
small heat-shock protein (sHsp) family and the β- and γ-crystallins, which together are part of a 
structurally homologous superfamily containing Greek key β-sheet motifs (1-3). Within the lens, 
crystallins have a structural role in maintaining a short-range array that facilitates a smooth refractive 
index gradient for correct light refraction and lifelong lens transparency (4-6). Crystallins are long-
lived, as necessitated by the lack of protein turnover in the lens fibre cells (7,8). However, they are 
subject to structural perturbations that can cause their partial unfolding and aggregation leading to lens 
opacification, i.e. the scattering of incident light, and, ultimately, cataract (3,9). Deleterious structural 
alterations can manifest either with age, via environmental insults and/or the accumulation of post-
translational modifications (PTMs) (10), or are apparent from birth/early age via mutations (11). The 
α-crystallins have an additional important function as molecular chaperone proteins to curtail lens 
protein unfolding and aggregation (12). 
Of the crystallin proteins in the human lens, ~40 % are α-crystallins (13,14) which comprise 
two subunits, αB-crystallin (αBc) and αA-crystallin (αAc), that share ~60 % sequence identity (3). On 
average, the αBc:αAc ratio in the young mammalian lens is 1:3 (14) and this changes to a 2:3 ratio by 
~55 years of age in the human lens (15), i.e. the proportion of αBc increases. While αAc is 
predominantly a lenticular protein (16), αBc is ubiquitous, where it acts as a molecular chaperone to 
minimise the aggregation of extra-lenticular proteins, for example, those associated with 
neurodengerative diseases (17) and degenerative muscular diseases (18,19).  
The eye lens is a highly crowded environment containing ~90 % crystallin protein at 300 - 400 
mg/mL (3,9). Such in vivo conditions contrast starkly with the dilute in vitro conditions under which 
most crystallin studies have been conducted. The crowded environment in vivo means that the 
crystallins are susceptible to entropically driven excluded volume effects (20). Under these conditions, 
the folding, conformation, oligomerization, and chaperone action of the major lens proteins αBc and 
αAc can be significantly affected (21). Between room and physiological temperature, both αBc and αAc 
are highly soluble and stable under dilute in vitro conditions (3,22). However, in vivo studies highlight 
a critical role for αAc in stabilizing αBc in the crowded environment of the lens. An αAc knockout 
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mouse model developed early-onset cataract, the aggregates of which were rich in αBc (23). Similarly, 
a homozygous recessive W9X nonsense mutation of the αAc gene in two human families, which 
essentially abolished functional αAc in the lens, also led to early-onset cataract (24). Conversely, αBc 
knockout mice were relatively normal in their lens development (25). 
Under dilute in vitro conditions, αBc is a polydisperse oligomer (26) with a 24-mer being one 
of its most populated forms (Fig. 1, A, top) (27). Dynamic subunit exchange between oligomers is a key 
feature of αBc which allows for the highly responsive shifts in oligomeric distribution needed for 
molecular chaperone function and hetero-oligomerization with related sHsps, e.g. αAc (28-30). There 
are three distinct regions in αBc of which the N-terminal region (NTR) and C-terminal region (CTR) 
(incorporating the C-terminal extension (CTE)) are largely disordered and flank the central conserved 
α-crystallin domain (ACD) which adopts an immunoglobulin-like, β-sheet-rich fold (Fig. 1, A, bottom) 
(31,32). Compared to αBc, αAc exhibits many similar structural and functional features with some 
notable differences: a lower isoelectric point, diminished hydrophobic surface area, reduced NTR 
solvent exposure, and generally poorer in vitro chaperone activity (33). The small number of in vitro 
based crowding experiments on the α-crystallins using non-proteinaceous crowding agents show that 
αBc size and molar mass increase (34) and αAc subunit exchange rate is slowed compared to the dilute 
environment (35). Additionally, the chaperone activities of human αBc, αAc, and bovine α-crystallin 
are all diminished (35,36). 
Previous in vitro crowding studies on αBc have yet to account for the lens opacification and 
cataract formation observed in αAc knockout mice (23) and in humans carrying the W9X αAc mutation 
(24). A detailed examination of αBc structure, stability and function in crowded conditions 
representative of the lens could offer mechanistic insight into how αBc can form aggregates that 
contribute toward lens opacification and, further, how interaction with its lens partner, αAc, functions 
to maintain a normal lens phenotype (37). Herein, we use a polysaccharide, Ficoll 400, and a protein, 
bovine γ-crystallin, as crowding agents to mimic the high concentrations inherent to the lens in order to 
study the physical, structural and functional changes of αBc relative to a dilute environment. Under 
crowded conditions, we show that αBc is destabilized, unfolds, increases in size, loses chaperone 
activity, and forms kinetically distinct amorphous and fibrillar aggregates. In vivo, such behaviour 
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Figure 1. Structural changes and the thermal stability of αBc under conditions of increasing 
macromolecular crowding. A, atomic-level model of αBc 24mer (PDB: 3J07) (27) (top) and a linearized 
schematic of the αBc monomer (38) (bottom) both coloured according to specific regions i.e. NTR (1-65, red), 
the ACD (66-148, blue), the CTR (149-163, yellow) and the CTE (164-175, navy blue). The two tryptophan 
residues (W9 and W60, dark red line) in the NTR and β-strands (β3-β9, dark blue arrows) (39) within the ACD 
are noted in the linearized schematic (bottom). B, Guinier and C, Kratky plot of 2.5 mg/mL deuterated αBc in 
Ficoll 400 concentrations from 0-250 mg/mL with 50 mg/mL increments at 37 °C in 28% D2O. D, correlation of 
Porod exponent (mid-q Dm, blue (0.05 Å-1 < q < 0.40 Å-1)) with the gradient of the Guinier region (low-q Dm, red 
(0.006 Å-1 < q < 0.018 Å-1)) against the aforementioned crowding conditions in B and C. Errors are given as the 
standard error of the fit. E, thermal stability of 0.3 mg/mL αBc in Ficoll 400 concentrations from 0-250 mg/mL 
with 50 mg/mL increments as measured using 218 nm CD (blue), barycentric mean fluorescence (λbcm) Trp 
fluorescence (red) and 360 nm light scattering (orange). Both 218 nm CD (0 – 250 mg/mL Ficoll 400) and 360 
nm light scattering (0 and 50 mg/mL Ficoll 400) have two transitions associated with thermal denaturation of αBc. 
A light colour shade is applied to the first transition while a dark colour shade is applied to the second. Errors are 
given as the standard error of a sigmoidal fit to the thermal denaturation data. 
 
would contribute directly to lens opacification, if not for the concomitant chaperone action of αAc that 
significantly increases the stability of αBc under crowded conditions and prevents aggregation. We 
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discuss how age-related modifications or mutations in vivo might contribute to cataract formation 
through either destabilizing αBc and/or inactivating αAc, and how therapeutic approaches to cataract 
prevention could be efficacious in such instances. 
 
Results 
Macromolecular crowding induces unfolding and thermal instability in αBc that leads to aggregation  
Contrast variation small-angle neutron scattering (SANS) provides a proven platform to 
investigate the effects of macromolecular crowding on protein structure (40,41). The neutron scattering 
of a highly concentrated hydrogenated crowding agent is attenuated using a molecule-dependent 
volume percentage of D2O, enabling the scattering of only the partner deuterated molecule (in this case, 
a protein) to be observed. In this study, hydrogenated Ficoll 400 was used as a model-crowding agent 
as its average mass is similar to that of the αBc oligomer. Deuterated αBc was mixed with increasing 
concentrations of hydrogenated Ficoll 400 whose scattering was matched out with 28 % D2O enabling 
the neutron scattering of only deuterated αBc to be observed.  
Quantitative estimation of a protein’s radius of gyration (Rg) from a Guinier plot (ln (I(q)) vs 
q2 where q the scattering vector) is contingent on the scattering from the low-q region maintaining 
linearity. Qualitative examination of the low-q region of a Guinier plot from αBc scattering in 0 – 100 
mg/mL of Ficoll 400 remained linear indicating a stable size (Fig. 1B). However, Ficoll 400 
concentrations from 150 – 250 mg/mL caused a significant upturn indicating protein aggregation. 
Interestingly, we noted the appearance of a Bragg peak in the SANS data with increasing temperature 
and time, particularly at 250 mg/mL Ficoll 400 (Fig. S1, A). Given Bragg peaks usually arise due to 
scattering from a defined repeating structure, this could indicate the presence of an ordered αBc 
aggregate (42). While protein aggregation from αBc precluded the determination of a Rg value across 
the entire Ficoll 400 concentration series, the influence of aggregation on the scattering intensity outside 
of this low-q region is significantly diminished (40). As such, we analyzed these data using a Kratky 
plot (q2I(q) vs. q) which provides a qualitative measure of the protein’s compactness and globularity 
i.e. its degree of foldedness (43). The Kratky plot for αBc at 0 mg/mL Ficoll 400 shows a trace with a 
prominent peak that trends downward towards the q-axis at mid-q values but stops just short of 
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convergence with the x-axis (Fig. 1, C). This indicates a largely folded globular protein with some 
unfolded regions, i.e. the central ACD and terminal regions, respectively (Fig. 1 A, top), and is 
consistent with a previous SAXS finding on related sHsps (44). As macromolecular crowding increases 
with Ficoll 400 concentrations from 50 to 200 mg/mL, the peak shifts to a higher-q value and there is 
an upturn in the mid-q region indicating an increasingly unfolded polypeptide. Finally, the peak at 250 
mg/mL Ficoll 400 is lost and a major upturn in the mid-q region is evident indicating that αBc is largely 
unfolded (Fig. 1, C). 
The foldedness of αBc can also be measured using the Porod exponent (Dm) which is 
determined over a mid-q range (0.05 Å-1 < q < 0.40 Å-1) using a power-law relationship (Eqn. 1, see 
Experimental Procedures) (Fig. S1, B). The Dm value reflects the internal scaling of interatomic 
distances over different length scales and can be interpreted as a fractal dimension, sensitive to the 
degree of compaction of the protein chain (45,46). A Dm value of 4 indicates a surface fractal which is 
smooth and globular-like, 3 is either a rough surface or a mass fractal equivalent to a clustered network 
of chains, and 2 is indicative of a random flight chain (47,48). The Dm value of αBc at 0 mg/mL Ficoll 
400 begins at 4.0 ± 0.2, indicating an unperturbed globular structure, and decreases sequentially with 
increasing Ficoll 400 concentration, indicating a loss of structure with increased crowding. At 250 
mg/mL Ficoll 400, the Dm value is 2.0 ± 0.1 indicating a random flight chain, i.e. a largely unfolded 
protein (Fig. 1, D, blue), which is consistent with the Kratky plot. We also applied Eqn. 1 over the low-
q range (0.006 Å-1 < q < 0.018 Å-1), where determination of the Rg value from the Guinier plot over the 
experimental series of 0 – 250 mg/mL Ficoll 400 no longer satisfied the condition of qRg ≤ 1.3 due to 
protein aggregation, giving rise to a low-q upturn (Fig. S1, B). This analytical method provided a 
unitless measure of the gradient of that upturn with a higher gradient value indicating greater 
aggregation. Similar to the Guinier analysis (Fig. 1, B), this value showed increasing aggregation from 
150 mg/mL upwards in concentration of Ficoll 400 (Fig. 1, D, red). Together, these values provide a 
representation of the interplay between the effects of macromolecular crowding on αBc foldedness and 
general structure using the mid-q Dm (Porod exponent) and on aggregation based on the low-q Dm. In 
summary, aggregation of αBc occurs between 100 and 150 mg/mL Ficoll 400 where αBc undergoes 
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significant but not complete loss of structure. Above 150 mg/mL, αBc continues to unfold and aggregate 
as crowding increases (Fig. 1, D). 
To investigate the impact of macromolecular crowding on the stability of the αBc native state, 
the thermal stability was measured using either the mid-point of unfolding (Tm) or aggregation (Tagg) at 
increasing concentrations of Ficoll 400. As αBc is heterogeneous in structure, different spectroscopic 
methods provided information on its various structural regions. Circular dichroism (CD) ellipticity at 
218 nm, representative of β–sheet secondary structure, provided information on structural changes 
associated with the β–sheet-rich ACD (Fig. 1, A, bottom (blue arrows)). Tryptophan (Trp) fluorescence 
provided information on the local environment of the NTR via W9 and W60 (Fig. 1, A, bottom (dark 
red lines)) and was analysed via λbcm (Eqn. 2) (Fig. S1, C). Finally, light scattering at 360 nm provided 
information on the overall size increase of αBc at the onset of aggregation. Thermal denaturation of 
αBc, monitored by CD, showed two transitions: the early decrease in ellipticity at 218 nm (lower Tm) 
was interpreted as a conformational change in the ACD (33), while the late increase (higher Tm) is 
indicative of denaturation (Fig. S1, D). Light scattering displayed a biphasic curve for Ficoll 400 
concentrations of 0 and 50 mg/mL, consistent with a previous study under similar dilute conditions 
(49), while all other aggregation curves were monophasic (Fig. S1, E). In the absence of Ficoll 400, the 
first transition Tm values for CD (61.1 ± 0.3 °C), Trp fluorescence (63.0 ± 0.6 °C) and Tagg for light 
scattering (65.7 ± 0.1 °C) (Fig. 1, E), were consistent with literature values (3,49,50). The second CD 
transition at 82.3 ± 0.1 °C has not been previously reported in the literature to our knowledge. The 
effects of macromolecular crowding on αBc thermal stability are most evident when comparing results 
in the presence of 0 and 250 mg/mL Ficoll 400, with differences in Tm (ΔTm) of 29.7 °C (β–sheet 
secondary structure change) and 42.6 °C (denaturation) for CD, 14.7 °C for Trp fluorescence and a 
difference in Tagg (ΔTagg) of 21.1 °C for light scattering. The CD Tm values are the most drastically 
affected indicating that the ACD is the most susceptible structural motif to crowding, in line with the 
observation above that unfolding precedes αBc aggregation under crowded conditions. Overall, for all 
methods of analysis, the mid-point temperature values decrease with increasing Ficoll 400 
concentration, indicating that macromolecular crowding significantly destabilizes αBc. 
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αBc undergoes kinetically distinct and concentration-dependent amorphous and fibrillar 
aggregation in a highly crowded environment 
To investigate further the nature of the crowding-induced aggregation of αBc and to decouple kinetic 
and temperature effects inherent to the SANS studies, a crowded solution of 250 mg/mL Ficoll 400 at 
37 °C and pH 7.3 was used to approximate the environment of the eye lens. The aggregation kinetics 
of 2.5 mg/mL αBc was monitored using light scattering at 360 nm (which is sensitive to both amorphous 
and fibrillar aggregation) and thioflavin T (ThT) fluorescence (which is sensitive to fibrillar 
aggregation); the latter was measured to inquire into the origin of the putative Bragg peak in the SANS 
data (51). Light scattering exhibited a strong sigmoidal response with a mid-point of ~0.5 hours and a 
maximum intensity at ~5 hours after which time a steady decrease in light scattering occurred due to 
protein precipitation (Fig. 2, A, blue). ThT fluorescence was initially high and decreased until ~10 hours 
(see later) after which the fluorescence increased in an exponential manner with a mid-point of ~16 
hours and a final fluorescence maximum at 33 hours (Fig. 2, A, red). 
 Negative stain transmission electron microscopy (TEM) was employed to understand better the 
aggregation processes that were monitored by light scattering and ThT fluorescence. As an initial 
control, the micrograph of αBc at 0 hours under non-crowded conditions displays individually 
dispersed, spherical oligomers of ~15 nm in diameter consistent with previous studies (52,53) (Fig. 2, 
B). In contrast, at 0 hours under crowded conditions (in the presence of 250 mg/mL Ficoll 400) 
individual αBc oligomers were not easily discernible, implying that volume exclusion effects forced the 
oligomers closer together (Fig. 2, C). TEM at specific time-points of the kinetic experiment (Fig. 2, A, 
black dashed lines labelled D – G) provided a snapshot of the size and morphology of the αBc 
aggregates in crowded conditions. At 0.5 hours of incubation, spheroidal aggregates of approximately 
40-50 nm were observed (Fig. 2, D, black triangles). After 5 hours, amorphous aggregates ranging from 
approximately 40-160 nm in diameter were observed (Fig. 2, E, black and white triangles, respectively), 
which grew to be very large over a further 11 hours of incubation (i.e. by 16 hours), however no fibrillar 
species were discernible, potentially due to their small size (Fig. 2, F). Finally, samples at 33 hours 
contained fibrillar species of various lengths and morphologies (Fig. 2, G, black triangles). In summary, 
these experiments confirmed that the light scattering kinetics represents fast-forming amorphous  
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Figure 2. Characterizing the aggregation of αBc under conditions of macromolecular crowding. A, 
representative aggregation assay assessing the kinetics of light scattering at 360 nm (left axis, blue) and ThT 
fluorescence (right axis, red) for 2.5 mg/mL αBc in 250 mg/mL Ficoll 400 at 37 °C. Black dashed lines at 0.5, 5, 
16, and 33 h, labelled D, E, F, and G, respectively, relate to the corresponding TEM micrographs. B-G, 
representative TEM micrographs of 2.5 mg/mL αBc in a dilute environment compared with the crowded 
environment sampled at specific time points during the kinetic experiment. Below each micrograph is listed the 
corresponding sampling time and Ficoll 400 concentration. White and black scale bars represent 100 nm and 200 
nm, respectively. Black and/or white arrows are used to highlight noteworthy aggregates. H, light scattering 
maximum at 360 nm (left axis, blue) and ThT fluorescence maximum (right axis, red) for αBc from 0.03-3.00 
mg/mL in 250 mg/mL Ficoll 400 at 37 °C. Errors are given as the standard deviation of three independent repeats. 
Light scattering maxima are fitted to a logistic function with an adjusted R2 of 0.991 (solid line, blue) while the 
ThT fluorescence maxima are fitted to an exponential function with an adjusted R2 of 0.998 (solid line, red). 
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aggregation of αBc while the ThT fluorescence kinetics represents the formation of slow-forming 
fibrillar species (Fig. 2, A). 
 A plot of the maximum light scattering and ThT fluorescence against αBc concentration 
revealed differences in the thermodynamics between the formation of the amorphous and fibrillar αBc 
species in crowded conditions of 250 mg/mL Ficoll 400 (Fig. 2, H and Fig. S2, A and B). Light scattering 
exhibited a logistic trend while final ThT fluorescence values showed an exponential trend. Notably, 
initial ThT fluorescence values over the αBc concentration range display a Gaussian trend with 
maximum at 1.5 mg/mL αBc (Fig. S2, C). This suggests that the source of the initial high ThT 
fluorescence and its subsequent decrease over approximately eight hours (Fig. S2, B) reflect a ThT-
binding structure of αBc that becomes increasingly exposed, and is then lost, under highly crowded 
conditions. Overall, these data indicate that the formation of amorphous aggregations in highly crowded 
conditions is favoured at low αBc concentrations but is limited at higher concentrations (≥ 1.5 mg/mL). 
Conversely, ThT fluorescence data show that the formation of fibrillar species is disfavoured at low 
αBc concentrations but increasingly favoured at higher concentrations. In conjunction with the kinetic 
data, a theoretical reaction coordinate diagram depicting amorphous aggregation as kinetically stable 
and fibrillar aggregation as thermodynamically stable, either as separate pathways or as a single 
pathway with amorphous aggregation as the reaction intermediate, can be used to rationalize these 
results (Fig. S2, D). 
 
The effects of macromolecular crowding on αBc structure, stability and aggregation propensity are 
accentuated by bovine γ-crystallin relative to Ficoll 400 
The use of polysaccharides such as Ficoll 400 is a mainstay of in vitro crowding studies, however their 
effects may not adequately mimic the biological environment (54). To verify the relevance of Ficoll 
400 as a model for the crowded environment of the eye lens, we used γ-crystallin extracted from bovine 
lens homogenate as a biologically relevant crowding agent (Fig. S3, A). Given the potential of protein 
crowding agents to obfuscate biophysical studies of protein targets, contrast matched SANS was again 
employed. The scattering of 125 mg/mL bovine γ-crystallin was matched out by 40 % D2O and its effect 
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on deuterated αBc structure, stability and aggregation propensity was compared with 125 mg/mL Ficoll 
400 and no crowding (dilute environment) in buffer containing 28 % D2O. 
Guinier analysis and the pair-wise distance distribution function (P(r)) were used to determine 
the initial Guinier and real-space Rg values, respectively, as well as the P(r) derived maximum 
dimension (Dmax), for αBc at 30 °C (Fig. 3, A and B, respectively). The Guinier (52.1 ± 0.5 Å and 53.5 
± 0.8 Å) and real-space (52.2 Å and 53.3 Å) Rg values were similar for conditions of no crowding and 
crowding using 125 mg/mL Ficoll 400, respectively, and were consistent with the previously reported 
Rg value for αBc (39,55). The Dmax of 190 Å for αBc under conditions of no crowding precisely matched 
that previously reported (39), while crowding using 125 mg/mL Ficoll 400 gave a Dmax of 178 Å. As 
the Rg values are similar and the shape of the P(r) function matches well until the highest r values (Fig. 
3, B), it is interesting that the P(r) function for αBc in 125 mg/mL Ficoll 400 abruptly drops, thereby 
producing a smaller Dmax. The likely explanation for this behaviour is mild compaction of the CTE 
(39,56), while the general oligomeric size and shape are maintained. In contrast, crowding with 125 
mg/mL γ-crystallin showed a ~28 Å increase in Rg value accompanied by an 86 Å increase in Dmax, 
relative to no crowding (Fig. 3, B), indicating a significant alteration in the overall structure of αBc 
(perhaps due to unfolding) or a shift in the size distribution of the oligomeric array. The general shape 
of the P(r) plot indicates that under conditions of no crowding and 125 mg/mL Ficoll 400, αBc is largely 
globular with extended regions as discerned by the predominant bell-shaped peak and a tailing shoulder 
at higher r values (Fig. 3, B, black and orange). However, crowding using 125 mg/mL γ-crystallin leads 
to an increase in the bell-shaped peak maximum r value consistent with an increase in overall size and 
an extensive multi-modal shoulder suggesting a more extended structure and/or new extended 
populations (Fig. 3, B, blue). 
A normalized Kratky plot (qRg2⸱I(q)/I(0) vs. qRg) (57) was used to determine relative changes 
in compactness and flexibility (i.e. ‘foldedness’) for αBc under no crowding and crowding conditions 
at 30 °C. In this plot, a globular folded protein exhibits a bell-shaped peak maximum value of 1.104 at 
a qRg of √3 (Fig. 3, C, dashed lines) while any departure from this intersection point indicates increased 
flexibility and hence unfolding (58). Under conditions of no crowding and crowding using 125 mg/mL 
of Ficoll 400, αBc has a normalized Kratky plot indicative of a partially folded protein with the latter 
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Figure 3. Effects of macromolecular crowding on αBc using bovine γ-crystallin compared to Ficoll 400 and 
the dilute environment via contrast variation SANS. A, Guinier plot, B, P(r) function and, C, dimensionless 
Kratky plot for deuterated αBc in conditions of ‘No crowding’ (black), ‘125 mg/mL Ficoll 400’ (orange), and 
‘125 mg/mL γ-crystallin’ (blue) at 30 °C. Parameters derived from these analyses are given on the plot in the 
colour corresponding to the crowding condition. D, thermally induced aggregation curves in the aforementioned 
crowding conditions followed as a function of the low-q Dm (0.006 Å-1 < q < 0.018 Å-1) or otherwise the gradient 
of the Guinier region which is sensitive to sample aggregation (squares). The data are fitted with a Boltzmann 
function (solid line). E, Kratky plot of αBc in 125 mg/mL Ficoll 400 (orange, light to dark with time), and 125 
mg/mL γ-crystallin (blue, light to dark with time) at 37 °C over a period of 36 hours. F, Rg value of αBc in 125 
mg/mL Ficoll 400 (orange), and 125 mg/mL γ-crystallin (blue) at 37 °C over a period of 36 hours. A red asterisk 
for αBc in 125 mg/mL γ-crystallin indicates the sample was aggregated, i.e. an upturn in the scattering data of the 
Guinier region no longer allowed the accurate determination of the Guinier Rg value within the limits of qmaxRg < 
1.3. No crowding and 125 mg/mL Ficoll 400 experiments were conducted in 28% D2O while the 125 mg/mL γ-
crystallin experiments were conducted in 40% D2O. All experiments used 2.5 mg/mL deuterated αBc. 
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condition indicating slightly more unfolding (Fig. 3, C, black and orange), commensurate with the Dm 
values of 3.7 ± 0.3 and 2.7 ± 0.2 respectively (Fig. S3, B). Crowding with 125 mg/mL γ-crystallin 
induces further unfolding relative to both of the other conditions as implied by the Kratky plot and a 
Dm value of 2.2 ± 0.1 (Figs. 3, C, blue and S3, B, blue). 
Given the decrease in thermal stability with increasing Ficoll 400 concentration (Fig. 1, E), αBc 
was examined to determine whether it was impacted in a similar way by 125 mg/mL γ-crystallin. Data 
were acquired from 30 – 80 °C by measuring the low-q Dm value for αBc under each condition via 
fitting of the power-law function (Fig. S3, C – E) as used in Fig. 1, D. The resultant data could be fitted 
to a sigmoidal Boltzmann function to extract the Tagg value, similar to that obtained from light scattering 
profiles (Fig. S1, E). The Tagg values for αBc under conditions of no crowding and 125 mg/mL Ficoll 
400 were 64.3 ± 0.3 °C and 55.1 ± 1.8 °C respectively (Fig. 3, D, black and orange), largely in 
agreement with the Tagg from light scattering data (Fig. 1, E, orange). However, 125 mg/mL γ-crystallin 
induced a Tagg value for αBc of 42.4 ± 1.1 °C (Fig. 3, D, blue). Thus, the thermal stability of αBc is 
mildly affected in 125 mg/mL Ficoll 400 but markedly so in 125 mg/mL γ-crystallin relative to the 
absence of crowding agents. 
Owing to the markedly reduced thermal stability of αBc, differences in the effects of 
macromolecular crowding between Ficoll 400 and bovine γ-crystallin on the kinetics of structural and 
size changes for αBc at 37 °C were evident from the low- and mid-q region scattering profiles (Fig. S3, 
F and G). Moreover, the Kratky plot showed significant structural change for αBc in 125 mg/mL γ-
crystallin over 36 hours from partially unfolded to increasingly unfolded as indicated by the steady loss 
of the bell-shaped peak (Fig. 3, E, blue) while the structure of αBc in 125 mg/mL Ficoll 400 αBc 
remained unchanged (Fig. 3, E, orange). Similarly, the Guinier-derived Rg value for αBc in 125 mg/mL 
γ-crystallin was elevated to 88.9 ± 2.1 Å at 0 hour, then increased further to 101 ± 4.1 Å between 5 – 6 
hours and was highly aggregated at time points after that (Fig. 3, F, blue). In contrast, αBc in 125 mg/mL 
Ficoll 400 had no significant change in both Kratky plot and Rg value giving an average Rg value of 
57.9 Å at 37 °C with a standard deviation of 1.0 Å over 36 hours (Fig. 3, F, orange).  
These thermodynamic and kinetic results imply that changes to the structure, stability and 
aggregation propensity of αBc are more pronounced under conditions of macromolecular crowding 
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induced by biologically relevant bovine γ-crystallin than by the polysaccharide Ficoll 400. A variety of 
reasons could account for this: (i) the large molar concentration difference (approximately 20 times 
higher) of γ-crystallin compared to Ficoll 400, (ii) the greater excluded volume effects for the smaller 
crowder, γ-crystallin (59), or (iii) ‘soft’ interactions between the protein crowder and αBc that 
preferentially destabilize αBc relative to that induced by Ficoll 400 (60). However, importantly, the 
underlying destabilizing effects on αBc structure and aggregation are the same as those noted at high 
concentrations of Ficoll 400. It is concluded therefore that the effects on αBc structure using Ficoll 400 
as a crowding agent observed herein are physiologically relevant. 
 
Macromolecular crowding diminishes the molecular chaperone ability of αBc 
The molecular chaperone action of αBc, along with that of αAc, is the primary defence against the 
unfolding and aggregation of the structural lens proteins, β- and γ-crystallin (61) and is of importance 
extralenticularly in cellular proteostasis (62). Thus, it is important to understand how macromolecular 
crowding affects the chaperone action of αBc. Accordingly, this was assessed in vitro against the 
amorphous aggregation of insulin induced via reduction of its disulfide bonds in the presence of 
increasing Ficoll 400 concentration. Reduced insulin and αBc were examined individually (Fig. S4, A 
and C) and also together in a 1:2 w:w ratio, respectively (Fig. S4, B). From these experiments, 
aggregation metrics including the lag time, rate of aggregation and maximum light scattering (Fig. 4, A 
– C, respectively), were calculated in the absence of Ficoll 400 and in the presence of increasing Ficoll 
400 concentration.  
The effect of macromolecular crowding on insulin aggregation at 37 °C results in a decrease in 
lag time and increase in both the rate of aggregation and maximum light scattering with increasing 
Ficoll 400 concentration (Fig. 4, A – C, blue), consistent with macromolecular crowding theory 
describing the promotion of association and aggregation (63). The effect of macromolecular crowding 
on 0.3 mg/mL αBc aggregation (i.e. the control, without any insulin present) is not evident until 250 
mg/mL Ficoll 400 (Fig. 4, A – C, yellow and Fig. S4, C) under which conditions the lag time is twelve 
times longer than that of insulin at the same Ficoll 400 concentration (Fig. 4, A). Therefore, αBc acts 
(in a chaperone manner) on reduced insulin (its B chain) while the former is in an oligomeric state i.e.  
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Figure 4. Chaperone ability of αBc against reduced insulin aggregation under conditions of increasing 
macromolecular crowding. A, lag time, B, rate of aggregation, and C, light scattering maximum for reduced 
insulin (blue), reduced insulin with αBc in at 1:2 w:w ratio (red) and αBc alone (yellow) at 37 °C. Errors are given 
as the standard deviation of three independent repeats. 
 
before it has amorphously aggregated. Within the range of 0 – 100 mg/mL Ficoll 400, insulin 
aggregation is significantly inhibited by the chaperone action of αBc as shown by an extended lag time 
and slower rate of aggregation (Fig. 4, A and B, red). At Ficoll 400 concentrations equal to or greater 
than 150 mg/mL, the chaperone ability of αBc was impaired. Relative to insulin alone, the lag time for 
the insulin-αBc complex was approximately five, three, and two times longer at 150, 200 and 250 
mg/mL Ficoll 400, respectively (Fig. 4, A, red). Similarly, the rate of aggregation was approximately 
three and two times slower for 150 and 200 mg/mL Ficoll 400, respectively, however there was no 
difference at 250 mg/mL Ficoll 400 (Fig. 4, B, red).  
At Ficoll 400 concentrations of 150 mg/mL and above, aggregates of the insulin-αBc complex 
(Fig. 4, C, red) exhibit a light scattering maximum that is significantly greater than insulin alone (Fig. 
4, C, blue). At 250 mg/mL Ficoll 400, the light scattering maximum for the insulin-αBc complex was 
1.8 times greater than αBc alone. Thus, the destabilized target protein, i.e. reduced insulin, can induce 
co-aggregation of the chaperone αBc under highly crowded conditions. 
 
Aggregation of αBc under conditions of macromolecular crowding can be curtailed by lens partner 
protein αAc via an increase in thermal stability 
In addition to αBc, the eye lens also contains molecular chaperone protein αAc which forms hetero-
oligomers with αBc, as described above at a ratio of approximately 1:3 αBc:αAc (14,15). To understand 
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the impact of α-crystallin hetero-oligomerization on kinetic and thermodynamic stability of αBc in a 
highly crowded environment, we examined both proteins separately and in 1:1, 1:2, and 1:3 αBc:αAc 
w:w ratios at 250 mg/mL Ficoll 400. Aggregation kinetics at 37 ⁰C showed that αBc aggregates in a 
concentration-dependent manner (Fig. 5, A, light blue and purple) (observed previously in Fig. 2, H), 
in contrast with αAc which does not aggregate under the same concentrations (Fig. 5, A, grey and dark 
grey). Mixing αBc:αAc at 1:1 and 1:2 w:w ratios significantly decreased the amount of aggregation 
relative to 0.1 mg/mL αBc alone and aggregation was no longer discernible at a ratio of 1:3 (Fig. 5, A, 
yellow, orange, and red, respectively). The percentage protection against aggregation for 1:1, 1:2 and 
1:3 αBc:αAc was subsequently quantified as 59.3 ± 6.0 %, 78.6 ± 4.3 %, and 92.5 ± 1.7 % respectively 
(Fig. S5, A), relative to the light scattering maximum at 0.1 mg/mL αBc.  
 To understand the basis of the difference in aggregation propensity between αBc and αAc in a 
highly crowded environment, we examined the thermal stability of the homo- and hetero-oligomers at 
the same concentrations used in the kinetic aggregation assay (Fig. S5, B). The thermal stability of αBc 
in a highly crowded environment indicates that the protein is highly destabilized in a concentration-
dependent manner as indicated by Tagg values of 44.9 ± 0.7 ⁰C and 49.7 ± 1.0 ⁰C for 0.3 and 0.1 mg/mL 
αBc, respectively (Fig. 5, B, blue and light blue). Interestingly, the thermal stability of αAc is not altered 
significantly by the same changes in protein concentration (Fig. 5, B, grey and dark grey). Mixing αBc 
with αAc led to enhanced thermal stability with the hetero-oligomeric complex having a ΔTagg value of 
+ 6.0 ⁰C on average relative to 0.1 mg/mL αBc (Fig. 5, B, yellow, orange, and red). 
The relationship between the steady-state light scattering maximum from the 37 ⁰C kinetic 
aggregation assay and the Tagg value indicative of homo- and hetero-oligomer thermal stability was 
examined. Both values were plotted on a scatter plot and the points fitted well to a single exponential 
function (R2 = 0.99) (Fig. 5, C). This correlation provides novel insight into how lens α-crystallin 
stability in a highly crowded environment can eventually lead to an exponential increase in light 
scattering under physiological conditions. 
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Figure 5. Chaperone action of αAc toward αBc and subsequent complex stability under conditions of 
macromolecular crowding. A, chaperone assay containing αBc and αAc in 250 mg/mL Ficoll 400 at 37 ⁰C. Both 
0.3 and 0.1 mg/mL αAc exhibited no detectable light scattering over 8 hours (i.e. their scattering trace is below 
that for the 1:3 αBc:αAc trace). Data are the average of three independent repeats. B, Tagg of homo- and hetero-
oligomers of αBc and αAc in 250 mg/mL Ficoll 400 with column colours corresponding to those indicated in A. 
Errors are the standard deviation of three independent repeats. C, light scattering maximum from the kinetic study 
(A) and the Tagg from the thermal stability study (B) reveal an exponential relationship between maximum light 
scattering in the kinetic study and complex thermal stability in 250 mg/mL Ficoll 400. The ratios of 1:1, 1:2, and 
1:3 αBc:αAc w:w are based on an αBc concentration of 0.1 mg/mL. Each mixture was equilibrated for one hour 
at room temperature before being used. 
 
Discussion 
Macromolecular crowding has manifold consequences that can be difficult to predict for proteins with 
dynamic, supramolecular structures such as αBc and other sHsps. Previous studies have noted that 
macromolecular crowding has a largely disruptive effect on both physical and functional 
characteristics of αBc, αAc and whole α-crystallin (35,64-66). Given a number of studies implicate 
αBc aggregation in cataract, this led us to reason that the highly crowded in vivo environment of the 
eye lens could have an adverse impact on the structure and function of αBc, resulting in it contributing 
to numerous cataract phenotypes (18,23,24,67,68). Further, as macromolecular crowding reduces the 
chaperone function of both homo- and hetero-oligomeric forms, the biological purpose of the 
association of αBc with αAc to form α-crystallin under such conditions warrants examination. Our 
current study significantly builds on previous findings for αBc under conditions of macromolecular 
crowding, and places the results in the context of the highly crowded eye lens where the preservation 
of crystallin stability is vital for the maintenance of lens transparency. 
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We have identified additional consequences of macromolecular crowding on αBc, i.e. 
unfolding and significant thermal destabilization, which ultimately lead to αBc aggregation (Fig. 1). 
The unfolding likely involves the β–sheet rich ACD which is significantly destabilized under crowded 
conditions. These results were recapitulated using a biologically relevant crowding agent bovine γ-
crystallin, i.e. there was a clear link between the loss of αBc structure and a decrease in stability, an 
increase in size and/or oligomeric state, and finally aggregation (Fig. 3). This was particularly striking 
given the concentration of γ-crystallin used here is only a conservative representation of the crowded 
environment of the eye lens, meaning these effects could be further magnified in vivo. The aggregation 
of αBc under crowded conditions occurred initially by relatively fast-forming amorphous and then slow-
forming fibrillar species (Fig. 2). A loss of chaperone function and significant co-aggregation of αBc 
with destabilized insulin in highly crowded conditions was also noted (Fig. 4). Aggregation, and hence 
light scattering, of αBc in highly crowded conditions was curtailed by its lens partner protein, αAc, 
which maintained its stability in crowded conditions and stabilized αBc such that its aggregation was 
prevented (Fig. 5). These processes are depicted schematically leading to either the maintenance of lens 
transparency or the formation of cataract (Fig. 6). 
The αBc ACD forms a dimer that provides the cornerstone for higher order assembly (27,52). 
Specific mutations that destabilize the dimeric interface, such as R120G and D109A (both residues are 
involved in a salt bridge across the ACD dimer interface in the APII register (69)), lead to similar 
structural and functional consequences to those observed in the present study on wild-type αBc under 
conditions of macromolecular crowding, i.e. both mutants exhibit unfolding, destabilization, an increase 
in size/oligomeric state and ultimately aggregation, with R120G also displaying a loss of chaperone 
activity and co-aggregation with a destabilized target protein (22,68,70,71). It follows that 
macromolecular crowding of αBc may have a similar deleterious effect on the ACD as does these 
cataract-associated mutations, thereby leading to structural alterations occasioning loss-of-function and 
aggregation. While excluded volume effects arising from macromolecular crowding are usually 
associated with the stabilization of the compact native form, they also encourage protein association 
(21,63,72). It would seem that further oligomerization of αBc relative to the dilute environment is 
favoured under crowded conditions as has been demonstrated for other sHsps, namely Hsp27 (HspB1)  
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Figure 6. Schematic depicting the pathways associated with normal vision and cataract as a consequence 
of changes to αBc under conditions of macromolecular crowding. Under dilute conditions, oligomeric αBc 
(blue, top left) is folded and the molecules are coloured according to specific αBc regions as in Fig. 1, A, bottom. 
The oligomer is in equilibrium and undergoing subunit exchange with a dimeric species. Oligomeric αBc is 
destabilized under conditions of macromolecular crowding (blue, top right) and becomes unfolded, increases in 
size/oligomeric state, loses thermal stability, has reduced chaperone ability and is prone to co-aggregation with a 
destabilized and aggregating target protein. From destabilized oligomeric αBc, kinetically favourable amorphous 
aggregates form quickly (middle right). In the lens, this occurrence could potentially lead to opacification and 
eventually cataract formation. Thermodynamically favourable fibrillar aggregation (bottom right) forms slowly, 
likely via the amyloidogenic regions in the ACD (38) after unfolding and rearrangement. Fibrillar aggregates may 
be associated with late-stage cataract (bottom left). Hetero-oligomerization with lens partner protein αAc (yellow, 
middle left) prevents the aggregation of αBc via a chaperone mechanism which increases the thermal stability of 
αBc thus facilitating lens transparency and normal vision (bottom left). This protective mechanism under highly 
crowded conditions could be circumvented by mutations or PTMs that either further destabilize αBc or diminish 
αAc chaperone ability. 
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(73) and Hsp20 (HspB6) (74). In light of this, we suggest that the structural defects inherent to the αBc 
mutants like R120G and D109A are potentially exaggerated in the crowded lens, making it difficult for 
αAc to chaperone them effectively and leading to the large-scale aggregation that is associated with 
their congenital cataract phenotypes (18,68). 
Partial unfolding at the ACD interface of the Hsp27 dissociated monomer under dilute 
conditions has been correlated with increased chaperone activity (75). Due to the conservation of the 
ACD, it was suggested this mechanism could be a ubiquitous feature across the sHsp superfamily. While 
αBc undergoes crowding-induced unfolding and significant destabilization of the ACD, the chaperone 
function was lost at higher crowding concentrations. The latter is consistent with previous studies using 
different crowding agents and target proteins (64,65). A loss of free subunits, i.e. chaperone-active 
dimeric species, along with an increased rate of target protein aggregation under crowded 
concentrations are potential reasons for the loss of chaperone function. However, as αBc’s ACD alone 
has been shown to exhibit chaperone ability (69), it is curious that its unfolding does not lead to 
increased chaperone function in a similar mechanism to Hsp27, thereby offsetting the other 
unfavourable consequences imposed on αBc by crowding. Interestingly, the partially unfolded Hsp27 
monomer species also has a heightened aggregation propensity at higher concentrations (75). Thus, 
there may be a delicate balance in the ACD between folding and unfolding for the optimal functioning 
and stability of αBc, a balance that seems to be tilted in favour of aberrant aggregation in a crowded 
environment. In vivo, PTMs that increase the chaperone activity of αBc (49,76-78) and interactions with 
endogenous compounds such as metals (65,79,80) could be pivotal in modulating the stability, structure 
and function of αBc under conditions of macromolecular crowding. 
The aggregation of αBc under highly crowded conditions led to significant light scattering, as 
observed previously in vivo (23), and the appearance of kinetically distinct ThT positive fibrillar species 
(Fig. 2). Differences in the kinetic and concentration-dependent formation of amorphous and fibrillar 
aggregates suggest two possible mechanisms of formation. The first mechanism consists of two distinct 
formation pathways whereby both amorphous and fibrillar aggregation are in competition for the same 
pool of native αBc (Fig. S2, D, red and blue). The second mechanism is a single pathway where 
amorphous aggregation occurs as a metastable intermediate in the formation of fibrillar aggregates (81) 
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(Fig. S2, D, purple). This competitive process is depicted using a theoretical reaction coordinate 
diagram (Fig. S2, D) where, in both pathways, amorphous aggregation has a lower activation energy 
(ΔG≠), indicating its kinetic favourability, while fibrillar aggregation has a significantly lower free 
energy (ΔG0), indicating its thermodynamic favourability (Fig. S2, D). Fibrillar aggregates are generally 
the most thermodynamically favourable protein conformation (82) which is even more so the case in a 
crowded environment as they provide greater reduction in excluded volume (63). However, their 
formation in this instance, i.e. constant crowding concentration and temperature, is only viable at high 
αBc concentrations to reach the requisite higher activation energy for formation, relative to amorphous 
aggregate formation (Fig. 2, H). One potential reason for the slow kinetics of αBc fibrillar aggregate 
formation under highly crowded conditions, even at high αBc concentrations, is that significant 
structural rearrangement precedes this process. As much of the ACD of αBc is predicted to be 
amyloidogenic, and is ostensibly ‘protected’ from this high amyloidogenicity by the presence of the 
unstructured and dynamic flanking NTR and CTR (38), significant unfolding and destabilization of the 
ACD, which occurs as a consequence of crowding (Fig. 1), is likely required before the fibrillar 
aggregation pathway can be accessed. In agreement with this, under dilute conditions, αBc is converted 
into amyloid fibrils with mild denaturant and heat (83,84). 
While amorphous aggregates are considered the hallmark of cataract (9,85), recent findings 
have presented evidence for amyloid structures in animal lenses (86) and post-mortem human lens 
tissues (87). Interestingly, while amyloid structures were not detected in juvenile human lenses, they 
were identified in mature non-cataract and cataract lenses (87). The authors suggested that amyloid 
structures may form before typical cataract symptoms manifest (87). The low abundance of amyloid 
structures observed in human cataract lenses (~7 % on average), can be explained by our observation 
in vitro that in the crowded environment of the lens the formation of mature fibres is kinetically slow. 
Thus, advanced, late-stage cataract lenses may exhibit fully formed fibrillar species, similar to those 
observed in this study. Potentially, this would be a useful in vivo finding as any therapeutic cataract 
treatment that staves off amorphous aggregation may still allow the formation of late-stage fibrillar 
aggregates, at least for αBc, which might also lead to a cataract-like phenotype. 
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Under dilute in vitro thermal stress conditions, it has been well demonstrated that αBc is the 
least stable α-crystallin subunit and that its thermally induced aggregation is prevented by the more 
stable αAc subunit (50,88-90). However, the effect of macromolecular crowding on this paradigm 
between αBc and αAc has yet to be explored despite its relevance to the eye lens. There was a clear 
contrast in the stability of the two subunits in highly crowded conditions with αBc being thermally and 
kinetically destabilized while αAc remained stable under simulated physiological conditions. Upon 
mixing αBc and αAc to form the α-crystallin hetero-oligomer, the thermal stability of the complex 
increased with increasing abundance of αAc. At a physiologically relevant ratio of 1:3 αBc:αAc, the 
kinetically favoured amorphous aggregation of αBc at 37 ⁰C was inhibited. These findings are consistent 
with the development of cataract in the mouse αAc and αBc knockout studies (23,25). The difference 
in stability could be related to the lower isoelectric point of αAc (3), thereby increasing electrostatic 
repulsion and discouraging aggregation, or features intrinsic to αAc’s native structure, such as disulfide 
bonding (91), which affords it further protection.  
The trend between αBc and αAc thermal stability and kinetic aggregation propensity in the 
crowded environment indicate that a loss of stability, below a threshold temperature, results in an 
exponential increase in kinetic light scattering (Fig. 5, C). While congenital cataract-associated αBc 
mutants, such as D109A (68) (which is also a mimic for αBc Asp isomerization (71)), R120G (18,70), 
D140N (92), and Q151X (93) largely exhibit different structural defects, the loss of stability relative to 
the wild-type is a common characteristic of all these mutants. Given αBc’s susceptibility to 
destabilization and aggregation under crowded conditions, it can be expected that destabilizing 
mutations or PTMs could further impact αBc stability and hence increase kinetic aggregation. Likewise, 
mutations or PTMs that affect the stability and thereby the chaperone ability of αAc, such as the F71L 
(94), will allow the development of early-onset cataract due to ineffective stabilization of αBc. One of 
the therapeutic treatment options for cataract is the use of small molecules that aim to stabilize the native 
state of crystallins (9). One such promising treatment involves the specific thermal stabilization of α-
crystallin in vitro via a sterol-based pharmacological chaperone that binds to the interface of the αBc 
ACD dimer (95). The sterol reversed cataract in an in vivo mouse model and improved the solubility of 
crystallins from human cataract lenses ex vivo. Our study affirms that approaches such as these are 
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viable to prevent the kinetic aggregation of αBc associated with cataract, and further imply that 
compound screening via stability assays in a simulated crowded environment might better inform 
current drug discovery efforts. Finally, we posit that these findings are also applicable to αBc more 
generally in the extra-lenticular environment where other sHsps such as the populous Hsp27 also 
stabilizes αBc in vitro (96) and in vivo (97). 
 
Experimental procedures 
Materials 
All materials, including buffer components, Ficoll 400, ThT, dithiothreitol (DTT), and insulin from 
bovine pancreas (I5500) were purchased from Sigma. Prior to SANS experiments, 1 mL aliquots of 25 
mM sodium phosphate buffer, 100 mM NaCl, pH 7.3 made up in H2O, were lyophilized, and 
reconstituted with the desired D2O:H2O ratio. Preparation of 1 mL of 450 mg/mL Ficoll 400 stock 
solution involved weighing 450 mg of Ficoll 400 on an analytical balance and adding 625 µL of 25 mM 
sodium phosphate buffer, 100 mM NaCl, pH 7.3. The volume to be added was calculated based on the 
expected solution displacement of a 450 mg/mL Ficoll 400 solution with a density of 1.2 g/mL which 
was experimentally verified to produce a 1 mL solution. Upon buffer addition to Ficoll 400, the solution 
was left to solubilize at room temperature overnight or until clear. The solution was then centrifuged 
and diluted with the same buffer as needed. Ficoll 400 solutions used in SANS experiments were made 
the same way with the only change being the use of a buffer with the desired D2O:H2O ratio. Protein 
concentrations were determined using an ultra-low volume spectrophotometer (Nanodrop (Thermo 
Fisher Scientific Inc.)). An E1% (280 nm) of 8.1 and 8.2 was used for αAc and αBc respectively (13), 
an average 21.0 was used for bovine γ-crystallin (98) and E1% (278 nm) value of 10.6 was used for 
insulin as per the manufactures product information sheet. 
 
Protein Expression, Deuteration and Purification 
 The expression vectors pET24a and pET43.1a encoding recombinant human αBc and αAc 
(Genscript) genes were transformed and expressed in BL21(DE3) E. coli cells. Both proteins were 
purified as previously described (99) with some modifications. Briefly, BL21(DE3) cells were induced 
118
 
 
using IPTG and left overnight, with shaking, at room temperature. The resuspended cell pellet was lysed 
using sonication. The cell lysate was initially purified using anion-exchange chromatography (HiPrepTM 
DEAE FF 16/10 (GE Healthcare)) using a 20 mM Tris-HCl buffer, pH 8.5 and a 0 – 1 M NaCl gradient. 
Fractions containing the protein were concentrated and finally subjected to gel filtration 
chromatography ((HiPrepTM 16/60 Sephacryl® S-300 HR (GE Healthcare)), in 50 mM sodium 
phosphate buffer, 100 mM NaCl, pH 7.4). Purified fractions were dialysed against MilliQ water, 
lyophilized and stored at - 20 ⁰C. 
 Deuterated αBc was overexpressed in BL21(DE3) E.coli cells after being transformed with 
pET24a plasmid containing the human αBc gene sequence.  The cells from single colonies were selected 
with kanamycin and gradually adapted to D2O-based minimal “Mod C1” media (100) containing a step-
wise increasing concentration of D2O from 0 to 100 %, and stored as glycerol stocks at - 80 ⁰C until 
needed.  The starter culture of 100 mL of 100 % D2O minimal medium containing 40 g/L glycerol-d8 
(Cambridge Isotope Labs) was used to inoculate 2 L RTF-5 fermentor bioreactors (Real Time 
Engineering) containing 900 mL of the same medium. Cells were cultured at 37 ⁰C with automatically 
regulated pH and dissolved oxygen, until the OD600 reached a value of 13 – 15, and were then induced 
to express αBc with 1 mM IPTG and the temperature lowered to 25 ⁰C.  After 15 hours, the biomass 
was harvested and stored at - 80 ⁰C or on dry ice until purification. Deuterated αBc was purified as 
described above for the hydrogenated form. MALDI-TOF mass spectrometry was carried out by the 
Mass Spectrometry Core Facility, University of Sydney, to determine the deuteration level of the 
protein.  By comparing the mass differences between H- and D-protein fragments relative to the 
calculated numbers of non-exchangeable H/D atoms (bound to carbon or sulfur), the level of deuterium 
substitution of αBc was determined to be 99.8%. 
 Bovine γ-crystallin was extracted and purified from whole lens homogeneate as previously 
described (101) and modified for a Tris buffer system (102). A HiPrepTM 16/60 Sephacryl® S-300 HR 
(GE Healthcare) gel filtration column was used to isolate the γ-crystallin fraction (Fig. S3, A) which 
was dialysed against MilliQ water, lyophilized and stored at - 20 ⁰C. 
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Small Angle Neutron Scattering 
SANS experiments were conducted on the Quokka SANS instrument located at the Australian Centre 
for Neutron Scattering (ACNS), ANSTO, Sydney (103). Neutrons (λ = 5 Å) from the cold source OPAL 
reactor were detected utilizing 1.3 and 12 m detector lengths which provided a q range of 0.007 – 0.4 
Å-1. Samples were loaded into a 2 mm circular quartz cuvette which was sealed with a stopper and 
parafilm to avoid evaporative loss.  The data were converted to absolute scale via normalization with 
the incident beam flux.  
In order to exclusively observe neutron scattering from αBc under crowded conditions, we used 
deuterated αBc and eliminated the high background scattering of the hydrogenated crowding agents 
Ficoll 400 and bovine γ-crystallin through contrast matching. The D2O match points of all solution 
components were predicted via the molecule’s scattering length density and experimentally tested using 
contrast-series SANS experiments. The match points were 100, 28 and 40 % D2O for deuterated αBc, 
hydrogenated Ficoll 400 and, hydrogenated bovine γ-crystallin, respectively. As such, experiments 
using hydrogenated Ficoll 400 were undertaken in 28 % D2O while those using hydrogenated bovine 
γ-crystallin were undertaken in 40 % D2O. Deuterated αBc in dilute conditions was studied with 28 % 
D2O present. All SANS studies used 2.5 mg/mL deuterated αBc in a 25 mM sodium phosphate buffer, 
100 mM NaCl, pH 7.3 along with relevant percentage of D2O. 
Initial experiments using deuterated αBc and hydrogenated Ficoll 400 at 0, 50, 100, 125, 150, 
200, and 250 mg/mL were conducted at temperatures of 3, 25, 37, and 45 ⁰C which was sequentially 
ramped over approximately 48 hours. Experiments to compare and contrast the effect of a soluble 
polysaccharide, hydrogenated Ficoll 400, and a relevant protein, hydrogenated bovine γ-crystallin, as 
crowding agents on deuterated αBc were conducted thermodynamically and kinetically at a crowding 
concentration of 125 mg/mL. Thermodynamic experiments involved temperature ramping and 
scattering collection at eight temperatures within the range of 30 – 80 ⁰C. Kinetic experiments were 
completed at 37 ⁰C for a total of 36 hours. Scattering from all SANS experiments was collected for 1.5 
hours per crowding concentration, temperature or time-point. 
The data were reduced to a 1D scattering profile using in-house macros within the IgorPro 
software suite (104). The data were subtracted from the scattering of an empty cell and buffer using 
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either IgorPro or PRIMUS (105). Low-q points near the beam stop were excluded. The data were 
analyzed by determining the Guinier Rg and I(0) value using PRIMUS and the real-space Rg and Dmax 
via the P(r) function calculated using GNOM (106). Analysis using power-law fitting (Eqn. 1) was 
completed using SasView 4.2.0 (107). 
                                                  𝐼ሺ𝑞ሻ  ൌ  𝑠 ∙ |𝑞|ି஽೘ ൅ 𝑏                                             (Eqn. 1) 
where I(q) is the scattering intensity in cm-1, s is a scaling factor, Dm is the Porod exponent (otherwise 
known as the ‘fractal dimension’) and b is the background in cm-1. Power-law analysis in the mid-q 
range (0.05 Å-1 < q < 0.40 Å-1) provided the Dm value which is directly related to the overall structure 
of the scattering molecule based on internal scaling inherent to its inter-atomic distances. However, 
power-law analysis in the low-q range (0.006 Å-1 < q < 0.018 Å-1) allowed a reproducible unitless 
measure of protein aggregation. For instance, if the determination of Rg via the Guinier plot no longer 
satisfied the condition of qRg ≤ 1.3 due to an upturn, this method provided a measure of the gradient of 
that upturn with a higher gradient value indicating greater aggregation. The data were also analyzed 
using Kratky or normalized Kratky plots. The latter was dependent on the acquisition of Rg and I(0) 
values. 
 
Thermal Stability 
CD, Trp fluorescence, and light scattering thermal stability experiments were conducted at 0.3 mg/mL 
αBc in 25 mM sodium phosphate buffer, 100 mM NaCl, pH 7.3 using 0, 50, 100, 150, 200, and 250 
mg/mL Ficoll 400. Experiments were performed using an Applied Photophysics Chirascan 
spectrophotometer with scanning emission monochromator attachment. CD spectra were acquired using 
a 1 mm path length quartz cuvette while Trp fluorescence and light scattering measurements were 
undertaken using a 1 cm path length quartz cuvette. Both cuvettes were fitted with stoppers to minimize 
evaporative loss. Step-wise temperature ramping was used from 25 – 90 °C at 0.5 °C increments per 
step using a Quantum Northwest TC 125 Peltier temperature controller. There was a 30 second 
equilibration time between each incremental temperature increase. CD spectra were acquired from 200 
– 260 nm and Trp fluorescence spectra from 300 – 400 nm both with a wavelength step width of 1 nm 
121
 
 
acquired for 1.5 seconds per step. Light scattering data were acquired and analyzed against temperature 
at the single wavelength of 360 nm to determine Tagg. The CD ellipticity at 218 nm, sensitive to β–sheet, 
was analyzed against temperature to obtain a Tm value largely related to the β-sheet rich ACD. A plot 
of the Trp fluorescence spectra versus temperature provided a Tm value related to the local environment 
of the NTR of αBc and were best analyzed using the whole spectrum for each temperature via the λbcm 
(Eqn. 2).  
                                                                  𝜆௕௖௠ ൌ  ∑ ூሺఒሻ∙ఒ∑ ூሺఒሻ                              (Eqn. 2) 
where λ is a wavelength within the emission range and I(λ) is the fluorescence intensity at that 
wavelength.  
Both Tm and Tagg values were elucidated via fitting of either a single Boltzmann function (Eqn. 
3) for distinct monophasic transitions or double Boltzmann function (Eqn. 4) for clear biphasic 
transitions using the mid-point(s) of the sigmoidal transition (x0, x01, and x02). 
𝑦 ൌ ஺భି஺మଵା௘ሺೣషೣబሻ/೏ೣ ൅ 𝐴ଶ          (Eqn. 3) 
where A1 and A2 are the lower and upper asymptotic values, respectively, dx is the rate of 
unfolding/aggregation against temperature, and x0 is the mid-point (Tm or Tagg) of the monophasic 
transition. 
𝑦 ൌ 𝑦଴ ൅ 𝐴 ൤ ௣ଵା௘ೣషೣబభೖభ ൅
ଵି௣
ଵା௘
ೣషೣబమ
ೖమ
൨            (Eqn. 4) 
where y0 is the y-axis offset, A is the sum of the first and second asymptotes, p is the fraction of A that 
is equal to the value of the first asymptote (i.e. if A = 10 and the first asymptote is 3, then p = 0.3), k1 
and k2 are the slope factors for the first and second transition, respectively, and x01 and x02 are the 
mid-points of the first and second transitions in the biphasic sigmoidal curve, respectively. 
 Thermal aggregation experiments on both αBc and αAc alone were undertaken at 0.1 and 0.3 
mg/mL while mixtures of 1:1, 1:2, and 1:3 αBc:αAc were based on w:w ratios with αBc having a fixed 
concentration of 0.1 mg/mL. Mixtures of αBc and αAc were allowed to equilibrate under dilute 
conditions for 1 hour at room temperature before acquisition. The experiments were all conducted at 
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250 mg/mL Ficoll 400 with the same settings and parameters as previously described for light scattering 
Tagg measurements at 360 nm.  
 
Aggregation and Chaperone Assays 
 Kinetic aggregation and chaperone assays were performed using a Biotek Synergy 2 microplate 
reader. Light scattering was monitored at 360 nm while ThT fluorescence used a 440 nm filter for 
excitation and a 485 nm filter for emission at a final dye concentration of 20 μM. Both clear (light 
scattering) and black (ThT fluorescence) 96 well plates (Greiner Bio-One) were sealed to prevent 
evaporative loss and a ‘slow shaking’ setting was engaged for the duration of all assays. All experiments 
were conducted at 37 °C in 25 mM sodium phosphate buffer, 100 mM NaCl, pH 7.3. 
 The aggregation of αBc in highly crowded conditions was monitored with light scattering and 
ThT fluorescence using 250 mg/mL of spectroscopically silent Ficoll 400. Concentrations of αBc 
studied were 0.03, 0.1, 0.3, 0.5, 1.0, 1.5, 2.0, 2.5, and 3.0 mg/mL. The maximum light scattering and 
fluorescence from their respective assays were measured and plotted against αBc concentration. 
 The chaperone assay using reduced insulin was modified from a previous study (49) to allow 
for changes in lag time and rate of aggregation due to the presence of crowding agent. Modifications 
included a lower insulin (0.15 mg/mL) and DTT (10 mM) concentration which allowed a gradual 
change in aggregation across the experimental crowding series. The experimental crowding series 
consisted of 0, 50, 100, 150, 200, and 250 mg/mL of Ficoll 400 with a fixed concentration of 0.3 mg/mL 
αBc giving a 1:2 w:w ratio of insulin:αBc. Aggregation kinetics were fitted to a single Boltzmann 
function (Eqn. 3) using Origin (OriginLab Corporation) and the fitting parameters were used to 
calculate the lag time, rate of aggregation and maximum light scattering as previously described (108). 
 The kinetic aggregation of αBc, αAc and mixed hetero-oligomers was studied via light 
scattering. The experimental conditions related to the mixtures of αBc and αAc were the same as 
described in the final Thermal Stability section and the experiment was conducted over 8 hours. The 
percentage protection of the αBc:αAc hetero-oligomers versus 0.1 mg/mL αBc alone was calculated as 
previously described (108). 
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Transmission Electron Microscopy 
 TEM samples were prepared using a 1 in 5 dilution with Milli-Q water of 2.5 mg/mL αBc at 0 
hour in 0 mg/mL Ficoll 400 and at 0 , 0.5 , 5 , 16 , and 33 hours in 250 mg/mL Ficoll 400 after incubation 
at 37 °C. The diluted sample (2 µL) was added to Formvar- and carbon-coated copper grids 
(ProSciTech, Australia). The grids were then washed three times with 10 μL of Milli-Q water and 
negatively stained with 10 μL of uranyl acetate (2 % w/v). Samples were viewed using a Hitachi 
H7100FA transmission electron microscope (Tokyo, Japan). 
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Supplemental Figure 1. Fitting of SANS and spectroscopic thermal stability data with increasing Ficoll 400 
concentrations. A, expanded SANS scattering plot of 2.5 mg/mL αBc in 250 mg/mL Ficoll 400 at four different 
temperatures collected sequentially over ~ 48 hours. A putative Bragg peak at 37 °C and 45 °C is fit with a 
Gaussian function (red, solid line) giving a spacing of ~ 15 nm. B, scattering plot of 2.5 mg/mL αBc in increasing 
Ficoll 400 concentrations at 37 °C using 28 % D2O. Scattering profiles are displaced along the y-axis with 
increasing Ficoll 400 concentration for comparison. The area of the mid-q (blue (0.05 Å-1 < q < 0.40 Å-1)) and 
low-q (red (0.006 Å-1 < q < 0.018 Å-1)) Dm is highlighted and fits to the power-law function are the solid lines 
through the scattering data at those respective mid-q and low-q limits. C-E, Thermal stability of 0.3 mg/mL αBc 
in increasing Ficoll 400 concentrations (colour key below) as monitored by C, tryptophan fluorescence analysed 
using barycentric mean fluorescence (λbcm), D, ellipticity at 218 nm (ϴ218) from circular dichroism and, E, light 
scattering at 360 nm. Data are presented as scatter and fits are solid lines. Thermal unfolding curves in D show 
two changes in ϴ exemplified by negatively and positively sloped single Boltzmann sigmoidal functions. Thermal 
aggregation curves for 0 and 50 mg/mL Ficoll 400 in E are the best fitted to a double Boltzmann sigmoidal 
function. All other transitions were fitted to a single Boltzmann sigmoidal function.
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Supplemental Figure 2. Light scattering and ThT fluorescence kinetics of αBc aggregates formed in 
crowded conditions in the presence of 250 mg/mL Ficoll 400. A, representative light scattering (360 nm) and 
B, ThT fluorescence kinetics for αBc from 0.03 – 3.00 mg/mL in 250 mg/mL Ficoll 400 at 37 °C. The colours of 
the traces are related to the concentrations of αBc used and are given below panels A and B. C, average initial 
(black) and final (red) ThT fluorescence from three independent repeats of the ThT assay in panel B. Errors are 
given as the standard deviation of three independent repeats. Initial ThT values versus αBc concentration are fitted 
to a Gaussian function (R2 = 0.99) while final ThT values are the same as those in Fig. 2, H, used here for 
comparison. This demonstrates that as αBc concentration increases at 250 mg/mL Ficoll 400 the initial and final 
ThT values are sensitive to two different structural aspects of the protein. D, conceptual reaction coordinate 
diagram to explain the distinct kinetics, via the first (ΔG≠) or second (ΔG≠') activation energy, and differences in 
abundance with increasing concentration, via the change in free energy (ΔG0), of amorphous and fibrillar 
aggregation. Three potential reaction pathways include distinct amorphous (blue) and fibrillar (red) aggregation 
pathways stemming from a native pool of native αBc or a single amorphous and fibrillar aggregation pathway 
(purple) with a metastable intermediate (likely a form of amorphous aggregate) implying a transition from an 
amorphous to a fibrillar aggregate.  
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Supplemental Figure 3. SANS data analysis of αBc using bovine γ-crystallin as a crowding agent. A, size-
exclusion separation of bovine lens homogenate showing the γ-crystallin fraction extracted (shaded) and used as 
a biologically relevant crowding agent. B, Porod exponent of 2.5 mg/mL deuterated αBc at 30 °C under various 
crowding conditions as indicated. C-E, Guinier plots (scatter) and power-law fits (solid line) of 2.5 mg/mL 
deuterated αBc at temperatures from 30 – 80 °C under conditions of C, no crowding, D, 125 mg/mL Ficoll 450, 
and E, 125 mg/mL γ-crystallin. The ‘low-q Dm’ value from the power-law fit is used to indicate the presence and 
extent of αBc aggregation. F and G, Scattering plots of 2.5 mg/mL deuterated αBc at 37 °C from 0 – 36 hours for 
F, 125 mg/mL Ficoll 400, and G, 125 mg/mL γ-crystallin.  
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Supplemental Figure 4. Assessing the chaperone ability of αBc against reduced insulin aggregation with 
increasing Ficoll 400 concentrations. Representative light scattering curves of A, reduced insulin, B, reduced 
insulin with αBc in a 1:2 w:w ratio and C, αBc alone as monitored at 360 nm in increasing Ficoll 400 
concentrations from 0 – 250 mg/mL. Ficoll 400 concentration is indicated by the color as per the key below the 
figures. 
  
139
 
 
 
Supplemental Figure 5. Chaperone effectiveness and thermal stability for αBc, αAc and hetero-oligomers 
in 250 mg/mL of Ficoll 400. A, percentage protection for αAc's chaperone activity on αBc calculated from data 
in Fig. 5A. B, thermal aggregation curves for αBc, αAc and different ratios of hetero-oligomers in 250 mg/mL 
Ficoll 400. The initial increase in light scattering for 1:1, 1:2, and 1:3 αBc:αAc is likely due to a significant 
increase in size of the α-crystallin oligomer with temperature. This size increase is then reveresed, likely by αAc 
chaperone action, before finally completely aggregating at higher temperatures. The Tagg for 1:1, 1:2, and 1:3 
αBc:αAc is measured as the transition after the initial increase and decrease in light scattering. All curves are an 
average of three independent repeats. 
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CHAPTER 4:  
STUDYING CONFORMATIONAL HETEROGENEITY 
USING CAPILLARY ELECTROPHORESIS 
 
 
 
 
 
 
 
“Real courage is when you know you’re licked before you begin, but you begin anyway and see it 
through no matter what. You rarely win, but sometimes you do.” 
– Harper Lee 
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 ABSTRACT: Separation of pure protein using free-solution capillary electrophoresis (CE) can resolve 
distinct protein conformers and provide insight into conformational heterogeneity. However, the 
method is seldom used for protein conformational characterization. To clearly demonstrate the 
application of CE toward the characterization of distinct protein conformers and conformational 
heterogeneity, we analyzed three well-characterized proteins, bovine serum albumin (BSA), yeast 
alcohol dehydrogenase (YADH), and bovine α–lactalbumin (BLA) under conditions that led to their 
structural alteration. A distribution of electrophoretic mobilities was obtained from CE and was 
juxtaposed with the conventional distribution of molar masses obtained by size-exclusion 
chromatography coupled to light scattering (SEC-MALS). Oligomers as well as two monomeric 
conformations of BSA were separated by CE and the conformational heterogeneity of two different 
oligomeric preparations was compared. Analysis of YADH resolved two distinct monomeric 
conformers as well as multiple tetrameric species while changes to the protein’s conformational 
heterogeneity could be followed upon removal of its intrinsic zinc ions and reduction of its disulfide 
bonds. While SEC-MALS profiles were indistinguishable for the apo- and holo-forms of BLA, CE 
resolved both species and also measured changes to the protein’s heterogeneity upon metal ion binding 
and removal. Further, comparison of these structurally unrelated proteins revealed novel insights into 
relative differences in molar mass and conformational heterogeneity. Overall, this analysis has 
improved our understanding of how CE separates protein oligomers and distinct conformers and their 
relationship to conformational heterogeneity. CE can provide additional and complementary structural 
information on proteins with varying degrees of conformational complexity compared to other 
traditional techniques. 
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 INTRODUCTION 
Protein structural characterization provides fundamental insight into the physical and chemical 
properties that underlie conformational features and functions of these essential biological 
macromolecules. Free-solution capillary electrophoresis (CE) is one separation-based characterization 
technique that has been used extensively in proteomics1,2, but has only recently begun to gain favor in 
relation to intact protein characterization. CE in the critical conditions (CE-CC) transcends traditional 
hydrodynamic based separation methods, i.e. separation dependent on hydrodynamic size, and instead 
separates on the basis of conformational and/or compositional feature(s) of a polyelectrolyte.3 This 
molar mass independent separation method has been repeatedly demonstrated in the literature for 
various polyelectrolytes including denatured protein-SDS complexes,4,5 DNA6 and synthetic polymers.7 
It is clear that above a certain molar mass (> ~10,000 gꞏmol-1)4 or degree of polymerization (> ~120 
N),7 unstructured charged macromolecules will have minimal variation in their electrophoretic mobility 
(μ), which is proportional to their velocity within an electric field.8 For intact proteins, this behavior 
implies that any differences in μ is likely due to conformational and/or compositional differences based 
on a relationship between shape, size, effective charge, counter ion condensation and hydration that 
exist on a timescale amenable to CE separation.9,10 To this end, the separation mechanism of CE-CC 
can be more aptly described as being effected by charge and electrostatic friction, sensitive to 
conformational differences rather than only hydrodynamic size. 
The complex relationship between charge and conformation in CE-CC has been exploited to 
characterize various protein conformations. Folding/unfolding studies using either chemical denaturant 
or temperature have shown a significant distinction in the μ between folded, partially unfolded and 
unfolded populations.9-14 Studies have interfaced CE with intact protein mass spectrometry (CE-MS)15 
to unambiguously assign different peaks, confirming the separation of conformers or post-
translationally modified isoforms.16 A folding transition has also been monitored using CE and has been 
validated through comparison with ion-mobility MS (IM-MS) which is sensitive to conformational 
differences via changes in protein cross-sectional area.14 Both open and closed conformations of a 
protein in the presence of ligands have been studied with kinetic CE using UV-detection17 and 
subsequently through coupling CE separation with IM-MS (CE-UV-IM-MS) to elucidate a more 
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 definitive link between enzyme conformation and function.18 While powerful, it is important to note 
that CE-MS faces significant challenges. It is difficult to select a suitable buffer system that can maintain 
a protein’s native conformation, is amenable to CE separation, and can provide sufficient ionization 
capacity. This can potentially lead to a compromise that results in a loss of resolution.16,19 Furthermore, 
while these studies focus on the separation and assignment of distinct conformations, it has also been 
recognized that the inherent broadness of a CE peak contains information related to multiple 
conformations with a similar μ.13,17 Thus, the ability to measure the CE peak broadness provides 
previously unstudied information related to the conformational heterogeneity of a protein. However, 
the methodology that allows this measurement in CE was only recently developed. 
CE data are acquired in the form of detector signal against migration time which can be 
transformed into a distribution of electrophoretic mobilities (W(µ)).20 This compensates for variations 
in electric field strength, electroosmotic flow (EOF) and peak area due to the different relative velocities 
of analytes in the detection window. Subsequently, due to the unique aforementioned separation 
mechanism of CE-CC, the W(µ) can be reflective of a distribution of conformational and/or 
compositional feature(s). Recently, the heterogeneity of the degree of acetylation of chitosan, a 
compositional component, and the heterogeneity of branching of poly(sodium acrylate), a 
conformational feature, have been quantified.3 However, this novel methodology has not been applied 
to proteins. When using CE-CC to characterize a protein devoid of significant post-translational 
modifications, any variance in the W(µ) should be reflective of differences in that protein’s 
conformation. This effectively allows quantification of the heterogeneity of conformation via a 
dispersity value (D(W(µ))) calculated from the protein's W(µ). 
Proteins can exhibit multiple forms of heterogeneity, namely with regard to molar mass, size, 
conformation and composition.21 Traditional techniques are limited in the information they can provide 
on highly heterogeneous proteins. Currently the most common method to investigate heterogeneity is 
size exclusion chromatography coupled to a multi-angle light scattering detector (SEC-MALS). This 
technique yields the in-solution distribution of molar masses (W(M)) and the dispersity value (Đ) 
thereof, as well as the number- and weight-average (Mw) molar mass. While SEC-MALS probes the 
heterogeneity in molar mass, no method has been able to provide a direct in-solution measure of the 
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 heterogeneity of conformational and/or compositional distributions. A better understanding of protein 
conformational heterogeneity inferred through changes in the D(W(µ)) from a CE experiment could 
provide information on shifts in conformational equilibrium related to enzyme or chaperone function, 
structural plasticity, and thermal stability or lability. 
Herein, we compare at physiological pH the respective W(µ) from CE with the W(M) acquired 
from SEC-MALS for three structurally well-characterized proteins: bovine serum albumin (BSA), 
alcohol dehydrogenase from Saccharomyces cerevisiae (YADH) and α-lactalbumin from bovine milk 
(BLA) under various structurally altering treatments. Juxtaposition of these distributions for each 
protein demonstrates the striking complementary and orthogonal features of the two characterization 
methodologies. The relationship between dispersity values and conformational heterogeneity is 
examined. Also, correlations between dispersity and corresponding weight-average electrophoretic 
mobility (μw) and Mw, respectively, are used to better understand how protein oligomerization affects 
CE separation and conformational heterogeneity. The data are interpreted within the framework of the 
extensive existing literature regarding the conformational features of these proteins. Finally, some new 
conformational insights are derived from the data. 
 
EXPERIMENTAL SECTION 
Materials. All lyophilized protein samples including albumin from bovine serum (oligomeric BSA 
(A7906)), albumin, monomer bovine (monomeric BSA (A1900)), alcohol dehydrogenase from 
Saccharomyces cerevisiae (YADH (A7011 – 75KU)) and α-lactalbumin from bovine milk (BLA (Ca2+ 
depleted (dep)) (L6010)) were purchased from Sigma and used without further purification. All other 
reagents including ethylenediaminetetraacetic acid (EDTA) and dithiothreitol (DTT), boric acid, 
sodium borate, CaCl2 and MgCl2, unless otherwise stated, were purchased from Sigma. All solutions 
were prepared using MilliQ water (18 MΩ cm-1, 0.22 μm membrane filter). A 200 mM stock solution 
of sodium phosphate buffer (NaPi) was produced by titrating acidic NaPi with NaOH to pH 7.4. It was 
then diluted to a working concentration of 5 mM to be used as the CE background electrolyte (BGE) 
and the SEC-MALS eluent for BSA and YADH. BLA experiments were conducted in 20 mM 
Tris(hydroxymethyl)methylamine-HCl (Tris-HCl) buffer, produced by titrating Tris base with HCl to 
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 pH 7.4. Protein concentrations were quantified using the protein’s extinction coefficient (E1%) value 
provided in the manufacturer’s product documentation and measured using an ultra-low volume 
spectrophotometer (Thermo Fisher Scientific Inc.). 
 
Determination of dn/dc values. For each protein sample, a concentration series consisting of 10 points 
between 0.5 g∙L-1 and 5.0 g∙L-1 was prepared from a stock solution. The relevant SEC-MALS eluent 
was sonicated for 5 minutes to remove dissolved gasses and then filtered (0.22 μm, Chromfilter) before 
use. The refractive index (RI) of the protein solution at each concentration was determined using an 
ultra-low volume refractometer (J357, Rudolph Research Analytical) at 25 °C in the aforementioned 
buffer. The data were plotted as differential RI (dRI) vs. concentration (gꞏmL-1) and the dn/dc value 
was taken as the slope of the linear fit. 
 
Capillary Electrophoresis and Pressure Mobilization. Both CE and pressure mobilization (PM) 
experiments were performed on an Agilent CE 7100 instrument (Agilent Technologies) using an 80.0 
cm total length (71.5 cm effective length) fused silica capillary (Polymicro, USA) with an internal 
diameter of 50 μm.  Capillary pre-treatment consisted of a 10 minute flush with fresh 1 M NaOH, 5 
minute flush with 0.1 M NaOH, 5 minute pre-treatment flush with Milli-Q water and a 5 minute flush 
with the BGE. This pre-treatment was also used before each new protein was analyzed. Between each 
individual experiment, the capillary was flushed for 5 minutes with the BGE. The capillary post-
treatment was a flush for 5 minutes with 1 M NaOH, 10 minutes with Milli-Q water and 10 minutes 
with air for storage. For both CE and PM, BSA and YADH were prepared to a concentration of 1 g∙L-1 
while BLA was used at 0.5 g∙L-1. Protein treatments (Table S1) were allowed to react for one hour 
before measurement. Protein samples were injected hydrodynamically into the capillary using 30 mbar 
of pressure for 10 seconds. CE separation was conducted at 30 kV while PM experiments were 
completed using 50 mbar of pressure. Oligo(sodium acrylate) (AA3) in 25 mM sodium borate buffer 
(pH 9.3) was used to validate the capillary (Figure S2).22 Dimethyl sulfoxide (DMSO) was used as a 
mobility marker at 0.2 % (v/v). All data were recorded at 191 nm (bandwidth of 2 nm) and treated as 
previously described3,20 using Origin 8.5. 
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 Size-exclusion chromatography with Multi-Angle Light Scattering. SEC–MALS experiments were 
performed using a DAWN HELEOS 8 (Wyatt) laser light scattering device and an Optilab rEX (Wyatt) 
RI detector connected in series. Both detectors were set at 25 °C and the eluent was degassed online 
with a Waters In-Line Degasser AF. Protein samples were prepared at 3 g∙L-1. Protein treatments (Table 
S1) were allowed to react for one hour before measurement. Sample separation was achieved using a 
Superdex 200 10/300 GL SEC column (GE Healthcare) for BSA and YADH while a Superdex 75 
10/300 GL SEC column (GE Healthcare) was used for BLA. The columns were equilibrated using the 
same sample buffers as for CE experiments prior to use. Samples were injected onto the column via a 
100 μL injection loop. Normalization of the MALS detectors was achieved using the monomeric 
fraction of BSA at 10 g∙L-1 in the aforementioned equilibration buffer. Data acquisition and processing 
were completed using ASTRA (5.3.4) (Wyatt).  
 
Circular Dichroism Spectroscopy (CD). CD experiments were performed using an Applied 
Photophysics Chirascan spectrophotometer attached to a Quantum Northwest TC 125 PELTIER 
temperature controller. Oligomeric and monomeric BSA was dissolved in 5 mM sodium phosphate, pH 
7.0, at a concentration of 0.3 g∙L-1. The spectrum was acquired in a 0.1 cm pathlength quartz cuvette 
from 180 – 250 nm at 25 °C. All spectra were acquired with a step width of 1 nm for 4 s and three 
repeats were taken. These parameters were used for three independent experiments which were 
averaged to produce the final spectrum. 
 
RESULTS AND DISCUSSION 
Analytical considerations. Initially, PM experiments were used to ensure there was no significant 
adsorption to the capillary wall that could affect electrophoretic separation and peak shape.23 PM 
experiments were repeated five times for each protein along with each relevant treatment and yielded 
largely symmetrical Gaussian peaks (Figure S1 A-C). These results qualitatively indicate minimal 
adsorption between the proteins and the capillary wall. Adjusted R2 values were obtained through fitting 
the peaks with a Gaussian function. The values, 0.951 - 0.993, indicate minimal peak asymmetry and 
thus confirmed adsorption was negligible across the experimental series (Table S2). 
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 The separation efficiency of the capillary was tested using a complex synthetic polymer 
mixture, AA3. The AA3 peaks could easily be assigned from their respective μ values using the 
literature24 (Figure S2) thereby indicating the effective separation of the capillary. Optimization of the 
separation conditions is a pivotal part of obtaining unambiguous separation data. While maintaining pH 
at the physiologically relevant value of 7.4, it was found that a low salt buffer and an 80 cm capillary 
were the ideal conditions for improved resolution. A comparison of separations at 40 cm and 80 cm 
capillary lengths (Figure S3) using the same injection volume illustrates the stark difference a longer 
capillary and sample overloading can make to the resolution of the separation. Transformation of raw 
CE data from migration time to μ requires taking into account the migration of a neutral molecule, 
DMSO, which is used as an EOF marker. This transformation accounts for variations between injections 
and ensures accuracy of the sample μ value. Post transformation, all relevant proteins and treatments 
were overlaid and visually inspected to ensure correct alignment of the EOF peak (Figure S4 A-C). 
The SEC-MALS measurements require the determination of a protein’s dn/dc value for 
accurate molar mass calculations. Each protein was dissolved in the relevant degassed buffer and the 
dn/dc value obtained from a linear fit (R2 > 0.99) of dRI against a concentration series (Figure S5 A-
C). Finally, the SEC chromatograms were examined to confirm that the treatments (Table S1) used had 
not greatly affected the retention time of the modified protein (Figure S6 A-C). 
 
Conformational Heterogeneity and CE Separation of BSA Oligomers. BSA can form various 
oligomeric species (e.g. monomer, dimer, trimer etc.) but can also be purified to a high percentage of 
monomer only.25,26 To understand how CE separates oligomeric proteins and assess the impact this has 
on conformational heterogeneity, we analyzed BSA in its oligomeric and monomeric forms and 
compared the results to those obtained by SEC-MALS. 
The W(M) of the oligomeric BSA preparation shows a broad tailing distribution with 
unresolved oligomers at higher molar mass (Figure 1A, black) which are not apparent for monomeric 
BSA (Figure 1A, red), as is expected since the latter preparation is largely monomeric. Single peaks at 
~63,000 gꞏmol-1 and ~120,000 gꞏmol-1 (peak max) correspond to the approximate molar masses for 
BSA monomer and dimer, respectively (Figure 1A). The W(µ) of oligomeric BSA (Figure 1B, black)  
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Figure 1. Separation and distribution analysis of oligomeric and monomeric BSA using SEC-MALS and CE. 
Representative distribution of (A) molar masses and (B) electrophoretic mobilities for oligomeric (black) and 
monomeric (red) BSA. (C) Far-UV CD spectra of oligomeric (black) and monomeric (red) BSA. (D) Ð plotted 
against the Mw for the whole sample. (E) D(W(µ)) plotted against the μw for the whole sample. 
 
also displays a broad tailing distribution with two distinct peaks but with a clear shoulder off the main 
peak while monomeric BSA (Figure 1B, red) has a far narrower distribution and two distinct peaks. 
The general shape of the W(µ) (Figure 1B) is qualitatively similar to that of the W(M) (Figure 1A) for 
both oligomeric and monomeric BSA. Therefore, as the peaks in the W(M) can be unambiguously 
assigned, we tentatively assigned similar peaks in the W(µ). In the oligomeric BSA preparation, the 
major peak with an μ of 1.72 × 10-8 m2∙V-1∙s-1 (peak max) was assigned as the monomeric form (Figure 
1B, black). A clear shoulder on this monomeric peak suggests more than one population of monomeric 
conformers may exist in this sample. The distinct peak at an μ of 1.82 × 10-8 m2∙V-1∙s-1 (peak max) was 
assigned as the dimeric form, with the subsequent tailing being attributed to higher oligomers. The W(µ) 
of the monomeric BSA preparation shows a shift to a higher overall μ (Figure 1B, red). The assigned 
monomer peak at 1.77 × 10-8 m2∙V-1∙s-1 aligns with the aforementioned monomeric peak shoulder 
observed in the oligomeric BSA preparation (Figure 1B, black) further confirming its assignment as a 
monomeric conformer. Finally, the distinct peak at an μ of 1.87 × 10-8 m2∙V-1∙s-1 (peak max), which 
exhibits the same shift as the monomer relative to the corresponding peaks in oligomeric BSA, was 
assigned to a small amount of dimer which is also seen in the W(M) for monomeric BSA.  
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 To ensure the shift in μ is not due to non-native structural perturbations between the two BSA 
preparations, we examined far-UV CD spectra of oligomeric and monomeric BSA (Figure 1C). Both 
spectra exhibit a classic α-helical spectrum and are superimposable down to a wavelength of 180 nm, 
indicating the proteins are structurally indistinguishable in terms of their overall secondary structure. 
Therefore, the possibility that partial denaturation is the cause of the shift in μ between the two 
preparations is unlikely.  
We quantitatively compared Mw and μw for the entire distribution to their respective Đ and 
D(W(µ)) values (Figures 1D and 1E, respectively). Consistent with the qualitative interpretations, 
oligomeric BSA is more disperse than monomeric BSA in both conformation and molar mass, with 
oligomeric BSA also having higher μw and Mw due to the presence of larger oligomeric species at higher 
μ and molar mass. 
Previously, with the exception of one study that showed multiple peaks for a BSA separation 
using CE with a polyacrylamide coated capillary,27 the separation of BSA by CE has largely been of 
very low resolution28,29, or effected through the use of an in-solution molecular sieving agent like 
dextran or polyethylene glycol.29,30 This is unsurprising given the low resolution obtained prior to 
optimisation (Figure S3 A). Considering CE separates on the basis of size to charge, it has been 
purported that the separation of BSA oligomers is not possible as both the size and charge are expected 
to scale uniformly upon oligomerization, essentially not providing any separable difference between 
oligomers in CE.30 We have shown this to not be the case (Figure 1B), further validating the separation 
mechanism in CE-CC as being on the basis of charge to electrostatic friction. However, we acknowledge 
that our separation, particularly of higher oligomers, could be improved with further optimization of 
the separation parameters. Indeed, the higher oligomeric forms that are readily observed have a higher 
μ than lower oligomeric forms. A similar CE separation of glucosamine-6-phosphate synthase also 
observed that the hexameric oligomer had a higher μ than the dimeric form.31 Together, these results 
indicate that oligomerization causes either a net increase in effective negative charge and/or a decrease 
in electrostatic friction allowing for separable differences related to the conformational changes inherent 
to oligomerization. 
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 CE separation also reveals further heterogeneity in the oligomeric BSA sample where SEC-
MALS did not. The heterogeneity of BSA has been studied in detail and can arise due to 
oligomerization, the formation of mixed disulfides, as well as the binding of metal ions or fatty 
acids.25,26,32,33 The preparation of monomeric BSA evidently favors the less abundant monomer present 
as a shoulder in oligomeric BSA, causing the shift in μ noted for the monomeric preparation. 
Interestingly, the shift in μ is also noted for the small amount of dimer observable in the monomeric 
BSA preparation (Figure 1B, red) indicating the modification does not completely prohibit 
oligomerization. The shift in μ between the two monomer peaks in oligomeric BSA and that exhibited 
by monomeric BSA is smaller than what is usually expected for a full unit charge difference e.g. 
glutathionylation, strong metal binding or deamidation.32,34 It therefore seems likely that either subtle 
conformational differences inherent to BSA’s structure e.g. a difference in intramolecular disulfide 
bonding, or, given BSA’s promiscuous binding nature, the loss of a bound molecule(s) e.g. fatty acids,33 
leads to the additional monomeric species with lower electrostatic friction. A more complete 
understanding of the exact nature of these differences would be furthered via coupling CE separation 
to MS detection.  
CE separation of BSA and indeed other protein preparations generally are important for quality 
control in industry where the use of traditional characterization techniques render some conformational 
differences indiscernible. It is also important in research where BSA is used extensively as a model 
protein for the in-depth study of aggregation35 potentially leading to erroneous interpretation if 
conformational aspects of a protein preparation are not known. Finally, for BSA, D(W(µ)) from CE 
(Figure 1D) and Ð from SEC-MALS (Figure 1E) correlate with one another, indicating that oligomeric 
BSA is more disperse in both conformation and molar mass. As such, using CE could provide a far 
more efficient alternative to SEC by providing more information in less time and with reduced sample 
volume and concentration. 
 
Conformational Heterogeneity of Monomeric and Tetrameric Populations of YADH. The YADH 
monomer contains a catalytic domain, comprising one catalytic zinc atom and one structural zinc atom, 
and a coenzyme binding domain.36,37 YADH monomers can adopt different conformations due to the 
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 rotation of the two domains around a substrate binding cleft and, when associating to form the tetramer, 
can come together in a symmetric or asymmetric manner. Therefore, both the YADH monomer and the 
tetramer are subject to significant conformational heterogeneity.36,37 YADH and structurally altered 
forms of the protein prepared by treatment with EDTA or DTT were separated by CE and SEC-MALS 
to assess the ability of CE to discern conformational heterogeneity inherent to oligomeric populations. 
The W(M) of YADH (Figure 2A, left – bottom) shows a small peak with a molar mass at 
~36,000 gꞏmol-1 and a large peak at ~144,000 gꞏmol-1. These molar masses correspond with those 
expected for a monomeric and tetrameric species, respectively.36 No other oligomeric species were 
observed. Changes in the oligomeric structure of YADH have been reported when using compounds 
that can chelate zinc from the protein such as EDTA or DTT, the latter can also reduce disulfide 
bonds.38,39 After one hour of incubation with EDTA, the peak associated with YADH monomer is lost, 
suggesting oligomerization to the tetramer (Figure 2A, left – middle). After treatment with DTT for the 
same time, the YADH tetramer dissociates to produce an approximately even mixture of monomer and 
tetramer (Figure 2A, left – top). Comparison of the W(M) with those of the W(µ) reveals 
complementarity that allowed monomer (highlighted in blue) and tetramer (highlighted in red) peak 
assignment when considering the peak alteration between the EDTA and DTT treatments.  
The W(µ) of YADH reveals two well resolved, equally populated monomer peaks with an μ 
of 9.21 and 9.82 × 10-9 m2∙V-1∙s-1 (Figure 2A, right – bottom). Given the single peak seen in the W(M), 
these two peaks can be ascribed to distinct monomeric conformers. They are likely the ‘open’ and 
‘closed’ forms which are observed in the crystal structure of YADH (Figure 2B, top).36 The YADH 
tetramer (Figure 2B, bottom) shows a broad W(µ) with multiple partially separated peaks at an μ of 
1.09, 1.16, 1.21, and 1.28 × 10-8 m2∙V-1∙s-1. Treatment of YADH with EDTA leads to a loss of both 
monomer peaks in the CE separation (Figure 2A, right – middle), consistent with the W(M). EDTA 
treatment also alters tetramer conformers as the peak at 1.09 × 10-8 m2∙V-1∙s-1 is lost, the peak at 1.16 × 
10-8 m2∙V-1∙s-1 is less resolved and exhibits a new shouldering peak at 1.13 × 10-8 m2∙V-1∙s-1. Treatment 
with DTT shows a single large monomer peak at 9.33 × 10-9 m2∙V-1∙s-1 with minor species tailing up to 
1.03 × 10-8 m2∙V-1∙s-1 (Figure 2A, right – top). This is consistent with an increase in the monomer peak 
in the W(M) however, it indicates that only one of the YADH monomeric conformers predominates 
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Figure 2. Separation and distribution analysis of YADH and two separate treatments with EDTA and DTT using 
SEC-MALS and CE. Representative distribution of (A) molar masses (left) and electrophoretic mobilities (right) 
for YADH (bottom), YADH + EDTA (middle) and YADH + DTT (top). (B) Crystal structure of YADH (PDB: 
4W6Z) showing a closed (cyan, top left) and an open (magenta, top right) monomer conformation. The back-to-
back YADH tetramer conformation (bottom) is shown with closed and open subunits coloured as above. (C) 
D(W(µ)) calculated for the YADH monomer and tetramer during treatments. The limits used are approximated by 
the blue and red coloured boxes encompassing the monomer and tetramer respectively in panel A, right. The black 
asterisk in place of the YADH + EDTA monomer indicates no D(W(µ)) value is applicable as there were no 
discernible monomeric peaks for this sample. (D) Ð plotted against the Mw for the whole sample. (E) D(W(µ)) 
plotted against the μw for the whole sample. 
 
under such conditions. The tetrameric profile is altered drastically displaying a peak at 1.10 × 10-8 m2∙V-
1∙s-1 with tailing species at higher μ, thus affirming that this peak is associated with a tetrameric 
conformer upon consideration of the corresponding W(M). The peaks seen outside of the monomer and 
tetramer assignment in the W(µ) could not be confidently assigned to YADH. These peaks may be forms 
of YADH that remain unaffected by EDTA and DTT treatments or may be minor impurities undetected 
by SEC-MALS.  
In order to quantitatively compare changes in the conformational heterogeneity for the 
monomer and tetramer upon treatment with EDTA and DTT, D(W(µ)) values were calculated from the 
corresponding W(µ) for both species using the limits indicated by the blue and red boxes respectively 
(Figure 2A, right). The YADH monomer in the native state and the DTT-treated sample have a D(W(µ)) 
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 of 1.00189 ± 0.00009, and 1.00120 ± 0.00038, respectively (Figure 2C, blue).  A D(W(µ)) value for the 
YADH monomer treated with EDTA could not be calculated due to a loss of the relevant peaks (Figure 
2C, black asterisk). The native YADH contains two distinct monomeric populations, while the DTT-
treated sample contains one. This is likely the reason for the higher D(W(µ)) for native YADH, 
indicating greater monomer conformational heterogeneity relative to the DTT-treated sample (Figure 
2C, blue). The D(W(µ)) values for the tetrameric species were calculated as 1.00395 ± 0.00012, 1.00317 
± 0.00022, and 1.00385 ± 0.00045, for native YADH, EDTA and DTT-treated samples, respectively 
(Figure 2C, red). Native and DTT-treated YADH tetramers exhibit similar D(W(µ)) values and are 
therefore similar in conformational heterogeneity despite the difference in peak profiles. The tetramer 
of EDTA-treated YADH has the lowest D(W(µ)) value and is therefore less conformationally 
heterogeneous which could be rationalized by the loss of distinct peaks relative to native YADH. The 
tetramer has a higher D(W(µ)) value than the monomer in all cases, indicating greater conformational 
heterogeneity for the higher oligomeric species (Figure 2C) in agreement with previous structural 
studies.36  
Quantitative parameters were calculated for W(M) and W(µ) for native YADH, EDTA and 
DTT-treated samples and plotted as the Ð versus Mw (Figure 2D) and the D(W(µ)) versus μw (Figure 
2E). A positive correlation exists between Mw and μw which is consistent with the findings for BSA. Ð  
and D(W(µ)) for YADH and the EDTA-treated samples have similar relative positions on the scatter 
plot. However, the relative difference in Ð between the DTT-treated sample and the native YADH and 
EDTA-treated samples is far more distinctive compared to the corresponding D(W(µ)), indicating that 
molar mass and conformational heterogeneity are discernibly different in this instance. 
Previously, CE studies involving YADH have focussed on monitoring the native enzyme’s 
catalytic activity40 or investigating its interaction with the surfactant sodium dodecyl sulfate.5 However, 
no study has used CE to characterize its structure. CE analysis of YADH provides, to our knowledge, 
the first in-solution separation of the closed and open monomeric conformers (Figure 2A, right – 
bottom) evident in the crystal structure36 and in native polyacrylamide gel electrophoresis.41 A similar 
CE experiment has assigned open and closed conformations of human trans-glutaminase.17,18 Given the 
open conformation for human trans-glutaminase has a lower μ, we suggest the peak at 9.21 × 10-9     
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 m2∙V-1∙s-1 be assigned to the open conformer of YADH and the peak at 9.82 × 10-9 m2∙V-1∙s-1 be assigned 
to the closed conformer (Figure 2A, right – bottom, blue). The open conformation is likely more 
permeable to counter ions and would therefore be subject to greater electrostatic friction relative to the 
closed conformation, thereby causing a lower mobility. However, amino acid charge differences due to 
alteration in tertiary structure may also be a contributing factor.  
The presence of multiple tetrameric peaks in the W(µ) indicates several conformational species 
are present in the native protein (Figure 2A, right – bottom, red). This is consistent with the noted 
asymmetry in the crystal structure of YADH and the different monomeric conformers which can 
oligomerize to adopt numerous tetrameric conformers. A potential further contribution to the observed 
heterogeneity is the alternative coordination sphere of the catalytic zinc ion which can induce slight 
changes in the zinc ions effective charge due to changes in the proximity of the Glu-67 side chain.36,37 
Akin to the monomer, the conformers inherent to the tetrameric population of YADH at a lower μ, e.g. 
1.09 × 10-8 m2∙V-1∙s-1, would likely have a more open conformation, while those at a higher μ, e.g. 1.28 
× 10-8 m2∙V-1∙s-1, would likely be more closed. Such differences in μ can similarly be influenced by a 
change in net negative charge. 
A previous study has examined the effect of EDTA and DTT on the catalytic function, zinc 
content, and heat-labile fraction of YADH.38 The study indicated no significant changes in zinc content 
when YADH is treated with low concentrations of EDTA similar to that used here which is consistent 
with no major shifts to higher μ. However, the reason that the monomeric species is abolished and 
changes occur to the peaks associated with tetrameric conformers upon EDTA treatment is not fully 
understood (Figure 2A, right – middle). Counter-ions, particularly bivalent cations, have an effect on 
the stability and oligomeric state of YADH.42 It is therefore possible that counter-ions in the sample38 
associate with native YADH to stabilize a small quantity of monomer. The addition of EDTA removes 
these ions and the monomeric subunits associate into the tetrameric form. Further, the loss of 
heterogeneity in the YADH tetrameric species could potentially be due to a change in inter-subunit 
electrostatic interactions upon removal of counter-ions.  
The intense single monomer peak observed for the DTT-treated sample indicates dissociation 
from the tetrameric state (Figure 2A, right – top), as noted in previous studies.36,39 This is likely the 
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 open conformer with an increased net negative charge due to the loss of structural zinc38, resulting in a 
slightly higher μ (Figure 2A, right – top). Similarly, the tetrameric population contains a peak at 1.10 × 
10-8 m2∙V-1∙s-1 which is likely related the peak at 1.09 × 10-8 m2∙V-1∙s-1 in the native enzyme. While 
EDTA is a stronger chelator of zinc, DTT is able to abstract the more exposed structural zinc from 
YADH.38 This is likely due to the removal of an obstructive disulfide bond but may also be helped by 
DTT providing a thiol ligand for interchange with the four cysteine thiol groups that coordinate the 
structural zinc.36,38 Abstraction of zinc from the structural site ultimately disrupts important interfacial 
subunit interactions, thereby leading to the noted large-scale dissociation to YADH monomer.  
This study of YADH suggests that the open monomer or tetramer conformer can exist without 
a structural zinc or disulfide bonds, leading to the conclusion that these structural features are pivotal 
in maintaining the closed conformation of YADH. Further, upon EDTA treatment, the monomer and 
the previously studied ‘heat-labile fraction’38 are lost while the opposite is noted for DTT treatment, 
providing a correlation between the YADH monomer and the enzyme’s heat-labile fraction. D(W(µ)) 
values have enabled quantitative comparisons of the conformational heterogeneity between oligomeric 
species within a sample, as well as between structurally altering treatments, thus aiding understanding 
in how D(W(µ)) is linked to protein conformational heterogeneity. Finally, while a deeper discussion 
on the structural and functional implications of these results is beyond the scope of this study, the results 
presented herein provide a platform for further studies to examine the link between enzyme-cofactor 
interaction, catalytic function and conformational heterogeneity. 
 
Metal Binding and Conformational Heterogeneity of Monodisperse BLA. BLA is a monomeric 
calcium-binding protein that undergoes a change in tertiary structure between the Ca2+ bound (holo-
form (Figure 3B, blue, top)) and unbound (apo-form (Figure 3B, yellow, bottom)) forms.43,44 To 
understand how changes in conformation and net charge affects a monomeric protein’s conformational 
heterogeneity, we used CE and SEC-MALS to separate BLA (Ca2+ dep) in its untreated state, BLA + 
EDTA which formed apo-BLA, and both BLA + Ca2+ and BLA + Mg2+ which formed holo-BLA. 
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Figure 3. Separation and distribution analysis of BLA (Ca2+ dep) and corresponding individual treatments with 
EDTA, Ca2+ and Mg2+ using SEC-MALS and CE. Representative distribution of (A) molar masses (left) and 
electrophoretic mobilities (right) for BLA + EDTA (bottom), BLA (Ca2+ dep) (middle, bottom), BLA + Ca2+ 
(middle, top) and BLA + Mg2+ (top). The holo and apo peaks are highlighted in blue and yellow respectively as 
discerned from the W(µ). The small shift in µ between BLA (Ca2+ dep), orange large-dash line, and BLA + Ca2+ 
and BLA + Mg2+, purple small-dash line, is indicated within the holo designation. (B) Crystal structure of holo-
BLA (blue, top, PDB: 1F6S) with a Ca2+ ion coordinated (green sphere) and apo-BLA (yellow, bottom, PDB: 
1F6R). (C) Ð plotted against the Mw for the whole sample. (D) D(W(µ)) plotted against the μw for the whole 
sample. 
 
The W(M) for all samples including BLA treated with EDTA, the Ca2+ depleted form, and the 
addition of Ca2+, and Mg2+ (Figure 3A, left – bottom, middle bottom, middle top, top, respectively) 
display a single peak with a molar mass of 14,200 gꞏmol-1 in agreement with the monomeric mass of 
BLA.45 In contrast, the W(µ) for BLA treated with EDTA (Figure 3A, right – bottom) displays a broad 
distribution with an μ at peak max of 1.29 × 10-8 m2∙V-1∙s-1. BLA (Ca2+ dep) showed two peaks, the less 
intense of the two is more easily distinguishable on the unstacked W(µ) (Figure S4C). The more intense 
peak corresponds with an μ of 1.12 × 10-8 m2∙V-1∙s-1 (Figure 3A, right – orange large-dash line) while 
the lower intensity peak has an μ of 1.29 × 10-8 m2∙V-1∙s-1 (Figure 3A, right – middle bottom). BLA 
treated with Ca2+ (Figure 3A, right – middle top) and BLA treated with Mg2+ (Figure 3A, right – top) 
both also show two peaks (Figure S4C). For these treatments, the more intense peak is seen at an μ of 
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 1.11 × 10-8 m2∙V-1∙s-1 (Figure 3A, right – purple short-dash line) and the less intense peak at 1.29 ×     
10-8 m2∙V-1∙s-1. 
The Ð versus Mw (Figure 3C) shows that, within error, there is no difference between the BLA 
samples, regardless of treatment. The D(W(µ)) versus μw (Figure 3D) however, shows a more disperse 
plot. BLA treated with Ca2+ and Mg2+ have similar μw and D(W(µ)), with both these values being lower 
than that of the other two samples. BLA (Ca2+ dep) and EDTA-treated samples have the same D(W(µ)) 
within error, however BLA (Ca2+ dep) has a lower μw than EDTA-treated BLA. 
 BLA has been used to show the effectiveness of CE in separating bovine whey proteins,46 to 
investigate how capillary temperature effects the μ of proteins,11 to examine protein interactions with 
surfactant5 and to demonstrate the ability of CE charge ladders to discern the effect of electrostatics on 
the thermodynamics of BLA unfolding.12 While CE-based structural studies on BLA have been 
insightful, the assignment of the apo- and holo-forms and the corresponding conformational change that 
occurs due to metal binding has, to our knowledge, not been addressed using CE. This is despite two 
distinct peaks being observed in previous CE separation studies of BLA.11,12 Considering Ca2+  and 
EDTA treatments of BLA, we have assigned two populations in the W(µ) at 1.11 × 10-8 m2∙V-1∙s-1 and 
1.29 × 10-8 m2∙V-1∙s-1 to holo- and apo-BLA, respectively (Figure 3A, right – blue and yellow, 
respectively). This is consistent with the apo-form being more negatively charged than the cation-bound 
holo-form thus resulting in a higher μ for the apo-form. 
 Metal binding, most notably by Ca2+, induces a conformational change in BLA43,44,47 and it was 
anticipated that these conformational differences might be resolved in CE. However, as the 
conformational change is contingent on metal binding, it would seem any distinct conformational 
changes are essentially masked by the charge difference of these species. Despite this, CE separation 
still displayed numerous differences that can be linked to changes in charge or conformational 
heterogeneity that were not evident in SEC-MALS. The similarities in μ for the holo-peak as well as a 
low overall D(W(µ)) for Ca2+ and Mg2+-treated BLA samples indicate that holo-BLA is comparably 
low in conformational heterogeneity. Interestingly, the holo-peak of BLA (Ca2+ dep) shows a shift to a 
slightly higher μ indicating a slight increase in negative charge or decrease in electrostatic friction. Also, 
the D(W(µ)) for BLA (Ca2+ dep) is increased relative to Ca2+ and Mg2+ treatments, which implies that 
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 BLA charge and/or conformational heterogeneity is increased. These results could potentially indicate 
a shift in metal binding equilibrium of BLA (Ca2+ dep), or the binding of adventitious metal ions that 
contribute less positive change than either Ca2+ and Mg2+, or the emergence of new BLA conformers in 
the Ca2+ dep-form. 
EDTA-treated BLA shows a shift to the apo-form with a higher μ due to metal being abstracted 
from the protein. The broad W(µ) of EDTA-treated BLA encompasses some μ values that are not 
assigned to either apo- or holo-BLA. It is unclear why the distribution displays this broadness however 
it is possible that an intermediate conformational exchange rate exists between apo- and holo-BLA 
conformers9 facilitated by metal interchange between chelator and BLA. The D(W(µ)) is also increased 
due to this conformational heterogeneity and is unexpectedly comparable to BLA (Ca2+ dep). This 
indicates that a BLA species that is between the apo- and holo-states (e.g. BLA (Ca2+ dep) and BLA + 
EDTA) can be characterized as having maximum charge and/or conformational heterogeneity. However 
holo-BLA (e.g. BLA + Ca2+ and BLA + Mg2+) and presumably pure apo-BLA can be characterized by 
low heterogeneity. 
CE separation of monomeric BLA during modulation of apo- and holo-forms has provided a 
new dynamic to previously discussed oligomeric proteins, BSA and YADH, showing an obvious 
orthogonality between CE and SEC-MALS separation. Analysing CE data in terms of the W(µ) enables 
assignment and characterization of different metal-bound states of BLA and the ensuing charge and/or 
conformational heterogeneity via the D(W(µ)) value. Such analyses are useful for industrial applications 
such as high-throughput quality control and research where it can be used to study sample heterogeneity 
and obtain metal binding affinities.  
 
Comparison of Molar Mass and Conformational Dispersity for Different Proteins. A direct 
comparison of the overall D(W(µ)) and Ð for all protein samples studied reveals further insight into the 
interplay between molar mass and conformational heterogeneity (Figure 4). Relative to all proteins 
used, holo- and apo-BLA have the lowest conformational and molar mass heterogeneity. This may 
indicate that preferentially detected charge-based changes associated with a monomeric protein such as 
BLA will only alter D(W(µ)) subtly in comparison to proteins with distinct oligomeric forms such as 
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Figure 4. Comparison of the D(W(µ)) and Ð, for BSA, YADH and BLA and related purified forms/treatments to 
discern comparative similarities and differences in conformational and molar mass heterogeneity. 
 
oligomeric BSA or those of high conformational dispersity like YADH. Relative to BLA, D(W(µ)) is 
increased in monomeric BSA and YADH + EDTA samples which both have similar Ð, the former being 
largely monomeric and the latter being largely tetrameric. However, both samples have significantly 
different D(W(µ)), which is likely indicative of the noted conformational heterogeneity inherent to 
YADH whereas monomeric BSA is more homogenous in terms of conformation. D(W(µ)) and Ð are 
similarly increased for both oligomeric BSA and native YADH relative to monomeric BSA and YADH 
+ EDTA, respectively, likely due to the presence of additional oligomeric forms in the BSA sample, 
and the presence of monomers and more distinct tetramers in native YADH. While there is no 
discernible difference in D(W(µ)) between YADH and YADH + DTT, there is a significant increase in 
Ð, perhaps due to the mass difference between equally intense monomer and tetramer populations being 
far greater than the difference in μ. 
 Information inherent to specific groupings when comparing protein D(W(µ)) and Ð values may 
provide a platform from which to compare proteins displaying similarities in conformational and molar 
mass heterogeneity and subsequently discern any physical or functional commonalities within 
groupings (Figure 4). Our studies indicate that protein’s with a high molar mass heterogeneity yet low 
conformational heterogeneity does not currently seem likely as high levels of oligomerization mostly 
occasioning high Ð will still lead to some increase in D(W(µ)) even if the individual oligomers are low 
in conformational heterogeneity, e.g. oligomeric BSA. 
162
 CONCLUDING REMARKS 
The ability for CE to discern distinct protein conformers that are otherwise not accessible with SEC-
MALS, and to infer the comparative level of conformational heterogeneity via the D(W(µ)) from the 
W(µ), has been demonstrated here. New structural information from CE separations was also 
highlighted and assigned with the aid of complementary SEC-MALS analysis. The structural 
information was used to rationalize differences when comparing D(W(µ)) with Ð which yielded novel 
insight into the relationship between conformational and molar mass heterogeneity. Overall, this study 
has introduced the application of D(W(µ)) to explore conformational heterogeneity of proteins and 
provided insight into what affects its quantification, leading to an additional important dimension of 
information for protein characterization by CE. Future studies will concern how these methods can be 
applied to examine the conformational heterogeneity of more complex proteins. This includes the α-
crystallins, which are structurally heterogeneous due to the formation of complex oligomeric arrays, 
and post-translationally modified crystallins, which can exhibit charge (phosphorylation and 
deamidation), and conformational (truncation and racemization) heterogeneity. 
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Figure S1. Baseline corrected representative elugrams obtained using PM which ensures that the protein has 
minimal adsorption on the capillary wall thereby validating separation in CE. Instrument and sample conditions 
for PM are detailed in the Materials and Methods. All comparable samples have been displaced along the y-axis 
for comparison. Slight differences in migration time are likely due to small deviations in pressure during the PM 
experiment. (A) BSA and mBSA. (B) YADH and two treatments, with EDTA and DTT. (C) BLA (Ca2+ dep) and 
three treatments using EDTA, Ca2+ and Mg2+ respectively.  
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Figure S2. Electropherogram of synthetic polymer mix AA3 used to validate the fused silica capillary before 
commencing experiments. Separation of this complex mixture containing different sized oligomers of synthetic 
acrylic acid (PAA) with or without reversible addition-fragmentation chain transfer (RAFT) agent allows the CE 
user to determine if separation efficiency is maintained.    
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Figure S3. Distributions of electrophoretic mobilities obtained using CE of (A) oligomeric BSA and (B) YADH 
illustrating the increase in the separation resolution between a 40 cm (black, solid line, 31.5 cm to detector) and 
an 80 cm (grey, dashed line, 71.5 cm to detector) fused silica capillary. The injection volume remained the same 
between both capillary lengths which may have led to overloading at the 40 cm length. All other sample conditions 
and concentrations for the respective proteins are as outlined in the Materials and Methods.  
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Figure S4. Overlaid W(µ). (A) Oligomeric BSA and monomeric BSA, (B) YADH only and also treated with 
EDTA and DTT, and (C) BLA (Ca2+ dep) and also treated with EDTA, Ca2+ and Mg2+. The peak from the neutral 
marker 0.2 % DMSO is labelled as the EOF. The presence of DTT is attributed to the shouldering seen on the 
EOF peak (B). 
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Figure S5. Calculation of protein dn/dc. The refractive index of (A) oligomeric BSA, (B) YADH, and (C) BLA 
(Ca2+ dep) are analyzed over 10 concentrations and fitted to a linear equation through point 0,0. The gradient of 
the linear fit is given as the protein’s dn/dc at 25 °C in 5 mM NaPi, pH 7.4 for BSA and YADH and in 20 mM 
tris-HCl, pH 7.4 for BLA. The dn/dc and R2 fit value are given on each respective plot. 
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Figure S6. Overlaid chromatograms used for W(M) determination obtained using SEC with refractive index 
detection. (A) Oligomeric BSA and monomeric BSA, (B) YADH only and also treated with EDTA and DTT, and 
(C) BLA (Ca2+ dep) and also treated with EDTA, Ca2+ and Mg2+. Salts and reagents added for treatments have 
been assigned based on the appropriate blank e.g. treatment only in relevant buffer. 
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 Table S1. Model protein and corresponding treatments for one hour at 25 °C, pH 7.4. 
CE Experiments SEC-MALS Experiments 
Protein Treatment Protein Treatment 
1 g∙L-1 BSA None 3 g∙L-1 BSA None 
1 g∙L-1  YADH 2 mM EDTA 3 g∙L-1  YADH 6 mM EDTA  
2 mM DTT  6 mM DTT 
0.5 g∙L-1 BLA 1 mM CaCl2 3 g∙L-1 BLA 6 mM CaCl2  
1 mM MgCl2  6 mM MgCl2  
1 mM EDTA  6 mM EDTA 
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 Table S2. Adjusted R2 for the fit of a Gaussian function to pressure mobilization data. Errors given as the standard 
deviation of five repeats. 
Sample  Average Adjusted R2  
BSA (oligomeric) 0.958 ± 0.014 
BSA (monomeric) 0.976 ± 0.009 
YADH 0.978 ± 0.002 
YADH + EDTA 0.971 ± 0.006 
YADH + DTT 0.951 ± 0.017 
BLA 0.976 ± 0.013 
BLA + Ca2+ 0.987 ± 0.018 
BLA + Mg2+ 0.992 ± 0.005 
BLA + EDTA 0.993 ± 0.001 
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CHAPTER 5:  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 
 
 
 
 
 
“Everyone has a hidden agenda. Except me!” 
– Michael Crichton 
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The work presented in this thesis aims to further our understanding of the molecular 
mechanisms inherent to cataract and find new methods of studying protein heterogeneity that may 
provide a novel perspective on lens crystallins. Changes in the lens with age, such as oxidation, and the 
impacts of significant macromolecular crowding can affect the crystallin proteins that maintain lens 
transparency. Therefore, the structure, function and aggregation-propensity of prominent lens crystallin 
proteins γS- (γSc) and αB-crystallin (αBc) under these conditions are of interest and have been studied 
herein. Further, this work examined the use of capillary electrophoresis (CE) to study protein 
conformational heterogeneity via a proof-of-concept study on well-characterised proteins that are also 
used as model aggregation-prone proteins. 
 Chapter 2 provided insight into how oxidation of lens proteins can contribute to age-related 
cataract (1). The crystal structure of the disulfide-linked human γSc dimer provided a clear view of the 
intra- and inter-molecular disulfide bond arrangement and, in conjunction with small angle X-ray 
scattering, the overall structure of the protein. This was an important step for structural characterisation 
of crystallins given full-length human γSc’s recalcitrance toward crystallisation (2, 3). The loss of the 
principal lens reductant, glutathione, with age leads to elevated oxidative conditions in the aging lens 
which is further worsened at the onset of cataract. Importantly, it was established that the C24-C24’ 
disulfide-linked γSc dimer was stable at glutathione concentrations akin to that in aged and cataractous 
lenses, but not in those of healthy/young lenses where the disulfide bond was reduced giving rise to the 
monomer. Biophysical and thermal stability studies provided a rationale for the greater aggregation 
propensity of the γSc dimer. The dimer was not structurally perturbed relative to the monomer but had 
an increased aggregation propensity and exhibited non-cooperative domain unfolding. These 
characteristics are markedly similar to that of the well-studied cataract-associated mutant G18V γSc, 
indicating that congenital and age-related forms of cataract may share similar developmental pathways 
on a molecular level. This work also supports the development of approaches, for example small 
molecule therapeutics, that stabilise the reducing environment of the lens to stave off oxidative events 
that lead to the destabilisation of the crystallins. 
 The role of disulfide formation in the lens and its relation to opacity is a pertinent field of 
investigation (4). In addition to the work described in Chapter 2 (1), a recent study has demonstrated 
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that γD-crystallin (γDc) has the ability to act as an oxidoreductase (5), while a lens proteomic analysis 
showed a shift from intra- to inter-molecular disulfides in crystallins of younger versus older lenses, 
respectively (6). These findings particularly underscore the importance of the characterisation of 
disulfide-linked crystallins and their contribution to cataract etiology. To this end, the formation of a 
C110-C110’ disulfide-linked γDc dimer has been associated with instability and heightened aggregation 
propensity when in the presence of Cu(II) (7, 8). However, no studies have purified this disulfide-linked 
crystallin to homogeneity and compared it to the reduced (monomeric) form as was undertaken in 
Chapter 2 of this thesis (1). It would be of interest to perform this analysis in order to unambiguously 
determine if disulfide-linked dimerisation has similar effects on γDc as for γSc, notably because the 
purported C110-C110’ intermolecular disulfide in γDc dimer would result in a C-terminal-to-C-
terminal domain linkage, a significantly different dimer architecture to that of N-terminal-to-N-terminal 
domain linked γSc dimer (via C24 of each monomer). An additional comparison to the disulfide-linked 
dimer formation of cataract-associated mutant R14C γDc, yielding a N-terminal-to-N-terminal domain 
γDc dimer-linkage, given R14 exhibits greater solvent exposure relative to C110, would also be of 
interest (9). Further, investigation into the formation of disulfide-linked dimers of γC-crystallin formed 
via its N-terminal domain in the presence of high equivalents of Hg(II) (10) would help to refine the 
hypothesis that disulfide-based dimerisation is ultimately deleterious in age-related cataract.  
 Chapter 3 investigated the structure and function of small heat-shock protein αBc in highly 
crowded conditions analogous to the eye lens using either high concentrations of a polysaccharide, 
Ficoll 400, or a protein, bovine γ-crystallin. Contrast variation small angle neutron scattering (SANS) 
and other biophysical techniques showed that αBc under crowded conditions became destabilized, 
unfolded, increased in size/oligomeric state, exhibited reduced chaperone ability and formed amorphous 
and fibrillar aggregates. The inherent stability of the lens partner protein αA-crystallin (αAc) stabilised 
αBc and prevented its aggregation in the crowded environment when mixed together at physiologically 
relevant ratios. 
Studies in the dilute environment in vitro have noted the difference in stability between αBc 
and αAc and demonstrated the ability of αAc to prevent the kinetic aggregation of αBc using heat stress 
(11, 12). Knockout studies in vivo showed that αAc knockout (i.e. αBc only) mice developed early-
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onset, αBc-rich cataract (13) while αBc knockout (i.e. αAc alone) mice developed a relatively normal 
lens phenotype (14). The results presented in Chapter 3 fill a gap in the literature by demonstrating the 
changes that αBc undergoes before aggregating and note that the stability difference between αBc and 
αAc is exaggerated under conditions of macromolecular crowding. These findings suggest that age-
related cataract associated with α-crystallin aggregation is related with post-translational modifications 
that cause αBc to lose stability, thereby encouraging aggregation, and/or cause αAc to reduce its 
chaperone ability, thereby providing ineffective prevention of αBc aggregation. Cataract-associated 
mutants R120G and D109A αBc destabilise the central β-sheet-rich α-crystallin domain (ACD) dimer 
interface and show very similar structural and functional features under dilute conditions to that of wild-
type αBc under crowded conditions (15-18). These correlations suggest a common mechanism for αBc 
aggregation in vivo which involves the loss of ACD stability and structure preceding aggregation. It 
also suggests that mutants such as R120G and D109A will be severely impacted in a highly crowded 
environment, making it difficult for these αBc mutants to be chaperoned by αAc as evidenced in vivo 
by their congenital cataract phenotypes. In addition, the congenital cataract-associated mutants of αBc 
that have been characterised all exhibit a loss of stability despite showing other differences in structure 
and oligomeric state. In light of this, therapeutics that are efficacious in treating cataract by stabilising 
αBc and its mutants, such as sterols that bind to the ACD dimer interface (19), would seem to negate 
this proposed mechanism of αBc aggregation under crowded conditions. 
While the formation of cataract has various mechanisms, αBc aggregation has been implicated 
in numerous congenital and age-related forms of cataract (13, 17, 20-22). Performing similar studies to 
those detailed in Chapter 3 on congenital cataract-associated mutants of αBc or αAc could provide the 
means to confirm the hypothesis that aggregation in a highly crowded environment such as the eye lens 
is largely associated with αBc while its prevention is largely the job of αAc. Given the mechanism put 
forth for αBc aggregation, the use of sterol-based compounds under conditions of macromolecular 
crowding could provide a means to not only to quell its aggregation, but also to determine if the stability 
of αBc is improved in this environment, as is observed for mixtures with increasing αAc. This could be 
useful as part of a screening assay for novel anti-cataract compounds as the stability change for αBc 
under crowded conditions is likely to be far more relevant to the physiological environment of the eye 
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lens. Further, an understanding of the crowding-induced unfolding of the αBc ACD could be important 
to the development of therapeutic compounds given this event precedes αBc aggregation. If crowding 
affects the excised αBc ACD, which forms a 20 kDa dimer (23), in a similar manner to that of the ACD 
in full-length αBc, then the preparation of 15N, 13C labelled ACD and characterisation by NMR 
spectroscopy under crowded conditions can provide an atomic understanding of the crowding-induced 
ACD unfolding. Finally, SANS can be employed to determine the impacts that high concentrations of 
β-crystallins (overall repulsive) have on αBc stability as opposed to γ-crystallins (overall attractive) 
which were used herein (24). These studies could also be extended to isoforms of β- or γ-crystallin with 
the overall aim being to provide a better understanding of the impacts of the lens make-up on αBc 
structure and stability. The proposed experiments provide a foundation to further expand our 
understanding of the role of macromolecular crowding in αBc aggregation. In addition, studies using 
macromolecular crowding in vitro can help to reconcile findings from the dilute in vitro and in vivo 
environment for other lens crystallins (25). 
Chapter 4 investigated the use of an uncommon protein characterisation technique, CE, to 
reveal novel insights into protein conformational heterogeneity. CE can separate proteins in-solution 
based on conformation and charge with distinct differences (i.e. open and closed conformers) being 
resolved into separate peaks, while more subtle differences result in peak broadening. As such, the 
width of a CE peak or peaks can provide information on the heterogeneity of conformations. Recently, 
analytical techniques were developed to calculate a distribution of electrophoretic mobilties (26) (which 
is sensitive to protein conformation) and analyse the distribution to obtain a dispersity value i.e. an 
analytical measure of peak broadness (27). As this technique had not yet been applied to proteins, a 
proof-of-concept study was conducted on structurally different, well-characterised proteins. Both 
monomeric and oligomeric proteins were used to discern how CE separates oligomeric species and how 
this could affect the measure of conformational heterogeneity. To this end, bovine serum albumin 
(BSA), yeast alcohol dehydrogenase (YADH), and bovine α-lactalbumin (BLA), along with various 
treatments and preparations that change the proteins’ conformation were separated and compared using 
CE. The raw data were transformed to a distribution of electrophoretic mobilities and were compared 
to the distribution of molar masses from common separation technique size-exclusion chromatography 
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coupled to multiple angle light scattering (SEC-MALS). The respective dispersity values were 
calculated and compared.  
BSA, which contains monomeric and oligomeric forms, was compared to a largely monomeric 
preparation. CE separated BSA oligomers and showed that as oligomeric state increases, so does 
electrophoretic mobility implying larger oligomers have less electrostatic friction or more effective 
negative charge or a combination thereof. CE was able to elucidate two different BSA monomeric 
populations what were not discerned by SEC-MALS. Overall, CE showed that conformational and 
molar mass heterogeneity scaled similarly, indicating that dispersity derived from the distribution of 
electrophoretic mobilities is also sensitive to changes in protein conformation due to oligomerisation. 
Wild-type YADH is largely a tetramer with a small amount of monomer. However, it was found that 
treatment with the metal chelator EDTA removes monomer while treatment with reducing agent DTT 
breaks down the tetramer. The monomeric and tetrameric populations of YADH were detected in the 
distribution of electrophoretic mobilities based on comparisons with the distribution of molar masses 
and on changes induced by the aforementioned treatments. CE showed two distinct monomer 
conformations, most likely arising from the open and closed forms of YADH which is observed in the 
crystal structure (28). Multiple partially separated peaks were observed for the tetrameric species. 
Overall, the tetramer was more conformationally heterogeneous than the monomer consistent with the 
multiple peaks present in the CE profile. Results from CE experiments with YADH showed that CE 
was able to discern and monitor changes to YADH conformers from two different oligomeric 
populations during a single experiment. BLA showed two peaks, most likely from apo- and holo-BLA, 
when separated by CE while only one peak was observed by SEC-MALS. Comparison of dispersity 
values from CE indicated apo-BLA was more conformationally heterogeneous than holo-BLA, 
however, molar mass heterogeneity for all forms of BLA was unchanged, consistent with BLA being 
monomeric. Comparing the dispersity from the distributions of electrophoretic mobilities and molar 
masses of all proteins and treatments in this study provided a comparison of the conformational and 
molar mass heterogeneity between these three unrelated proteins and their treatments. The proteins that 
grouped together within this plot could be rationalised based on the preceding experiments and the 
extensive literature available. 
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These CE experiments and results provide a platform for the investigation of conformationally 
heterogeneous proteins such as the crystallins which form complex oligomeric structures, e.g. αBc and 
αAc, or are post-translationally modified, e.g. isolated from an in vivo source. Recently, microfluidic 
electrophoresis was used to investigate the heterogeneity of αBc in-solution by separating its dominant 
oligomeric species according to their different electrophoretic mobilities (29). The basis of separation 
(electrophoretic mobility) is the same as CE, however the timescale of separation was in the order of 
seconds for the microfluidic device as opposed to minutes for CE. This is an important consideration 
as αBc subunit exchange at room temperature is in the order of minutes (30) and to effectively resolve 
inter-converting species, the separation would need to occur faster than subunit exchange (31). While 
CE separation is comparable to the timescale of αBc subunit exchange at room temperature, this 
potential impediment can be overcome via reducing the temperature to slow subunit exchange to an 
order of hours thereby facilitating a higher resolution CE separation. However, if complete separation 
of αBc was not achieved by CE, the application of the dispersity of electrophoretic mobilities would 
allow a relative measure of the in-solution heterogeneity of αBc. CE also has the added benefit of 
allowing the resolving power to be further tuned through simply increasing capillary length, while a 
similar modification would be more difficult to achieve with a prefabricated microfluidic device. 
Nevertheless, the successful identification of oligomeric species of αBc in solution via their 
electrophoretic mobilities provides evidence that the future goal of this proof-of-concept CE study to 
apply CE to crystallin proteins such as αBc is feasible. In addition to αBc, the heterogeneity of other 
oligomeric small heat-shock proteins such as αAc and Hsp27 could also be investigated by CE, 
particularly in comparing modifications that change their oligomeric state, e.g. phosphorylation (30, 
32).  
With age, lens crystallins undergo extensive post-translational modification, particularly 
deamidation (33, 34). CE coupled to mass spectrometry (CE-MS) might provide a means to identify 
deamidated crystallins unambiguously, as the additional negative charge(s) changes the electrophoretic 
mobility of the protein (33). CE-MS would also enable quantitative measurement of the concentration 
of proteins or digested peptide fragments using UV detection rather than determining this information 
from the relative MS intensity (34, 35) which can be inherently inaccurate due to differences in the 
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ionisation efficiencies of species. In addition to numerous analytical research opportunities, and given 
the level of detail determined from CE protein separation, this method could potentially be translated 
to industrial applications. They include quality control in protein production or analysis of the long-
term viability of protein therapeutics, where a high-throughput, ultra-low volume technique that is 
easily automated would provide complementary and orthogonal information on protein heterogeneity 
that is otherwise not accessible by other separation techniques e.g. SEC-MALS. 
This thesis provides novel insight into a protein aggregation disorder, cataract, and a technique 
(CE) that yielded novel perspective on protein heterogeneity. Future work will aim to acquire an even 
deeper understanding of the structural changes that lens crystallins undergo with age, to aid in the 
development of treatments to prevent cataract. With funding for basic science on the decline in 
Australia, the chance that basic research will lead to groundbreaking new insights into the molecular 
underpinnings of disease is diminished. It is critical this is redressed so that astute investigation is 
allowed unencumbered to provide the linkages, some of which are detailed herein, leading to the 
treatment of cataract and other protein folding disorders that undoubtedly exists. 
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“Oh, there are pictures. I keep them where I need the most cheering up.” 
– Homer J. Simpson 
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APPENDIX 1: 
ROLE OF UNSTRUCTURED N- AND C-TERMINAL 
REGIONS IN αB-CRYSTALLIN 
 
 
 
 
 
 
“If you really want something in this life, you have to work for it. Now quiet, they’re about to 
announce the lottery numbers!” 
– Homer J. Simpson 
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Abstract Small heat-shock proteins (sHsps), such as αB-
crystallin, are one of the major classes of molecular chaperone
proteins. In vivo, under conditions of cellular stress, sHsps are
the principal defence proteins that prevent large-scale protein
aggregation. Progress in determining the structure of sHsps
has been significant recently, particularly in relation to the con-
served, central and β-sheet structured α-crystallin domain
(ACD). However, an understanding of the structure and func-
tional roles of the N- andC-terminal flanking regions has proved
elusive mainly because of their unstructured and dynamic na-
ture. In this paper, we propose functional roles for both flanking
regions, based around three properties: (i) they act in a localised
crowding manner to regulate interactions with target proteins
during chaperone action, (ii) they protect the ACD from delete-
rious amyloid fibril formation and (iii) the flexibility of these
regions, particularly at the extreme C-terminus in mammalian
sHsps, provides solubility for sHsps under chaperone and non-
chaperone conditions. In the eye lens, these properties are highly
relevant as the crystallin proteins, in particular the two sHsps
αA- and αB-crystallin, are present at very high concentrations.
Keywords AlphaB-crystallin . Small heat-shock proteins .
Molecular chaperone . Structure . Function . Unstructured
regions
Abbreviations
ACD α-Crystallin domain
αAc αA-Crystallin
αBc αB-Crystallin
IF Intermediate filament
NAC Non-amyloid-β component
sHsps Small heat-shock proteins
Introduction
The intimate relationship between a protein’s structure and its
function is a basic tenet of biology (Bagowski et al. 2010;
Worth et al. 2009). Major advances in structural biology tech-
niques over the past 20 or so years have led to the determination
of the higher order structures of a wide range of globular pro-
teins. However, amongst the most elusive of proteins whose
structures have yet to be fully elucidated are the mammalian
small heat-shock proteins (sHsps). Recent progress in this quest
has, however, been significant and is summarised in a variety of
review articles (Bakthisaran et al. 2015; Basha et al. 2012;
Hochberg and Benesch 2014; Treweek et al. 2015). X-ray crys-
tallographic studies have determined the atomic-level structure
of the excised α-crystallin domain (ACD) of sHsps which en-
compasses approximately the central 80 amino acids of the
protein. Solid state NMR studies have also provided such in-
formation about the ACD, in addition to some detail about the
structural arrangement of the N-terminal region (Jehle et al.
2009; Jehle et al. 2011). However, the atomic-level structure
of the N- and C-terminal regions and their relationship to the
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ACD in determining the overall quaternary arrangement have
proved refractory to accurate determination. Mass spectrome-
try, X-ray solution scattering, cryo-electron microscopy and
molecular modelling have also provided important structural
information that, when combined, has enabled the construction
of a variety of models for the oligomeric structure of αB-
crystallin (αBc, HspB5), the principal sHsp (Baldwin et al.
2011b; Jehle et al. 2010). However, a detailed understanding
of the structural and functional roles of the N- and C-terminal
flanking regions of mammalian sHsps represents a significant
gap in our knowledge.
sHsps are ubiquitous and numerous intracellular proteins
and are one of the major classes of molecular chaperone pro-
teins. Under conditions of stress (elevated temperature, infec-
tion, oxidation, etc.), they selectively interact, in an ATP-
independent manner, with target proteins that are destabilised,
for example, to form intermediate states that are prone to as-
sociation and subsequent large-scale aggregation.
Accordingly, sHsps exhibit specificity for target proteins that
enter off-folding pathways towards either an amorphous or
amyloid fibrillar aggregated form (Fig. 1) (Kulig and Ecroyd
2012; Treweek et al. 2015). As a result, sHsp levels are
up-regulated markedly under cellular stress conditions,
although significant constitutive expression can occur in
some cell types presumably to regulate the correct confor-
mation and levels of target proteins. Accordingly, sHsps
play an important role in the maintenance of cellular pro-
tein homeostasis or proteostasis. Indeed, in a recent study
of the proteome of aged nematodes (C. elegans), sHsp
levels (and not those of other molecular chaperones) were
elevated markedly to compensate for enhanced general
protein aggregation that occurs with ageing, highlighting
the crucial role of sHsps in maintaining cellular
proteostasis (Walther et al. 2015).
In humans, there are ten sHsps. The most populous and
widespread (in terms of tissue distribution) of the sHsps is
αBc which is also found at high levels, along with its
closely related partner αA-crystallin (αAc, HspB4), in
the eye lens. Both sHsps naturally co-associate and func-
tion in a chaperone manner to maintain lens transparency
via inhibition of crystallin protein aggregation. Most of
the recent sHsp structural work has been undertaken on
αBc and it will be the focus of much of the discussion in
this paper.
sHsps, in particular the mammalian ones, are difficult to
characterise structurally because of their heterogeneous and
dynamic nature. Such behaviour is not conducive to their
crystallisation and hence structural characterisation by X-
ray crystallography. For example, αBc has a monomeric
subunit mass of around 20 kDa but exists as an ensemble
of oligomers (Aquilina et al. 2003) with a mass distribution
of 420 to 980 kDa and an average mass of 650 kDa under
physiological conditions (Haley et al. 1998). The con-
served central ACD in sHsps is highly β-sheet in character
with the β-strands arranged in an immunoglobulin-like fold
(Bagneris et al. 2009; Laganowsky et al. 2010). The ACD
is flanked by N- and C-terminal regions that are variable in
length and lack sequence similarity between sHsps. Apart
from short sections of transient helical and β-sheet struc-
ture in the N-terminal region (Jehle et al. 2011), the
flanking regions adopt little ordered secondary structure
and exhibit significant dynamism. Indeed, the last 12 amino
acids of αBc (along with similar regions in other mamma-
lian sHsps) have been recognised for over 20 years as a C-
terminal extension that is unstructured and has great flexi-
bility, comparable to isolated peptides of the same length
(Carver 1999; Carver et al. 1992; Esposito et al. 1998).
Figure 2 provides a schematic of the various structural re-
gions in αBc.
The polydisperse nature of αBc (and some other mam-
malian sHsps) is intimately related to the exchange of
individual αBc subunits, a process that is highly temper-
ature dependent with subunit exchange rate increasing
significantly at higher temperatures (Baldwin et al.
Fig. 1 Schematic of the protein folding/unfolding pathway (horizontal)
and the off-folding pathways (vertical). The folding/unfolding pathway
depicts both folded (F) and unfolded (U) states whilst the intermediate (I)
represents the partially folded state(s) between these two extremes which
is characterised by having elements of secondary structure and has the
potential to enter the off-folding pathways to form amorphous aggregates
and/or amyloid fibrils. The oligomeric sHsp αBc is depicted with small
black ‘squiggly’ protrusions representing the solvent-exposed and
flexible C-terminal extension. The various junctures at which αBc
interacts on the folding/unfolding and off-folding pathways (Cox et al.
2014; Treweek et al. 2015) are indicated with black arrows labelled 1, 2, 3
and 4. Briefly, 1. Interaction with destabilised native-like species, 2.
Interaction with intermediate species to prevent or delay amorphous ag-
gregation, 3. Interaction with intermediate species to prevent or delay the
generation of prefibrillar aggregates and also to dissociate prefibrillar/
oligomeric species back to an intermediate or native state, 4. Binding to
amyloid fibrils in order to stabilise them and prevent further elongation
and fragmentation which may lead to secondary nucleation
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2011c; Bova et al. 1997; Hilton et al. 2013; Sobott et al.
2002). Much insight into the mechanism of subunit ex-
change has come from recent combined structural inves-
tigations of αBc using X-ray crystallography, NMR spec-
troscopy and mass spectrometry (Baldwin et al. 2011a;
Baldwin et al. 2011c; Hochberg and Benesch 2014). The
important role of the conserved IXI sequence in the C-
terminal region (I159-P160-I161 in αBc) in interacting
with an adjacent subunit is now well recognised.
Subunit exchange may play an important role in oligo-
meric sHsp chaperone action by facilitating dissociation
from the oligomer and interaction with the target protein.
The role of the various sHsp regions in chaperone ac-
tion is unclear, more so of late with the observation that
the isolated ACD of αBc has significant chaperone ability
to prevent the aggregation of target proteins (Hochberg
et al. 2014), implying that the chaperone activity (and
hence target protein interaction site(s)) is encompassed
within this central domain. However, other studies have
implicated the N- and C-terminal regions of sHsps in in-
teraction and binding with amorphously aggregating tar-
get proteins during chaperone action (Mainz et al. 2015;
McDonald et al. 2012; Rajagopal et al. 2015). The obvi-
ous question to ask, therefore, is what are the structural
and functional roles of the N- and C-terminal flanking
regions in sHsps? In this paper, we address this question
in a general context in terms of the role of unstructured
regions in proteins and specifically in relation to flanking
regions in sHsps. The role of these regions has been
discussed previously in a review of existing structural
data (Sudnitsyna et al. 2012).
Do the flanking regions in sHsps facilitate initial
target protein interaction and act as localised
crowding agents to regulate interactions with target
proteins?
Earlier work by Hall (Hall 2006; Hall and Dobson 2006) ex-
amined the effect of conformational changes inherent to an
inert biopolymer, through either association/dissociation or
undergoing a shape transition from an expanded to a compact
form, in regulating macromolecular crowding by altering the
excluded volume component of the solution. It was concluded
that folding of destabilised proteins was promoted under the
conditions that maximised molecular crowding, i.e. when
greater excluded volume of the solution occurred. In agree-
ment with this, random polymer chains undergo significant
compaction under conditions of macromolecular crowding
(Le Coeur et al. 2009).
Conceivably, sHsps could utilise such means to regulate
the excluded volume within the crowded environment of the
cell, i.e. the highly malleable nature of their unstructured
flanking regions would lead to conversion between structural
compaction and expansion whilst the extensive subunit ex-
change would oscillate the proteins between smaller (e.g. di-
mer) and larger oligomeric species. Subunit exchange in
sHsps may simply be a way of facilitating the initial interac-
tion with the target protein by enabling enhanced malleability
in the terminal regions, since the dynamic nature of these
regions would be no longer relatively constrained within the
oligomer. Within the lens fibre cells, where αAc and αBc
are present at high concentrations and are by far the pre-
dominant species, these properties would be exacerbated.
Phosphorylation of large oligomeric sHsps such as Hsp27
(HspB1) and αBc (HspB5) may enable this to occur as
well, as has been investigated via the use of phosphomimics of
these two sHsps. In these two cases, the phosphomimics have
altered oligomeric size and/or mass distribution (Ecroyd et al.
2007; Peschek et al. 2013; Hayes et al. 2009) and, depending
on the particular target protein and type of aggregation (amor-
phous or fibrillar), they exhibit enhanced sHsp chaperone abil-
ity (Ecroyd et al. 2007; Jovcevski et al. 2015).
The unfolded flanking regions, particularly when they are
associated to form large heterogeneous oligomers as in the mam-
malian sHsps, would increase molecular crowding in the vicinity
of, and when interacting with, intermediately folded (I) target
proteins (Fig. 1). In doing so, the sHsps could stabilise these
target proteins, stop their unfolding and thereby facilitate their
refolding back to the native state via transient interactions. One
could conceive of this as a localised molecular crowding
phenomenon arising from the close proximity of the two
proteins. Hall (2006; Hall and Dobson 2006) has shown that
increasing the concentration of a partially folded crowding agent
(e.g. a protein) leads to greater structure in the crowding agent, a
process that could be applicable to how sHsps function in their
Fig. 2 Schematic diagram of the three structural regions in αBc. The
colour scheme for (a) and (b) is indicated at the top of the figure. (a)
The crystal structure of a truncated αBc monomer (PDB: 3L1G)
incorporating residues 68–162 which is the majority of the structured
ACD and part of the unstructured C-terminal region including the con-
served IXI sequence (I159-P160-I161). The highly flexible C-terminal
extension of 12 amino acids and the N-terminal region were not included
in order to facilitate crystallisation (Laganowsky et al. 2010). (b) A
linearised αBc sequence displaying the relative lengths of the ACD and
the flanking N- and C-terminal regions as well the location of the con-
served IXI motif and the flexible C-terminal extension
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initial interaction to stabilise aggregation-prone target proteins.
Thus, the unstructured terminal regions of sHsps initially act as
akin to a ‘lasso’ to capture the unfolding target protein. The
subsequent step of compaction of the sHsp and interaction of
the target protein with the structured ACD leads to more intimate
association of the two proteins and stabilisation of the intermedi-
ately folded target protein. The rationale above provides an ex-
planation for the observation that the ACD is all that is required
for the chaperone action of αBc in vitro (Hochberg et al. 2014).
Of course, this is an artificial and simple system compared to the
crowded nature of the cell where numerous competing interac-
tions are possiblewith a diversity of cellular components. Finally,
interaction and binding of the intermediately folded target protein
with the sHsp during chaperone action, and its subsequent
refolding, would couple folding to binding (Ganguly and Chen
2011; Shammas et al. 2016). Thereby, sHsps, either as individ-
uals or in partnership with each other and other molecular chap-
erones (the latter potentially also utilising ATP hydrolysis),
would contribute to the maintenance of cellular proteostasis
(Jeng et al. 2015).
The importance of the N-terminal region of αBc in
capturing amorphously aggregating lysozyme was dem-
onstrated by Mainz et al. (2015). They used a combina-
tion of truncation mutants and chaperone assays to show
that truncation of the N-terminal region leads to a
marked loss of chaperone activity. Furthermore, specific
interactions of the N-terminal region in intact αBc were
inferred by solid-state NMR through chemical shift
changes and alterations in dynamics of resonances in
the N-terminal region (Mainz et al. 2015). Similarly,
the N-terminal region of Hsp20 (HspB6) has multiple
sites of interaction with a target protein as well as a
role in regulating chaperone activity (Heirbaut et al.
2014) whilst also being important in the formation of
a hetero-oligomer with Hsp27 (Heirbaut et al. 2016).
There is evidence from interactome studies that the N-
terminal region of plant sHsps is involved in interacting
with amorphously aggregating target proteins (Jaya
et al. 2009). Another example of the unstructured N-
terminal region of sHsps’ involvement in interacting
with other proteins comes from the recent work of
Sluchanko et al. (2017) who determined the crystal
structure of a complex between a phosphorylated form
(at Ser16) of the dimeric sHsp, Hsp20 (van de Klundert
et al. 1998; Weeks et al. 2014) and the 14-3-3σ dimer,
i.e. the two proteins form a 2:2 complex. Phosphoserine
16 in Hsp20 interacts with the binding grove of 14-3-3σ
via a long loop containing the N-terminal region of the
former protein. The dimeric ACD region of Hsp20, in
an immunoglobulin fold conformation, binds in an
asymmetric manner to one of the 14-3-3σ monomers.
One key target for sHsps is the intermediate filament
(IF) cytoskeleton as evidenced by the range of diseases
(cataract, myopathies, neuropathies), caused by mutations
in Hsp27, HspB3, αAc, αBc and Hsp22 (HspB8) (Perng
and Quinlan 2015), which in all cases cause characteristic
histopathological aggregates into which IFs are also con-
centrated. The mutations span the primary sequence of the
sHsps involved, including the N- and C-terminal regions,
but there does not seem to be any clustering. Suffice to
say that when the C-terminal region is completely re-
moved, as with the cardiomyopathy-causing mutation
Q151X in αBc, it is as, if not more, efficient in binding
to desmin filaments and also in modulating their assem-
bly. Indeed, data from pin array studies show that IF pro-
teins are bound by multiple sequences throughout αBc
(Ghosh et al. 2007). There also appears to be no particular
requirement for phosphorylation of sHsps for them to as-
sociate with IFs (Nicholl and Quinlan 1994). IF proteins
all possess intrinsically disordered domains located on the
filament surface (Herrmann and Aebi 2016) and the pos-
sibility of synergy (Landsbury et al. 2010) with similarly
structured N- and C-terminal regions in sHsps when
bound to the filaments has not been explored. Germane
to this discussion is that IFs also provide binding sites for
other molecular chaperones such as Hsp70 (Perng et al.
1999) as well as the proteasome (Olink-Coux et al. 1994),
so the proteostatic machinery is appropriately partitioned
on IFs, structures that are integral to the cellular stress
response.
The sHsps interact with all elements of the cytoskele-
t o n (Land s bu r y e t a l . 2 0 10 ; Qu i n l a n 2002 ) .
Microfilaments, microtubules and IFs are all dependent
upon sHsps for their competence (Quinlan 2002), and all
are modulated by them. There appear to be multiple bind-
ing sequences across the primary sequences of all the
sHsps, both in the ACD and in the N- and C-terminal
regions (Ghosh et al. 2007). Indeed, deletion of the N-
terminal region does not prevent sHsps from binding to
actin (Guo and Cooper 2000) or to tubulin and from
chaperoning microtubules (Ohto-Fujita et al. 2007).
Whilst there is evidence that sequences from the N-
terminal region and the ACD of both Hsp27 and αBc
are effective inhibitors of actin assembly in vitro
(Wieske et al. 2001), the topic is contentious since
Hsp27 mutants can stimulate actin polymerisation (Butt
et al. 2001) whereas another study using wild-type
Hsp27 reported little to no significant change (Graceffa
2011). A common theme emerges from these studies: the
assembly and dynamics of all three major cytoskeletal
elements in the cell are modulated by sHsps, including
Hsp27, αBc, HspB7 and Hsp22. Whilst studies some-
times focus on one specific element of the cytoskeleton
(Almeida-Souza et al. 2011; Shimizu et al. 2016), it is
obvious that both the competence and the integration of
the different elements of the cytoskeleton rely on sHsps.
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Do the unstructured flanking (terminal) regions
prevent deleterious aggregation of the structured,
central α-crystallin domain?
Hall (Hall and Hirota 2009; Hall et al. 2005) and Abeln and
Frenkel (Abeln and Frenkel 2008; Abeln and Frenkel 2011)
have examined the effect of unstructured flanking polypeptide
regions on the aggregation propensity (to form both amyloid
fibrillar and amorphous aggregates) of central regions. They
conclude that the flanking regions have a marked propensity
to prevent the central regions from aggregating; they do so by
‘frustrating the encounter event’ that, of course, is the crucial
event in the aggregation process. Furthermore, the presence of
the flanking regions on both the N- and C-terminal ends pre-
vents aggregation to an enhanced degree, i.e. the location of
the aggregating region in the middle of an unstructured poly-
peptide chain is most advantageous for the suppression of
aggregation.
We have undertaken a survey of the regions of the ten hu-
man sHsps (HspB1 to HspB10) with a propensity to form
amyloid fibrils via the algorithm ZipperDB, which determines
the presence of so-called amyloid zipper sequences within the
amino acid sequence of a particular protein (Goldschmidt et al.
2010). Figure 3 (along with Fig. S1 and Supplementary
Table 1) summarises the results of these analyses for the
sHsps. It is readily apparent that all sHsps contain significant
regions of fibril-forming propensity that is mainly found in their
ACD. In general, in silico analysis with other fibril prediction
algorithms (TANGO and Zyggregator) (Fernandez-Escamilla
et al. 2004; Tartaglia et al. 2008) gives similar results to the
ZipperDB analysis (Fig. 3 and Fig. S1) in implying a signifi-
cant tendency for the ACD to have more fibril-prone residues
than the two other (terminal) regions (Supplementary Table 1).
Specifically, the ACD of αAc and αBc have large portions
of their sequences that are predicted to form amyloid fibrils
(18.1 and 20.2% respectively via ZipperDB analysis, Fig. 3,
Supplementary Table 1). There is experimental evidence to
support this. The isolated peptide encompassing K70 to K88
in αAc (and the corresponding region in αBc, D73 to K92)
has marked chaperone ability to prevent amorphous target
protein aggregation (Sharma et al. 2000). The peptide has
been named ‘mini-chaperone’ by Sharma and co-workers. In
addition, F71-K88 αAc forms amyloid fibrils (Raju et al.
2016; Tanaka et al. 2008). However, addition of the last ten
amino acids of αAc, i.e. the flexible C-terminal extension, to
the C-terminus of the αAc ‘mini-chaperone’ prevents the pep-
tide from forming amyloid fibrils but retains its chaperone
ability (Raju et al. 2014). Furthermore, Laganowsky et al.
found that the 11-amino acid fragment K90-V100 in αBc
(encompassing a loop region between two strands of anti-
parallel β-sheet) was highly amyloidogenic based on
ZipperDB and experimental analyses (Laganowsky et al.
2012). Indeed, K90-V100, readily formed classic amyloid fi-
brils, in addition to a β-sheet oligomer whose structure was
determined by X-ray crystallography. Furthermore, the oligo-
mer was cytotoxic.
Fig. 3 ZipperDB analysis (Goldschmidt et al. 2010) of the amino acid
sequences of the ten human sHsps displayed as linearised sequences
aligned at the N-terminal end of the ACD. The colour scheme is indicated
at the top of the figure. The position of the published IXI sequences
(Delbecq et al. 2015) and the C-terminal extensions (Carver 1999) are
displayed in the C-terminal region. The red regions are those residues
associated with the start of a hexapeptide that has a high propensity to
form amyloid fibrils as determined by ZipperDB, i.e. these residues have
a Rosetta energy that is less than or equal to the threshold energy of
−23 kcal/mol. (*)The C-terminal extensions for HspB1/Hsp27, HspB2/
MKBP and HspB6/Hsp20 were identified from 1H NMR spectroscopic
studies of sHsps from other mammals, i.e. mouse, rat and rat respectively
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Our work with αAc and αBc has shown that they form
amyloid fibrils under slightly destabilising conditions, for ex-
ample, in the presence of low concentrations of denaturant and
elevated temperature (Meehan et al. 2004; Meehan et al.
2007). The E. coli sHsp IbpA forms amyloid fibrils under
physiological conditions in vitro, which is prevented by the
presence of its co-chaperone IbpB (Ratajczak et al. 2010).
IbpB, the other E. coli sHsp, shares 48% sequence identity
with IbpA but does not form fibrils under physiological con-
ditions. The ACD of IbpA is slightly more aggregation-prone
than the ACD of IbpB by ZipperDB analysis (Supplementary
Table 1).
Furthermore, as stated above, the ACD of sHsps adopts an
immunoglobulin-like fold, a motif that is prone to amyloid
fibril formation, possibly because of its highly β-sheet char-
acter which is primed for conversion into the amyloid fold.
Thus, immunoglobulin light chains, or its fragments, form
amyloid fibrils in amyloid light chain amyloidosis. Likewise,
superoxide dismutase 1 and β2-microglobulin both adopt the
immunoglobulin fold and are the principal components of the
amyloid fibrillar deposits associated with amyotrophic lateral
sclerosis and haemodialysis-related amyloidosis (Knowles
et al. 2014).
Thus, the ACD of αBc (or at least part(s) of it) is prone to
form fibrils which, if were also true for the intact protein,
would be highly deleterious to the protein’s functionality
in vivo. As αBc (and other sHsps) do not form fibrils under
normal physiological conditions, the implication is that the
flanking regions have a modulating effect on the
amyloidogenicity of the ACD.
The dynamic nature of the flanking regions,
particularly the polar, flexible C-terminal extension
in mammalian sHsps, acts as a solubilising agent
for the protein under chaperone and non-chaperone
conditions
The unstructured and dynamic nature of the N- and C-
terminal regions is well recognised, particularly so for the
C-terminal extension of mammalian sHsps, located at the
extreme C-terminal end of the protein that has flexibility
comparable to small peptides of comparable length and
hence is amenable to observation in solution by NMR spec-
troscopy (Carver 1999; Carver and Lindner 1998; Treweek
et al. 2010). Figures 2b and 3 provide a comparison of the
length of the C-terminal extension observed by solution
phase NMR spectroscopy for Hsp27 (HspB1) through to
Hsp20 (HspB6). It is of note that the remaining four mam-
malian sHsps (HspB7 to HspB10) have not been studied by
NMR spectroscopy to ascertain whether they also possess a
flexible C-terminal extension. The structure and function of
this region have been well characterised, as summarised in
various reviews (Carver 1999; Carver and Lindner 1998). It
is suffice to state that removal of the C-terminal extension
leads to destabilisation of the protein and reduces its chap-
erone effectiveness (Lindner et al. 2000) whilst replacement
of charged amino acids with uncharged alanine in this region
leads to similar effects (Morris et al. 2008; Treweek et al.
2007). It is concluded that the C-terminal extension has an
important solubilising role for at least some mammalian
sHsps, and is required to offset the inherent exposed hydro-
phobicity, a factor that is probably of importance for the
proteins’ chaperone function. The same role for this exten-
sion is utilised under chaperone conditions to solubilise the
complex that sHsps form with amorphously aggregating tar-
get proteins.
Discussion
In this paper, we have proposed a variety of functional roles
for the N- and C-terminal regions of sHsps:
1. They regulate the interaction and stabilisation of target
proteins during chaperone action via localised molecular
crowding action.
2. They effectively shield the central ACD from potential
aggregation to form amyloid fibrils.
3. Their dynamic nature, particularly from the C-terminal
extension, acts as solubilising agents for the protein under
normal physiological conditions and during chaperone
action.
The N- and C-terminal flanking regions in sHsps
The role and importance of structural disorder in molecular
chaperone action have been considered by others (Bardwell
and Jakob 2012; Tompa and Csermely 2004; Tompa et al.
2015), along with the realisation that many proteins are un-
structured in their native state, or have large regions of their
polypeptide chain that are disordered (Tompa 2012).
Unstructured proteins are classified as intrinsically disordered
proteins (Dunker et al. 2008). Mammalian sHsps have many
properties of intrinsically disordered proteins because of their
mainly unstructured flanking terminal regions.
The flanking regions in mammalian sHsps share very little
sequence similarity, are highly variable in length (Fig. 3) and
are present in all sHsps (Kappé et al. 2003). The proposed
roles of these regions are consistent with the absence of con-
served sequence. Thus, all that is required are regions of poly-
peptide that lack structure and are flexible, malleable and pre-
dominantly hydrophilic in character. Many sequences of ami-
no acids can satisfy these requirements.
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Our data regarding the unfolding of αAc and αBc in the
presence of urea showed that the ACD is more exposed to
solution than the N-terminal region (Carver et al. 1993).
Likewise, the highly mobile C-terminal extension is very ex-
posed to solution (Treweek et al. 2010). Thus, for the sHsp
oligomer, the unstructured C-terminal region most likely un-
dergoes the initial interaction with target proteins, prior to
more intimate association with the ACD and/or the N-
terminal region, which may be coupled with subunit
dissociation.
The mammalian sHsps, Hsp20 and Hsp22 (HspB8) do not
form large oligomeric assemblies but exist as smaller species,
for example, dimers in the case of Hsp20 (van de Klundert
et al. 1998; Weeks et al. 2014; Shemetov et al. 2008). Because
of their dissociated nature, it is conceivable that these sHsps
largely have their N- and C-terminal regions exposed and, as
such, may have some basal level of activity that supports the
proteostasis network.
The well-defined oligomeric sHsps, e.g. wheat Hsp16.9
andMethanococcus Hsp16.5, have no flexible C-terminal ex-
tension, nor does yeast Hsp26, yet they undergo subunit ex-
change (Benesch et al. 2010). However, they all have the
conserved IXI sequence which facilitates subunit exchange.
Hence, they can still potentially act as a ‘lasso’ via their N- or
C-terminal regions, as per mammalian sHsps, during chaper-
one action.
The arguments relating to unstructured regions acting as
localised crowding agents could be applied to other molecular
chaperones. For example, Hsp70 has large regions of disorder
which could function in a similar manner to the terminal re-
gions in sHsps in the initial interaction with an unstructured
target protein, prior to the instigation of protein folding along
with ATP hydrolysis. For Hsp60 (GroEL), encapsulation of
the target protein within the protein cage leads to crowding of
the target protein and hence facilitates folding, via an ATP-
dependent mechanisms. The concept of ‘molecular shields’
has been proposed to account for the chaperone action of
unstructured Late Embryogenesis Abundant (LEA) proteins
(Chakrabortee et al. 2012). Their mode of action is via tran-
sient interactions that shield the hydrophobic regions of target
proteins from association to prevent aggregation. This behav-
iour is comparable with that of localised molecular crowding
proposed for the flanking terminal regions in sHsps. In sHsps,
these transient interactions encourage the structurally
destabilised target proteins, e.g. potentially amyloid fibril-
forming α-synuclein, to return to its natively unfolded (intrin-
sically disordered) state (Cox et al. 2014; Treweek et al. 2015).
From our other studies, it is apparent that the unrelated mo-
lecular chaperones, clusterin, caseins and 14-3-3ζ, all exhibit
a very similar mechanism of ATP-independent sHsp-like
chaperone action (Carver et al. 2003; Holt et al. 2013; Thorn
et al. 2015; Williams et al. 2011). In E. coli, curli proteins (e.g.
CsgA) form functional amyloid extracellularly. Intracellularly,
specific molecular chaperones (e.g. CsgC) prevent inappropri-
ate curli fibril formation via a sHsp-like mechanism (Taylor
et al. 2016).
Under stress conditions in vivo, e.g. heat shock, large-scale
protein unfolding and potential aggregation occurs. sHsps,
such as αBc, are activated (which may involve structural
change and/or dissociation from the oligomer to form the di-
mer species) to interact with and bind to destabilised target
proteins to form a high molecular weight complex (Lindner
et al. 1998; Stamler et al. 2005). By contrast, under non-heat
shock (i.e. constitutive) conditions, transient interaction of
destabilised target proteins with non-activated sHsps occurs
which does not lead to complex formation (Cox et al. 2014;
Kulig and Ecroyd 2012; Treweek et al. 2015). The interaction
ofαBcwith amyloid fibril-forming proteins, e.g.α-synuclein,
ataxin-3, apolipoprotein C-II, kappa-casein and β2-
microgobulin, is such a situation (Cox et al. 2016; Esposito
et al. 2013; Hatters et al. 2001; Rekas et al. 2004; Rekas et al.
2007; Robertson et al. 2010). The variation in sHsp chaperone
mechanism depending on conditions and the degree of
unfolding of the target protein is consistent with various stud-
ies. We have shown that under mild stress conditions, i.e.
slightly elevated temperature, target proteins such as malate
dehydrogenase and α-lactalbumin interact with the α-
crystallin oligomer via complex formation that is consistent
with intercalation into the porous surface of the oligomer. The
target proteins are readily accessible to interaction with mo-
lecular chaperones (e.g. Hsp70) that are capable of refolding
target proteins, coupled to ATP hydrolysis (Regini et al.
2010). However, under conditions of significant stress, i.e.
high temperature, the target protein (in this case γE-
crystallin) is inserted into the central cavity of the α-
crystallin oligomer (Clarke et al. 2010). Mchaourab’s work
on the chaperone action of sHsps with T4 lysozyme mutants
of varying stability also implies sHsp activation during chap-
erone action that is directly related to the degree of unfolding,
and hence binding affinity, of the particular T4 lysozyme mu-
tant (Mchaourab et al. 2002; Shashidharamurthy et al. 2005).
The central α-crystallin domain of sHsps
Goldschmidt et al. (2010) noted that fibril-forming regions in
globular, structured proteins are buried and therefore not ex-
posed to solution and any subsequent potential interaction
with other similar regions. For unstructured peptides and pro-
teins, the presence of fibril-forming regions in the middle of
unstructured peptides and proteins is a general phenomenon
(Goldschmidt et al. 2010). Thus, the non-amyloid-β compo-
nent (NAC), fibril-forming region in α-synuclein, is embed-
ded in the middle of the unstructured protein. Our results
(Rekas et al. 2012) showed that when the first 60 amino acids
of α-synuclein were absent, i.e. the region immediately N-
terminal to the NAC region, fibril formation occurred rapidly.
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Others have shown that deletion of portions of the C-terminal
region leads to enhanced fibril formation of α-synuclein
(Hoyer et al. 2004). Consistent with these data, the fibril-
forming region of unstructured κ-casein is in the middle of
the protein (Ecroyd et al. 2008). Likewise, the crucial fibril-
forming residues of amyloid β (Glu11 to Ala21) are in the
middle of the peptide (Serpell 2000). Recently, we have
shown that a four amino acid tract in the centre of the sequence
of SEVI, a peptide which potentiates HIV infection, is crucial
in promoting fibril formation (Elias et al. 2014). Finally, the
observation that addition of the C-terminal extension to the
αAc ‘mini-chaperone’ prevents its fibril formation (Raju et al.
2014) is also consistent with the ability of flexible, unstruc-
tured peptide flanking regions to prevent core regions from
fibril formation.
Oligomerisation of sHsps
The role of subunit oligomerisation, and the associated sub-
unit exchange, in sHsp chaperone action is an unresolved
matter of debate within the literature (Haslbeck et al. 2005).
There is evidence that chaperone action is enhanced under
conditions of faster subunit exchange, for example, at higher
temperature (Carver et al. 2002). However, the cross-linked
oligomeric form of α-crystallin is chaperone-active
(Augusteyn 2004), as is an immobilised form of the protein
(Garvey et al . 2011). One explanat ion for sHsp
oligomerisation is that it may protect against fibril formation,
for example, within the ACD, in addition to the protection
provided by the unstructured flanking regions. Other protein
oligomers associate for such a reason, as we have shown for
the unstructured milk casein proteins in which micelle
(oligomer) formation by the four unrelated caseins (either with
themselves individually, or with other caseins, or all of them to
form the casein micelle in milk) prevents amyloid fibril for-
mation by κ- and αs2-casein via mutual chaperone interaction
and also (principally within the casein micelle) by the chaper-
one action of theβ- andαs1-caseins (Holt et al. 2013; Holt and
Carver 2012; Thorn et al. 2015). Similarly, transthyretin fibril
formation requires initial dissociation from a tetrameric spe-
cies prior to a conformational change within the monomer
which leads to an aggregation-prone intermediate (Colon
and Kelly 1992). Furthermore, methionine oxidation of apo-
lipoprotein A1 reduces its oligomerisation and leads to en-
hanced amyloid fibril formation of the protein (Wong et al.
2010).
Relevance to crystallin proteins in the eye lens
The short, flexible C-terminal extensions in mammalian
sHsps impart heterogeneity and enhance solubility to the pro-
teins. Via their chaperone action in the eye lens, the α-
crystallin subunits also prevent aggregation and precipitation
of the β- and γ-crystallins and hence lens opacification. The
two α-crystallin subunits, αAc and αBc (in a 3:1 ratio in the
human lens), are the predominant lens proteins. The unrelated
β-crystallin subunits also have highly flexible and unstruc-
tured terminal extensions (at both termini in the basic β-
crystallins, but only at the N-terminus in the acidic β-
crystallins) and are oligomers (dimers to octamers). The γ-
crystallins are structurally related to the β-crystallins and form
similar two-domain, Greek key motif, highly β-sheet struc-
tures, but are monomers. The major γ-crystallin, γs, has a
short, flexible, four amino acid N-terminal extension
(Cooper et al. 1994). The other γ-crystallins do not have ter-
minal extensions. In support of the role of unstructured, highly
flexible terminal extensions in preventing aggregation of the
crystallins, truncation mutants of α- and β-crystallins without
terminal extensions (and parts thereof) are prone to aggrega-
tion and potential precipitation (Lampi et al. 2002; Treweek
et al. unpublished results). In the same vein, deletion of the C-
terminal region of αBc (i.e. removal of residues 151 to 175
inclusive) leads to insolubilisation of the protein and the for-
mation of inclusion bodies (Asomugha et al. 2011), although
the protein retains some chaperone activity despite losing
much of its secondary structure, and has a reduction in its
oligomeric status (Hayes et al. 2008).
Goto and co-workers have described the amorphous,
glassy state of supersaturated protein solutions and com-
pared it to the amyloid fibril state (Yoshimura et al. 2012).
Their conclusions have direct relevance to the arrangement
of crystallin proteins in the eye lens. The glassy protein
state is present in the lens; the very high concentration of
crystallin proteins (up to 400 mg/mL in the centre) is high-
ly stable and maintains solubility (and hence transparency)
for tens of years without forming crystals or amyloid fi-
brils. The amorphous, glassy state of crystallin protein ar-
rays or aggregates that are responsible for lens transparen-
cy arise because the proteins are Bhighly flexible and var-
ious intermolecular interactions are possible^ (Yoshimura
et al. 2012). Specifically, with respect to the lens, the flex-
ibility of the terminal regions in αAc and αBc, the β-
crystallins and the N-terminal extension in γs-crystallin,
along with extensive subunit exchange of αAc and αBc,
ensure that the lens crystallin protein mixture does not
crystallise or form amyloid fibrils, occurrences that would
be highly deleterious to lens transparency. It is the
crystallin mixture that behaves as such, because individual,
isolated β- and γ-crystallin subunits readily form well-
ordered crystals whose structures have been determined
by X-ray crystallography (Lapatto et al. 1991; Moreau
and King 2012; Norledge et al. 1996). Thus, from a simple
consideration of the highly dynamic nature of the crystallin
proteins and supersaturation of a concentrated protein
(crystallin) solution, the transparency of the lens can be
explained. Transparency occurs despite a very high lens
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crystallin concentration, a situation that normally favours
large-scale aggregation, for example, to form crystals or
amyloid fibrils.
Concluding comments
We have proposed that the largely unstructured N- and C-
terminal regions of mammalian sHsps have multi-faceted
roles: (i) they perform the initial interaction with target pro-
teins during chaperone action, (ii) they protect the structured
and sHsp-defining ACD from the possibility of misfolding
into potentially non-functional and toxic amyloid fibrils and
(iii) because of their dynamic, polar and unstructured nature,
they act as solubilising agents for sHsps under chaperone and
non-chaperone conditions. Experimentally, (iii) has been
shown, in general, to be correct, at least for the C-terminal
extension. However, there is plenty of scope and opportunity
to undertake experiments to test (i) and (ii) and thereby deter-
mine the veracity or not of these two hypotheses, and whether
they could be expanded to non-mammalian sHsps.
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Figure S1. ZipperDB analysis (Goldschmidt et al. 2010) of the amino acid sequences of the ten human sHsps. 
The N-terminal, ACD, and C-terminal regions are segmented by the black vertical dashed lines in that sequential 
order. The blue, green, yellow and orange lines are hexapeptide residues that are of increasing Rosetta energy 
respectively, while the red lines that cross the threshold of -23 kcal/mol (black horizontal line) are those residues 
associated with a hexapeptide that has a high propensity of forming fibrils. 
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 Supplementary Table 1. Comparison of the predicted fibril-forming or β-aggregation propensity of all ten human 
sHsps and two E. coli sHsps using three different prediction algorithms, i.e. ZipperDB (Goldschmidt et al. 2010), 
TANGO (Fernandez-Escamilla et al. 2004) and Zyggregator (Tartaglia et al. 2008). Percentages are given as the 
number of residues classified as having a 'high propensity' to form fibrils within a specific region over all the 
residues within that specific region of the protein, e.g. N-terminal, ACD or C-terminal regions. 
 
 
Name and 
Abbreviation 
Protein Details and 
Program Used 
N-terminal 
Region 
Alpha-
crystallin 
Domain 
C-terminal 
Region 
Heat shock protein 
beta-1 (HspB1)/ Heat 
shock 27 kDa protein 
(Hsp27) 
Amino Acid Range 1-85 86-168 169-205 
No. of residues 85 83 37 
ZipperDB (≤ -23) 2.35% 12.05% 8.11% 
TANGO (> 0) 0.00% 0.00% 0.00% 
Zyggregator (≥ 1) 5.88% 20.48% 2.70% 
Heat shock protein 
beta-2 (HspB2)/ 
MDPK-binding 
protein (MKBP) 
Amino Acid Range 1-64 65-147 148-182 
No. of residues 64 83 35 
ZipperDB (≤ -23) 1.56% 6.02% 11.43% 
TANGO (> 0) 12.50% 12.05% 20.00% 
Zyggregator (≥ 1) 4.69% 10.84% 0.00% 
Heat shock protein 
beta-3 (HspB3)/ Heat 
shock 17 kDa protein 
(Hsp17) 
Amino Acid Range 1-61 62-144 145-150 
No. of residues 61 83 6 
ZipperDB (≤ -23) 1.64% 20.48% 0.00% 
TANGO (> 0) 0.00% 42.17% 0.00% 
Zyggregator (≥ 1) 0.00% 21.69% 0.00% 
Heat shock protein 
beta-4 (HspB4)/ 
Alpha-crystallin A 
chain, αA-crystallin, 
(αAc) 
Amino Acid Range 1-61 62-144 145-173 
No. of residues 61 83 29 
ZipperDB (≤ -23) 8.20% 18.07% 0.00% 
TANGO (> 0) 9.84% 21.69% 0.00% 
Zyggregator (≥ 1) 21.31% 18.07% 10.34% 
Heat shock protein 
beta-5 (HspB5)/ 
Alpha-crystallin B 
chain, αB-crystallin, 
(αBc) 
Amino Acid Range 1-65 66-149 150-175 
No. of residues 65 84 26 
ZipperDB (≤ -23) 4.62% 20.24% 0.00% 
TANGO (> 0) 0.00% 22.62% 0.00% 
Zyggregator (≥ 1) 4.62% 16.67% 0.00% 
Heat shock protein 
beta-6 (HspB6)/ Heat 
shock 20 kDa protein 
(Hsp20) 
Amino Acid Range 1-64 65-147 148-160 
No. of residues 64 83 13 
ZipperDB (≤ -23) 1.56% 21.69% 0.00% 
TANGO (> 0) 0.00% 32.53% 0.00% 
Zyggregator (≥ 1) 0.00% 2.41% 0.00% 
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Heat shock protein 
beta-7 (HspB7)/ 
Cardiovascular heat 
shock protein (cvHsp) 
Amino Acid Range 1-72 73-151 152-170 
No. of residues 72 79 19 
ZipperDB (≤ -23) 23.61% 11.39% 5.26% 
TANGO (> 0) 13.89% 22.78% 0.00% 
Zyggregator (≥ 1) 6.94% 18.99% 5.26% 
Heat shock protein 
beta-8 (HspB8)/ Heat 
shock 22 kDa protein 
(Hsp22), (H11) 
Amino Acid Range 1-86 87-169 170-196 
No. of residues 86 83 27 
ZipperDB (≤ -23) 0.00% 13.25% 3.70% 
TANGO (> 0) 0.00% 21.69% 0.00% 
Zyggregator (≥ 1) 0.00% 12.05% 18.52% 
Heat shock protein 
beta-9 (HspB9)/ 
Cancer/testis antigen 
51 (CT51) 
Amino Acid Range 1-44 45-130 131-159 
No. of residues 44 86 29 
ZipperDB (≤ -23) 2.27% 12.79% 13.79% 
TANGO (> 0) 0.00% 13.95% 17.24% 
Zyggregator (≥ 1) 9.09% 15.12% 10.34% 
Heat shock protein 
beta-10 (HspB10)/ 
Outer dense fiber 
protein 1 (ODFP1) 
Amino Acid Range 1-115 116-200 201-250 
No. of residues 115 85 50 
ZipperDB (≤ -23) 7.83% 24.71% 0.00% 
TANGO (> 0) 6.09% 22.35% 0.00% 
Zyggregator (≥ 1) 33.91% 35.29% 4.00% 
Small heat shock 
protein IbpA (IbpA) 
(E. coli) 
Amino Acid Range 1-40 41-122 123-137 
No. of residues 40 82 15 
ZipperDB (≤ -23) 2.50% 14.63% 0.00% 
TANGO (> 0) 0.00% 40.24% 0.00% 
Zyggregator (≥ 1) 7.50% 8.54% 13.33% 
Small heat shock 
protein IbpB (IbpB) 
(E. coli) 
Amino Acid Range 1-39 40-121 122-142 
No. of residues 39 82 21 
ZipperDB (≤ -23) 7.69% 13.41% 0.00% 
TANGO (> 0) 25.64% 32.93% 0.00% 
Zyggregator (≥ 1) 10.26% 26.83% 0.00% 
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